70 YEARS OF THE
ANNUAL MEETING
25-27 June 2018 LIVERPOOL BT CONVENTION CENTRE
CONFERENCE PROGRAMME
#BAUS18 @BAUSurology www.baus.org.uk Social Programme The MuseumofUrology @BAUS 2018 Registration Information Registration Fees Wifi Programme General Information Introduction by theHonorary Secretary Welcome from thePresident Sponsors 3 Contents and Teaching Courses Female, Neurological &Urodynamic Urology Andrology &Genito-Urethral Surgery Academic Urology Incorporating MeetingsoftheSectionsof: BAUS ANNUAL MEETING Accompanying Persons Registration Exhibition-only Registration Cancellations Badge Scanning Diary Dates 2018/19 Venue Twitter Travel andParking Scientific Sessions Satellite Sessions Registration Desk Prayer Room Paper andePoster Sessions Media Check Local Information Exhibition Location andOpening Delegate Badges Continuing MedicalEducation Conference Catering Badge Scanning Abstract Book
10 16 13 11 4 11 11 11 11 8 7 9 9 9 9 9 9 9 9 8 8 8 8 8 8 8 8 8 8 8
Emergency Procedures Introduction Teaching Courses in Urology BAUS MeetingofCore Trainees ePoster Sessions Best Academic Paper Session BAUS Upcoming Events Exhibitor List Exhibition Plan Speaker Biographies Meeting Programme Section MeetingsMonday 25June Satellite Sessions 25-27 June 2018 - Liverpool BT Convention Centre Urodynamic Urology Female, Neurological & Andrology &Genito-Urethral Surgery Academic Urology Course Outlines Course List Wednesday 27 June Tuesday 26June Monday 25June BAUS ANNUAL MEETING 25-27 June2018 BT CONVENTION LIVERPOOL CENTRE 50 46 49 54 98 86 55 83 32 86 88 29 33 87 32 25 51 21 17 41 21 2
Contents Sponsors Hitachi MedicalSystems UKLtd Sponsors oftheOffice of Education Skills Course & Lanyard Sponsor Conference Bag Oncology Systems Limited App Sponsor 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 3 Sponsors Association. in February andwe are delighted they willbecome partofourvery special new (non-voting) membershipcategory was agreed by theBAUS Trustees to welcome our first medical student members to ourAnnual Meeting–this CTs) isconvening ameetingfor core trainees inurology andwe willalsohope afternoon. OnWednesday DominicHodgson (Education Lead for FYs and session between Andrology (AGUS) andFemale (FNUU)sectionsonMonday be holdingtheirannualmeetingsonMonday 25June. There willbeajoint The Academic Urology, Andrology (AGUS) andFemale (FNUU) Sectionswill relevant to allofusinourworking lives. us asession on‘AUR –Adverse Events, Urologists & Resistance’ whichwillbe to beavery thoughtprovoking lecture. Professor Kevin Turner then brings David Sellu whohasagreed to share hisexperiences withus–thispromises on theimpactofadverse events. This year’s BAUS Guest Lecturer isMr Last year we hadasession entitled‘When thingsgowrong’ whichfocused Goldman (Cleveland, Ohio, USA) andDrFrank van derAa(Leuven, Belgium). (Stellenbosch, SouthAfrica), DrAndrea Saloni(Milan,Italy),DrHoward Matt Neilsen(Chapel Hill,NorthCarolina, USA), DrAndre van derMerwe confirmed speakers includeProfessor BenChew (Vancouver, Canada), Dr travel to Liverpool andfor theircontributions to thescientificprogramme: week. We are grateful to allourinternational speakers for takingthetimeto led by DuncanSummerton aswell asparticipating insessions throughout the in the‘GlobalUrological Practice –SimilaritiesandDifferences’ session being will bereceiving Honorary MembershipofBAUS. They willbothbe speakers Partin, the2018 St Paul’s Medalwinner, andProfessor Sanjay Kulkarni, who definitely not to bemissed. We are alsodelighted to welcome Professor Alan Review advisingtheNational HealthService onitsdigitalstrategy –asession Technology in Englandwhichresulted inthepublication oftheWachter Wachter chaired theNational Advisory Group onHealthInformation California inSanFrancisco) willbegivingtheBJUIGuest Lecture. Professor Wachter (Professor andChairofthe DepartmentofMedicine, University of number ofkey opinion leadersjoiningusfor themeeting.Professor Robert In additionto state oftheartpaperswe are delighted, once again,to have a Getting itRightFirst Time (GIRFT) project for Urology inhisJCUaddress. continues thisthemeandSimonHarrisonwillbegivinganupdate onthe on thisimportantsubject.JamesGreen’s session onqualityimprovement innovations inthespecialtyandProfessor Tony Young isleadingasession support thedelivery ofcare, ourpatients have undoubtedly benefitted from front linecontinue to bechallengedby theresources available to usto Tuesday 26Junewhichwillmarkthismilestone. While thoseofusonthe It isthe70 being. cover bothclinicalissues aswell asonesthat supportourhealthandwell- programme aimsto berelevant to allofusinourworking lives –thesubjects last year was excellent and2018 seesusbuildonthissuccess. The meeting Scientific Meeting. The feedback we received aboutthenew format for BAUS On behalfofBAUS Council Iamdelighted to welcome you to the2018 Annual Welcome from thePresident th anniversary oftheNHSthisyear andwe have asession on 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 4
President’s Welcome President BAUS Kieran O’Flynn success inthismost prestigious role. Ilookforward to seeingyou at themeeting. Presidency to DuncanSummerton at themeetingandwould like to wishhimevery for my second, andfinal,meetingasBAUS President. Iwillbe handing over the ‘Scouse BAUS’ always proves to bepopular–andIamgladyou willbejoiningme the enormousamountofwork they have putinto planningthismeeting. (Events Manager)and HarryHeald(Events Co-ordinator) intheBAUS Office for to Maelstrom, ourExhibitionManagersand,most importantly, to HannahDoyle all thesubmitted abstracts, to MrSamHampsonfor proof reading theabstracts, together excellent sessions, to ourAbstract Reviewers for reading andmarking Committee and Section Executive Committees for theirhard work inputting relevant meetingprogramme. Ourthanksalsogoto membersoftheProgramme Secretary Elect)for leadingthedevelopment ofanexceptional andhighly I would like to thankPaul Jones(Honorary Secretary) andAsifMuneer(Honorary times into theprogramme to allow you to visittheexhibition hall. stands intheMedicalandTrade Exhibitionduringtheweek. We have scheduled the Education Committee. Ihopeyou willshow your appreciation by visitingtheir educational activities,includingmeetings runby theSectionsandcourses runby companies for continuing theirvery generous supportoftheAssociation’s Our thanksgoto ourcolleagues from thepharmaceutical andequipment colleagues. in theiconic Liver Building.This isagreat opportunityto catch upwithfriendsand The mainsocialevent ofthemeetingisadrinksreception heldonMonday 25June Urology over thepast year. promises to give afantastic overview ofrecent publications anddevelopments in from eachoftheSectionsandbreaking news. This isa‘must attend’ session and The meetingconcludes onWednesday afternoon withasession givingupdates Methodology andtheUrology FinishingSchool. Course onMRIandTarget Biopsy aswell asnew Teaching Courses onResearch we expect they willprove to bepopular. We willbeintroducing anew Skills plan to attend aTeaching orSkillsCourse - pleasebookearlyasplaces are limited; The programme ofcourses willrunagainthisyear and,asever, we adviseifyou 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 5
President’s Welcome THE BAUS 2018 ANNUAL MEETING
BJU International John Blandy Prize Presentation and Lecture
BJU International Prize for the Best Paper at BAUS 2018
BJU International Guest Lecture Achieving the Promise of Digital Health: Are We There Yet? If Not, When… and How? Robert Wachter
BJU International Teaching Course Quality Improvement led by James Green
Official journal of BAUS
The CPD portal for Urologists
www.bjui.org www.bjuiknowledge.org
LOOK OUT FOR MEET THE EDITOR EVENTS AT STAND 430 Honorary Secretary Paul Jones All suggestions for BAUS Glasgow 2019 willbewell-received. improved. weaknesses ofthemeetingand what you thinkcould beadded,removed or possible whichwillinform theprogramme committee onthestrength and I would urge you to provide asmuchfeedback onthemeetingas Industry whohave sogenerously supported themeeting. exhibition, Ihopethat you willtake thistimeto speakto ourcolleagues from We have scheduled timesinto theprogramme to allow you to visitthe include a15-minute ‘Best oftheprevious twelve months’overview. to undertake a10-minute synopsis onthebest ofLiverpool BAUS and meeting withadifferent format where thesection representatives are going This year’s Highlightssession onWednesday afternoon concludes the test oftheirknowledge Challenge where trainees take ontrainers inabroad andlight-humoured On alighter note DuncanSummerton willbechairingthisyear’s University of their guest lectures onArtificialIntelligence andGIRFT respectively. andaremanslaughter’ equallygrateful to theBJUIandJCUfor organisation BAUS guest lecture entitled‘Myjourney through gross negligence criminal We are privileged to invite MrDavid SelluFRCSto deliver thisyear’s agenda whichhasbeenorganised by DominicHodgson. widespread acclaim last year anditpromises aneven more engaging The Tuesday afternoon trainee and medicalstudent session enjoyed Emotional resilience andthehistory ofourNHS. Improvement, MDTs functionality, aMedico-legal debate onConsent, This year’s mainauditorium programme includesNHSInnovations, Quality aspects ofgeneral urology that isof specialinterest to UK urology. endeavoured to organise a programme with wideappealthat encompasses The ‘Best ofBritish’theme was similarlywell-received andwe have kept to this preferred format for 2018. over 600respondents) to retain the shorter meeting duration, andwe have Last year’s trialmeetingof3days gained 80% positive affirmation (with matter, delivered by experts intheirfields. the NHSandourprogramme ispacked with fresh anddiverse subject This year’s annual meeting celebrates the70th Year anniversary of Introduction by theHonorary Secretary 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 7
Honorary Secretary’s Introduction CME point. The Satellite Sessions are eachaccredited with1 Wednesday 27 June Tuesday 26June Monday 25 June as follows: This meetinghasbeenaccredited withCMEpoints Continuing MedicalEducation Exhibition, Hall2. Lunch willbeavailable for purchase withinthe Exhibition Hallfrom Monday to Wednesday. Complimentary drinkswillbe provided inthe Conference Catering Please note that there isacharge of£1peritem. Wednesday 27 June Tuesday 26June Monday 25June will beopenat thefollowing times: The Cloakroom islocated ontheground level and Cloakroom then donotallow your badgeto bescanned. to disclosethisinformation to Satellite Sponsors sponsors isnotcompulsory. Ifyou DONOT wish again, Badgescanningby Satellite Session Satellite Session andgettingyour badgescanned, You willreceive 1CMEpointfor attending a scanned. to exhibitors thendonotallow your badgeto be If you DONOT wishto disclosethisinformation Badge scanningby exhibitors isnotcompulsory. (as you specifyonyour onlineregistration form) - Work Emailaddress (as you specifyonyour onlineregistration form) - Name, JobTitle, Place ofWork information: barcodes inorder to download thefollowing Sponsors are ableto scandelegate badge as leadretrieval. Exhibitors andSatellite Session This year we willagainbeusingbadgescanning Badge Scanning Conference Edition oftheJCU. Abstracts willbeavailable onlineinthe Abstract Book General Information 6points 6points 6points 0715 -1630 0715 -1945 0730 -1830 further details. observance, pleaseasktheregistration team for throughout theconference for private religious Backstage Room 1willbe available to delegates Prayer Room available on themeetingapp. Full detailsofthepresenters andePosters willbe Paper andePoster Sessions [email protected]. directed to theEvents Team at BAUS on: Any queriespriorto themeetingshouldbe meeting. will besentto allspeakers well inadvance ofthe Exhibition intheHall2Foyer. FullAV information Media CheckInwillbelocated outsite the Media Check Email: [email protected] liverpool/ www.accliverpool.com/visiting-us/destination- For information onvisitingLiverpool, pleasevisit: Local Information companies whodo nothave anexhibition stand. is NOT available to personnelfrom commercial Please note: entryto theconference orexhibition Wednesday 27 June0800-1415 Tuesday 26June0800-1800 Monday 25June0800-1800 the following times: The exhibition islocated inHall2willbeopenat Exhibition -Location andOpeningHours Registration Desk. and socialevents. Badgeswillbeissued from the times to beadmitted to theconference centre the official BAUS 2018 delegate badges atall accompanying personsandexhibitors must wear For securitypurposes,alldelegates, Delegate Badges 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 8
General Information withdrawal of speakers from the programme, for any reason. cannot beheldresponsible for changesdue to circumstances beyond theircontrol, includingthe All Conference content, speakers andtimingsare correct at timeof publication. The Organisers Tel: +44(0)151475 8888 L3 4FP Liverpool Liverpool Waterfront Kings Dock The BT Convention Centre Venue guidance inrespect to socialmedia. Delegates are reminded oftheGMCandBMA #BAUS18 @BAUSurology BAUS 2018 isonTwitter: Twitter travelling-here visit: http://www.accliverpool.com/visiting-us/ For travel andparking information, please Travel andParking exhibition stand. commercial companies whodonothave an exhibition isNOT available to personnelfrom registration andentryto theconference or delegates. Pleasenote that delegate Scientific sessions are onlyopen to registered Scientific Session Access Satellite Sessions willbeheldinHall1A Satellite Sessions Wednesday 27 June0730 -1415 Tuesday 26June0730 -1800 Monday 25June0800-1800 will beopenat thefollowing times: desk willbesituated insidetheExhibition,Hall2.It collected from theBAUS Registration Desk.The All relevant conference documentation shouldbe Registration Desk Final Programme PDFto atablet. instead usethemeetingapporsave acopy ofthe programme at BAUS 2018. Delegates should For thefirst time we willnothave aprinted Programme SEC, Glasgow 24-26 June2019 2019 BAUS AnnualMeeting Leicester BAUS Core Urology Course, College Court, 7-10 January2019 University ofYork BAUS SectionofOncology AnnualMeeting, 6-7 December 2018 College, Oxford BAUS FRCS(Urol) Revision Course, St Catherine’s 17-21 September 2018 Keble College, Oxford BAUS SectionofEndourology AnnualMeeting, 6-7 September 2018 Diary Dates 6. 5. 4. 3. Browse to aweb site ofyour choice 2. 1. Convention Centre Free WiFi isavailable throughout The BT WiFi 25-27 June 2018 - Liverpool BT Convention Centre The pageofyour choice willthenload Click onthe‘FREEWI-FIACCESS’ button Landing Page You willbere-directed to theACC Liverpool eg. www.accliverpool.com network) Connect to theFree_Wifi SSID (wireless Enable thewireless functiononyour device BAUS ANNUAL MEETING 9
General Information Registration Fees Non-Members BAUS Members Urology Trainee categories below) (not appearingin Urologist /Other Specialist Associate Urological Associate / Full, Overseas,
Radiographers. etc.) Administrators, (Nurses, Professional Health Care Medical Students Trainee Honorary &Senior Doctorate Fellows) PhD Student/Post- Scientist (registered conference areas) no access to professionals, (Healthcare Exhibition Only
Early Rate -Upuntil31May Wednesday Wednesday Tuesday / Tuesday / Monday / Monday / (per day) (per day) No Fee n/a 185 135 135 215 40 50 70
Meeting Meeting No Fee Whole Whole 520 370 370 610 n/a 175 90 15
Standard Rate -From 1June- 25-27 June 2018 - Liverpool BT Convention Centre Wednesday Wednesday Tuesday / Tuesday / Monday / Monday / (per day) (per day) 10:00 BST on22June No Fee 255 255 255 235 235 n/a 70
BAUS ANNUAL MEETING Meeting Meeting No Fee Whole Whole 670 670 730 730 730 170 n/a 30
From 10:00BST Onsite Rate - Wednesday Wednesday on 22June (perday) Tuesday / Tuesday / Monday / Monday / (per day) No Fee 255 255 275 275 275 90 30 10
Registration Fees do nothave anexhibition stand. Entry to theconference orexhibition isNOT available to personnelfrom commercial companies who please seethesocialprogramme for detailsofthecoffee morningon Tuesday 26June. advance ontheonline registration form. There isnoformal Accompanying Persons Programme but are invited to attend theLiver BuildingonMonday 25June. Places for events shouldbebooked in There isnoregistration fee for partnersofdelegates butbadgeswillbeissued. Accompanying persons Registration Accompanying Persons Exhibition-only registration willnotbeavailable on-site. 2018. to conference sessions). Exhibition-onlyregistrations willonlybeaccepted until23:59 (BST) on31May For asmalldailyfee, healthcare professionals canregister to view theexhibition only (noadmittance Exhibition-Only Registration writing andwillbesubjectto a10%administration charge. refunded onany cancellations after 31May 2018. Cancellations before thisdate must beconfirmed in Fees for boththe conference andtheOffice of Education teachingandskills coursescannot be Cancellations information to Satellite Sponsorsthendonotallow your badgeto bescanned. Badge scanningby Satellite Session sponsorsisnotcompulsory. Ifyou DONOT wishto disclosethis You willreceive 1CMEpointfor attending aSatellite Session andgettingyour badgescanned,again, exhibitors thendonotallow your badgeto bescanned. Badge scanningby exhibitors isnotcompulsory. Ifyou DONOT wishto disclose thisinformation to (as you specifyonyour onlineregistration form) Work Emailaddress (as you specifyonyour onlineregistration form) Name, JobTitle, Place ofWork Sponsors are ableto scandelegate badgebarcodes inorder to download thefollowing information: This year we willagainbeusingbadgescanningasleadretrieval. Exhibitors andSatellite Session Badge Scanning Registration Information 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 11
Registration Information
extent basedonEighteenth andNineteenth Century models. change in1948themedical service which was still to some and theurology departments inGreat Britain saw ahuge a History ofUrology lecture to celebrate this.The urologists Service (figure 4)andfor thefirst time at BAUS there willbe 2018 isalsothe70th anniversary oftheNational Health (figure 3). gleaned from research carriedoutover thepast four years are revisiting that themebutwithnew, updated information urologists whowere caughtupinthat conflict. This year we 2014 theMuseumofUrology looked at somewell known it consumed theearlyyears oftheTwentieth Century. In World War, calledtheGreat War ortheWar to EndallWars than Place, 2018 seesthecentenary oftheendFirst This year theMuseumofUrology isfocussing more onTime well assomethemedexhibits. that have beendonated orloanedto theMuseum thisyear as of urology. The cabinetswillshow someofthelatest artefacts relax andhave your coffee whilst learningaboutthehistory stand intheExhibitionHall.Always agreat place to meet, As always theMuseumofUrology welcomes you to their It’s agreat story; I’d encourage you to read it. that Gow’s place inthisstory hasbeensomewhat overlooked. change’ inurology. InwritingthisarticleI’ve come to realise him to Hopkinsandto apartnershipthat endedinatrue‘sea- photography anddesire to take cystoscopic photographs led Sefton General and Wrightington Hospitals.Gow’s interest in Liverpool urologist, borninthe cityandwhoworked at both those meetingswas withJimGow (1917–2001) (figure 2)a up theworld of modern endourology (figure. Oneof 1) who by aseriesofcoincidences andchance meetingsopened amazing story of Harold Hopkins(1918–1994),thescientist article inyour abstract book.This year we are lookingat the Urology have graciously allowed meto includeahistorical Once againtheEditor andteam at theJournalofClinical today. of urology andshow you how we allgotto where we are of Urology willbethere to snatch you from themodernworld once again,acitysteeped inurological history. The Museum BAUS 2018 isbackonthebanksof Mersey inLiverpool Curator oftheMuseumUrology Jonathan Goddard @ BAUS 2018 The MuseumofUrology 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING Figure 1:Harold Hopkins Figure 2:JamesGow 13
BAUS History The Museum ofUrology @BAUS 2018 -continued The MuseumofUrology, BAUS. Curator, Jonathan Goddard Enjoy themeeting! @urology_history www.baus.org.uk/museum website andyou canfollow usonTwitter. Remember theMuseumofUrology ishosted ontheBAUS will beavailable to view throughout themeeting. work there andalotoffascinating thingsto learn.The e-Posters year sopleasemake sure you view theposters; there’s alotof historical research to BAUS. The session isnotmoderated this of topics. It’s great to seesomany urology trainees submitting The History Posters thisyear againpresent anastonishing array own cystoscope. Cystoscope’. When you visitthedisplay you willseeSirEric’s 3] andwas later instrumental increating a‘BritishUniversal endourology, Richeswas adecorated hero of theWar [figure with theothermuseumthemesofFirst World War and like mindstook place whichledto BAUS beingcreated. Linking BAUS andindeeditwas inhishousethat thefirst meetingof a well known urologist inthelast century. Hewas very active in focussing ononemaninparticular, SirEricRiches.was objects willbeondisplay at BAUS 2018. This year we willbe very happy) to donate information andartefacts. Many ofthese well known Britishurologists whohave beenvery generous (and acquisitions. We have beenincontact withseveral families of expanding therooms onthewebsite andalsoofdonations and This last year hasbeenvery active for theMuseuminterms of seem nodifferent to today. also haditsproblems, many ofwhich,especially around money, their urology departmentsinthefollowing years. Centralisation that occurred spurred many hospitalsto create ormodernise BAUS was bornoutoftheplansfor theNHSandchanges 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING Eric RichesinWW1 uniform Figure 4:1948NHSleaflet Figure 3:
14
BAUS History
of theCity. A bluebadgetour guidewillbeinattendance to recommend attractions andplanatour her for acoffee morninginthe Connectivity Pullman HotelLounge ofthe at 1030. Muireann O’Flynn,thewife oftheBAUS President MrKieran O’Flynn,invites you to meet Tuesday 26June, 1030 Accompanying Persons –The Hotel Pullman Citation by: MrKen Anson,St George’s Hospital,London Presented to: Professor SamMcClinton, Aberdeen Royal Infirmary urology asacorporate entity. individual orindividualswhohave contributed to thedevelopment andadvancement of The BAUS GoldMedalwas instituted by BAUS Council in2008andisawarded to an The BAUS GoldMedalwillbeawarded at theDrinksReception: availability. Exhibitor tickets cost £25plusVAT. PleaseseetheBAUS Registration deskfor ticket Delegate tickets cost £20andcanbepurchased ontheonlineregistration system. The dress code issmart/casual. Entryto thereception willbeby delegate badge. Building. by Council Members.This year’s socialevent willbeaDrinksReception at The Liver Time to gettogether witholdfriendsandcolleagues to enjoy aglass ofwine. Hosted Monday 25June, 1830 Welcome Reception –The Liver Building Social Programme 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 16
Social Programme Speaker: Each Satellite Session willtake place inHall1Aandhasbeenaccredited with1CMEpoint. Satellite Sessions Boston Scientific Monday 25June1200-1230 products willbediscussed. This promotional symposium hasbeenfullyfundedandorganised by Astellas PharmaLtd andAstellas BET18005UKa(1) |March 2018 In theend,onlyyou can decide. Join ourpanelaswe debate theprinciples oftreatment choice inOAB. Does onesize fitallin OAB, orissuccess dependentonamore individualisedapproach? Is cycling through antimuscarinicsreally aneffective treatment approach? in OAB? Are we rightto maintainourheavy reliance onantimuscarinicsasafirst-line treatment benefitting from increased treatment choice’ alternative treatment class, patients withOAB are still not ‘This housebelieves that five years after thelaunchofan Astellas satellite symposium Monday 25June1700–1800 ƐƚĞůůĂƐƐĂƚĞůůŝƚĞƐLJŵƉŽƐŝƵŵ DŽŶĚĂLJϮ ƉĂƚŚǁĂLJĨŽƌƉĂƚŝĞŶƚƐ ǁŽƵůĚŵŽƐƚ :ŽŝŶŽƵƌĞƐƚĞĞŵĞĚĨĂĐƵůƚLJĂƐƚŚĞLJŵĂŬĞĂĐĂƐĞĨŽƌƚŚĞƚƌĞĂƚŵĞŶƚƉĂƚŚǁĂLJƚŚĞLJďĞůŝĞǀĞ ǁŝůůďĞĚŝƐĐƵƐƐĞĚ͘ dŚŝƐƉƌŽŵŽƚŝŽŶĂů dϭϴϬϬϱh<;ϭͿŐ /ŶƚŚĞĞŶĚ͕ŽŶůLJLJŽƵĐĂŶ hƌŽůŽŐŝƐƚ͕ĂŵďƌŝĚŐĞ DƌEŝŬĞƐŚdŚŝƌƵĐŚĞůǀĂŵ ^W < Z DĂŬŝŶŐĂĐĂƐĞĨŽƌ͗ ŽĞƐƌĞĂů ĐůĂƐƐ dŚŝƐŚŽƵƐĞďĞůŝĞǀĞƐƚŚĂƚĨŝǀĞLJĞĂƌƐ Presented by theMovember Foundation Life after Prostate Cancer: ACharity’s Perspective ƚƌŝĞĚĂŶĚƚĞƐƚĞĚ ͕ ƉĂƚŝĞŶƚƐǁŝƚŚKĂƌĞƐƚŝůůŶŽƚďĞŶĞĨŝƚƚŝŶŐĨƌŽŵŝŶĐƌĞĂƐĞĚƚƌĞĂƚŵĞŶƚĐŚŽŝĐĞ Ͳ Paul Villanti, Executive Director, Programmes ǁŽƌůĚĚĂƚĂƉŽŝŶƚƚŚĞǁĂLJƚŽĂĚŝĨĨĞƌĞŶƚƉĂƚŚǁĂLJĂŶĚŝŵƉƌŽǀĞĚƉĂƚŝĞŶƚŽƵƚĐŽŵĞƐ͍ ϱ :ƵŶĞϭϳ ůŝŬĞůLJďĞŶĞĨŝƚƉĂƚŝĞŶƚƐǁŝƚŚŽǀĞƌĂĐƚŝǀĞďůĂĚĚĞƌ͘ ͮ ƐLJŵƉŽƐŝƵŵ DĂ ϬϬ ĂŶƚŝŵƵƐĐĂƌŝŶŝĐ LJ – ϮϬϭϴ ϭϴ ĚĞĐŝĚĞ ϬϬ ŚĂƐďĞĞŶĨƵůůLJĨƵŶĚĞĚĂŶĚŽƌŐĂŶŝƐĞĚďLJƐƚĞůůĂƐWŚĂƌŵĂ>ƚĚĂŶĚ ͘ ͲůĞĚ ĂĨƚĞƌƚŚĞ KƚƌĞĂƚŵĞŶƚĐŚŽŝĐĞ Ŷ DĂŬŝŶŐĂĐĂƐĞĨŽƌ͗ hƌŽůŽŐŝƐƚ͕ZĞĂĚŝŶŐ Dƌ^ƚĞǀĞ&ŽůĞLJ ^W < Z 25-27 June 2018 - Liverpool BT Convention Centre ŝŶĚŝǀŝĚƵĂůŝƐĞĚĂƉƉƌŽĂĐŚƚŽ ůĂƵŶĐŚŽĨĂŶĂůƚĞƌŶĂƚŝǀĞƚƌĞĂƚŵĞŶƚ ƚƌĞĂƚŵĞŶƚƉĂƚŚǁĂLJ DĂŬŝŶŐĂĐĂƐĞĨŽƌ͗ ͲĨŽĐƵƐĞĚ ĨůĞdžŝďůĞ͕ƉĂƚŝĞŶƚ BAUS ANNUAL MEETING ƐƚĞůůĂƐƉƌŽĚƵĐƚƐ 17
Satellite Sessions
Olympus Tuesday 26June1245-1330 Prostate Cancer UK Tuesday 26June0800-0830 1315-1330 1305-1315 1250-1305 1245-1250 PLASMA BPH–AsaDay Case? and views ofmen Active Surveillance -What we canlearnfrom theexperiences Registered company 02653887. Prostate Cancer UKisaregistered charityinEnglandandWales (1005541) andinScotland (SC039332). option for menwithlow-risk, localisedprostate cancer. clinician /patient discussions whenitcomes to considering active surveillance asatreatment informed andsupported duringthiscriticaltime. This session willexplore theimportance of with prostate cancer, whoare thinkingaboutactive surveillance asatreatment option, are well- will alsobeusedto inform Prostate Cancer UK’s Education andHealthInformation sothat men on thebest practice approach to active surveillance intheUK.The importantpiece ofresearch research ishelpingto inform awiderpiece ofwork we’re doingto achieve aclinicalconsensus also conducted asurvey alongsidethiswork that captured theviews ofaround 400men.The with researcher LizHetherington to carryoutapiece ofqualitative research withmen.We best outcomes for thesemen,andshouldtherefore berecommended to clinicians.We worked were onactive surveillance. This was withtheaimoffindingoutwhichapproaches result inthe the experiences andviews ofmenwithlocalisedprostate cancer whohadbeenoffered and low-risk localisedprostate cancer. Prostate Cancer UKset outlast year to better understand Active surveillance isshown to beavery importanttreatment option,especiallyfor menwith University NHS HealthBoard, Swansea &Swansea University SchoolofMedicine. Mr Jay Khastgir, Consultant Urologist &SeniorLecturer, Abertawe Bro, Morgannwg PLASMA Enucleation: ANew GoldStandard for BPHTreatment North Bristol NHSTrust. Miss HelenaBurden, Consultant Urologist, SuperficialBladderCancer Co-lead, What Pathway Changesare Neededto Achieve Day Case? Western Sussex HospitalsNHSFoundation Trust Mr SimonWoodhams, Consultant Urologist, ClinicalDirector Cancer Services, What istheValue ofPLASMA for BPHasaDay Case? Western Sussex HospitalsNHSFoundation Trust Mr SimonWoodhams, Consultant Urologist, ClinicalDirector Cancer Services, Welcome andIntroduction 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 18
Satellite Sessions
Bayer products may bediscussed at thismeeting.Prescribing information willbeavailable at thismeeting. All 1750-1800 All 1740-1750 Foundation Trust 1730-1740 1720-1730 1715-1720 Bayer Tuesday 26June1715-1800 Prostate Cancer The Window ofOpportunity:Treatment ofMetastatic Castration-Resistant Q&A Session Panel Debate Multidisciplinary ManagementofmCRPCTreatment Treatment ofmCRPC:ahistorical perspective Introduction Chair’s Nuclear MedicinePhysician, Guy’s andSt Thomas’ HospitalNHS University ofGlasgow &Professor Valerie Lewington, Consultant Professor Rob Jones,Honorary Consultant inMedicalOncology, for Urology, Royal Liverpool andBroadgreen University HospitalNHSTrust Phil Cornford, Consultant Urological Surgeon andClinicalDirector for Urology, Royal Liverpool andBroadgreen University HospitalNHSTrust Phil Cornford, Consultant Urological Surgeon andClinicalDirector 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 19
Satellite Sessions
Astellas Oncology Wednesday 27 June1000-1030 interactive casestudies Practical aspectsofmanagingpatients withprostate cancer: Job code: XTD18003UKa Date ofpreparation: May 2018 This symposium isfundedandorganised by Astellas PharmaLtd. Astellas products willbediscussed at thissymposium. with managementorsurgical optionspositionedasinteractive questions to theaudience. castration-resistant prostate cancer (mCRPC).Focus willbeplaced ondelegate participation parametric MagneticResonance Imaging(mpMRI)pre-biopsy andchallengesinmetastatic Objective: This symposium willutilisepatient casestudies inorder to discuss theuseofmulti- Speakers: Chair: 10.30 10.00 Time Session Meeting Close Meeting summary • prostate cancer (mCRPC) Case Study 2:Challengesinmetastatic castration-resistant • Magnetic Resonance Imaging(mpMRI)pre-biopsy Case Study 1:Useofmulti-parametric • • Welcome &Introduction Presentation, discussion andaudience questions Presentation, discussion andaudience questions Welcome to thefaculty Overview oftheagendaandobjectives Chair University ofSouthampton Faculty ofMedicine Dr SimonCrabb, Associate Professor inMedicalOncology, St Thomas’ Hospitals Mr BenChallacombe, Consultant Urological Surgeon, Guy’s and Mr MarkSpeakman,Consultant Urological Surgeon, Taunton 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING Mark Speakman Simon Crabb Ben Challacombe Mark Speakman, Speakers 20
Satellite Sessions future ofdata andauditto drive improvements inpatient care. relevant andengagingsessions withexcellent speakers andachance for you to helpshapethe consultant andIwould really encourage colleagues to joinusfor theday. Iamanticipating highly So theAcademic SectionMeetingat BAUS 2018 isfor everyone -clinicalorscientific,trainee or collaborative ideaandwillbeappraised by apanelofexperts. Den where trainees orconsultants willpitch theirideasfor thenext bignational research collaborative willbegiven, withupdates ontheIDENTIFYproject. We willendwithaDragon’s Kasivisvanathan. Anoverview oftheactivities oftheworld-leading trainee-led BURST research session, where opportunitiesfor multi-centre collaborative work willbediscussed by MrVeeru ever increasing growth ofthetrainee research collaborative. We endtheday withtheBURST We endtheday withtheBURST session, where ouryounger colleagues willupdate usonthe for UKurology. so Iwould really encourage you to joinusandhelpinform thediscussion onthisimportanttopic practice andclinical care ofpatients intheirdailypractice. Voting willbeavailable to theaudience their views onwhat data andauditactivitythey thinkiskey to improving theirprofessional In theafternoon, representatives from allSectionsandalsothegenerality ofBAUS, willoutline securely linkthemto produce thehigh-qualitycancer intelligence needed to improve outcomes. CORECT-R willbringtogether allofthedatasets that are relevant to colorectal cancer and Cancer Research UKprogramme that isestablishing aUKwidecolorectal cancer data repository. Leeds Institute ofCancer andPathology. Professor Morriswilldescribeherwork leadinga£3.4m We are thendelighted to welcome Professor Eva Morris,Professor ofCancer Epidemiologyat the across BAUS. of BAUS, willsetthescene anddiscuss theon-going work to review data andauditactivities discussion ontherole ofdata andauditinimproving urological care. MrKieran O’Flynn,President to bringtogether alloftheSectionsandbroad membershipofBAUS to have aninteractive The late morningandafternoon session willfollow anew format for BAUS 2018 andisintended student essay andCTauditprizes. Mr IanPearce, Editor oftheJCU, willthenbeannouncingthewinnersofcompetitive medical International anditsEditor, Prokar Dasgupta,for supportingthisfirst session. sure willonce againgive credit to Professor Blandy’s memory. We are very grateful to theBJU This isfollowed by alecture from therecipient ofthisyear’s JohnBlandyPrize, whichIam by theAbstract Committee, to anaudience ofcriticalfriends. select group ofyoung researchers theopportunityto present theirwork, whichhasbeenchosen For BAUS 2018, we are continuing thevery popular‘Best Academic Paper Session’ andgivinga meeting inLiverpool. I amvery pleased,onbehalfoftheSection’s Executive Committee, to welcome you to thisyear’s Mr JohnMcGrath, Chairman,BAUS SectionofAcademic Urology Introduction Room 3B 0855-1700 BAUS SectionofAcademic Urology Annual Meeting Monday 25June 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 21
Section of Academic Urology 0855-0900 Room 3B MrSachaMoore, University ofSouthampton 1045-1200 Room 3B 1030-1045 1025-1030 Room 3B 1000-1025 Room 3B 0900-1000 Room 3B
Mr Mikolaj Kowal, University ofManchester (notattending) Chair’s WelcomeChair’s andIntroduction della Scienza,University ofTurin, Italy Dr Francesca Pisano , MD, PhDStudent, Dept.ofUrology, A.O CittàdellaSalute e The role ofre-transurethral resection inthemanagement ofhighriskNMIBC International Introduced andpresented by: Professor Prokar Dasgupta,Editor-in-Chief, BJU John BlandyPrize and Lecture See page54for details Chairs: Trinity Bivalaqua &JohnMcGrath Prize for theBest Paper at BAUS 2018 Best Academic Paper Session –BJUInternational Mr JohnMcGrath, Royal Devon &Exeter NHSTrust 1050-1115 1045-1050 Chair: Professor Howard Kynaston, Cardiff University What doesData Purpose Collection Serve? Announcement ofWinner ofBest Paper session Bristol Mr Ricky Ellis,NottinghamCityHospital& Mr George SouthmeadHospital, Hill, BAUS Audit / QuipCompetition Winners Medical Student Best Essay Winner Presented by: MrToby Page, Freeman Hospital,Newcastle-upon-Tyne Medical Student Best Essay andAudit Prizes Refreshments, Exhibition andePoster viewing inHall2 BAUS Data andAudit – allchange? Introduction Mr Kieran O’Flynn,President ofBAUS Mr Professor Howard Kynaston, Cardiff University 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 22
Section of Academic Urology 1530-1700 Room 3B 1200-1230 Hall 1A 1330-1530 Room 3B 1200-1330 1455-1530 1440-1455 1425-1440 1410-1425 1355-1410 1340-1355 1115-1145 1330-1340 London Chairs: Tharani Nitkunan, EpsomandRashmiSinghKingston andSouth West what shouldBAUS’s focus be? Targeted Data for Research, Audit orRegistries - Debate: See page17for details Satellite Session –Boston Scientific 1145-1200 1530-1540 & MrTaimur Shah, ImperialHealthNHSTrust Chairs: MrVeeru Kasivisvanathan , University College Hospital,London Progress Projects, Opportunities for Trainees andUpdates on Dragon’s Denfor new Multi-Centre Collaborative BURST session:
Lunch Break, ExhibitionandePoster Viewing Discussion Mr HenryLazarowicz, Broadgreen Hospital,Liverpool Representing theGenerality ofUrology Mr Rowland Rees, University HospitalSouthampton Representing theSectionofAndrology Mr Jonathan Glass, Addenbrooke’s Hospital,London Representing theSectionofEndourology Mr Nikesh Thiruchelvam, Addenbrooke’s Hospital,Cambridge & Urodynamic Urology Representing theSectionofFemale, Neurological Mr KrishnaNarahari, University HospitalofWales, Cardiff Representing theSectionofOncology Mr JohnMcGrath, Royal Devon &Exeter NHSTrust Introduction Discussion, Questions andAnswers lessons from colorectal cancer Registry Data to Drive Research andImproved Care – and Opportunitiesfor Trainees Overview ofBURST Research Collaborative Leeds Institute ofCancer andPathology Professor Eva Morris,Professor ofCancer Epidemiology, Mr Veeru Kasivisvanathan, University College Hospital,London 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 23
Section of Academic Urology 1700-1800 Hall 1A 1550-1600 1540-1550 See page17for details Astellas Satellite Session Panel: 1610-1700 1600-1610
Multi-Centre Collaborative Projects Dragon’s Den:Presentations for new National Throughout theYear Updates from BURST Committee onProgress The Future ofIDENTIFY Update onIDENTIFY Mr SinanKhadhouri,Royal Devon &Exeter Hospital Simon Morton, JosephNorris,Nikita Bhatt Presenters: Taimur Shah,Veeru Kasivisvanathan, Kevin Gallagher Professor Graeme MacLennan, MrJonAning,JohnMcGrath, BURST Committee Members Mr Kevin Gallagher, Western General Hospital,Edinburgh 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 24
Section of Academic Urology causing complex deformities, penileshortening andcomplete ED. So, for our3 One ofthemost challengingproblems inandrological surgery isadvanced Peyronie’s disease- but alsohow to counsel, avoid andsalvage problems relating to circumcision intheobese. there isnodoubtthat central obesityisariskfactor for apooroutcome. Iwillconsider causation, As andrologists, we are asked to seemenwhosecircumcision hasnotmetwithexpectations, and what isbest practise inthissituation. have difficulty conceiving. MajidShabbir, whospanslarge fertilityandoncology centres willoutline diagnosis andtreatment ofurological cancer, storing upyet anotherblow to survivors whomay then managed ineveryday practise. Malefertility considerations canoften beoverlooked duringthe The next session -‘Andrological Challenges’focuses onthree areas that are notalways optimally eminently qualified to update us. speakers are fullyimmersedinboththeclinicalandacademicaspectsoftheirsubjectsare and advances inthefieldsofErectile dysfunction, Peyronie’s diseaseandmaleinfertility. Allthree We willstart with Monday morningwithourpopular‘Updates’ session –highlighting recent changes and Ihopeyou canjoinusfor anupdate. in Andrology andgenito-urethral surgery. This dynamic fieldisgoingthrough significantchanges, common feature ofevery Urologist’s practise, andouraimisto update allofyou inwhat isgoingon annual sectionmeetingat thisyear’s BAUS meetinginLiverpool. Malegenitalconditions are a On behalfofthesection’s executive committee, itgives mehugepleasure to invite you allto our Mr Rowland Rees, Chairman,BAUS SectionofAndrology andGenito-Urethral Surgery Introduction Urology Joint Session: Andrology &Genito-Urethral Surgery andFemale, Neurological &Urodynamic 1500-1700 Hall 1A 0900-1445 Surgery Annual Meeting BAUS SectionofAndrology andGenito-Urethral Monday 25June decision-making andoutcomes whentreating incontinence after radiotherapy. teach urethroplasty inIndia.This will befollowed by Tamsin Greenwell, whowillhelpusunderstand issue inBritishurology, andSanjay Kulkarni willreturn to the stage to tell ushow hemanagesto to thankthesection’s chair, ChrisHarding, for helpinputtingthat together. Training isatopical We willthenjointheFNUUsectionfor ajointsession onreconstructive urology, andIwould like the managementandoutcome oftherisingepidemicuro-rectal fistulae. his vast experience ofrepairing posterior urethral injuriesinIndia,followed by Professor Mundyon we have two ofthegreats ofUrethral surgery intheworld –Sanjay Kulkarni from willtell Pune usof exciting developments in thefieldof stem cell research inurethral stricture disease. Following that After lunchwe move over to Urethral surgery -andwe start withDanielaAndrich outliningthe will enjoy it. of therelated socialand ongoingmedicalchallengesisbothmoving andinspiring,Iamsure you Africa, who hassuccessfully ledapeniletransplant programme at Stellenbosch University. Histale To conclude ourmorning,we are privileged to welcome Professor André van derMerwe from South interventions to salvage suchsituations. Ralph withshare hiswealth of experience andopinionontherole ofgrafts, implantsandother 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING rd challenge, David 25
Section of Andrology and Genito-Urethral Surgery To complete a packed and exciting day, Amar Alhasso and Mark Lucky will remind us on how to manage the urinary and sexual complications in cauda equina syndrome and the neurologically compromised. I’m sure that many will find this update on neuro-urology useful. Finally – I should add that the AGUS section will also be running a session on Tuesday afternoon of the main meeting, with some distinguished speakers covering the latest evidence on how treating sexual dysfunction can benefit general health. There is also our poster session on Wednesday, and of course our regular courses. I do hope that all of above and your trip to Liverpool will leave you appropriately updated, give you a chance to catch up with colleagues, and most of all to enjoy yourselves.
Hall 1A 0900-0920 Chair’s Welcome Mr Rowland Rees, University Hospital Southampton
Hall 1A 0920–1020 Andrology Updates Chairs: Mr Gareth Brown, Royal Glamorgan Hospital, Wales and Mr Richard Pearcy, Derriford Hospital, Plymouth
0920–0940 Non-invasive Treatment Options for Peyronie’s Disease Mr CJ Shukla, Western General Hospital, Edinburgh 0940–1000 Investigation and Treatment of the Infertile Male – Role of the Urologist Mr Kevin McEleny, Freeman Hospital, Newcastle-upon-Tyne 1000–1020 Erectile Dysfunction – Update on UK and European Guidelines Mr Asif Muneer, University College Hospital, London
Hall 1A 1020-1120 Andrological Challenges Chairs: Professor Raj Persad, Southmead Hospital, Bristol and Mr Duncan Summerton, Vice-President of BAUS & Leicester General Hospital
1020–1040 Fertility Preservation in Patients with Cancer Mr Maj Shabbir, Guy’s & St Thomas’ Hospital, London 1040-1100 Circumcision in the Obese Mr Rowland Rees, University Hospital Southampton 1100-1120 Penile Prothesis Insertion - The Future Challanges Mr David Ralph, University College Hospital, London
Hall 1A 1120-1200 Guest Lecture Introduced by Mr Rowland Rees, University Hospital Southampton Penile Transplantation Professor André van der Merwe, Stellenbosch University, South Africa Surgery and Genito-Urethral Section of Andrology
BAUS ANNUAL MEETING 25-27 June 2018 - Liverpool BT Convention Centre 26 1500-1700 Hall 1A 1430-1500 Refreshments, Exhibition andePoster viewing inHall2 1200-1230 Hall 1A 1330-1430 Hall 1A 1200-1330 LunchBreak, ExhibitionandePoster Viewing inHall2 1600-1700 1530-1600 1410-1430 1350-1410 1640-1700 1620-1640 Satellite Session –Boston Scientific 1500-1530 Rees, University HospitalSouthampton Chairs: MsSheilaghReid, Royal Hallamshire Hospital,Sheffield &MrRowland and Female, Neurological &Urodynamic Urology Joint Session: Andrology &Genito-Urethral Surgery 1330-1350 Anderson, Russells HallHospital,Dudley Chairs: MrTrevor Dorkin,Freeman Hospital,Newcastle-upon-Tyne and Mr Paul Urethral Reconstruction Update See page17for details Mr AsifMuneer,University College Hospital,London Mr ChrisHarding, Freeman Hospital, Newcastle-upon-Tyne Mrs Mahreen Pakzad, University College Hospital,London 1600-1620
Panel: Miss Tamsin Greenwell, University College Hospital,London and Outcomes Incontinence Surgery after Radiotherapy: Options Pune, India Dr Sanjay Kulkarni , Kulkarni Reconstructive Urology Center, Urethroplasty Training OutsideEurope Professor Tony Mundy, University College Hospital,London Management ofUro-rectal Fistulae Pune, India Dr Sanjay Kulkarni, Kulkarni Reconstructive Urology Center, Posterior Urethral Injury Miss DanielaAndrich,University College Hospital,London Regenerative MedicineandUrethroplasty Cauda Equina Syndrome –CasePresentations /MDT Mr Marc Lucky, University HospitalAintree Erectile Dysfunction inNeurological Disease Mr AmmarAlhasso, Western General Hospital,Edinburgh Bladder Urological ManagementofCaudaEquina Syndrome 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 27
Section of Andrology and Genito-Urethral Surgery 1700-1800 Hall 1A Astellas Satellite Session See page17for details 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 28
Section of Andrology and Genito-Urethral Surgery be enjoyable, usefulandinformative. I lookforward to seeingyou allat themeeting andhopethat the programme we have plannedwill finishes offwithMoBelal summingupthehighlightsof conference from an FNUU perspective. Wednesday seesthesecond FNUUposter session chaired by NeilHarrisandShahzadShah and of FNUU. and later onRichard Parkinson will speakat theCore Trainees session onbehalfofthesub-section pills, potionsandprocedures. InadditiononTuesday we have thefirst oftheFNUUposter session in diagnostics withAsedAliandthenexplore theevidence for various preventative treatments – encountered by most ifnotallUrologists –UrinaryTract Infection. We will lookat thecontroversies In themainpartofconference programme onTuesday we debate atopic whichiscommonly We are delighted to welcome anotherinternational speaker, DrSanjay Kulkarni for thissession. reconstructive surgery after radiotherapy andtheMDT managementofCaudaEquina syndrome. the sectionofAndrology andGenito-urethral Surgery withtalksonurethroplasty training, treatments for Stress Incontinence. The remainder oftheafternoon willbeajointsession with in thefieldof OAB managementandProfessor van derAawillgive ushisinsightonsurgical Professor Frank van derAafrom Leuven. Professor Goldman willtalkaboutnew developments “State lectures oftheArt” –they are Professor Howard Goldmanfrom theCleveland Clinicand For Monday afternoon we are delighted to welcome two internationally-renowned guests to deliver reconstruction. bladder reconstruction andNikhilVasdev andTamsin Greenwell willdebate openversus robotic urology where RajKavia willlookat therelative meritsofIlealConduit urinarydiversion versus on Nocturiafrom ArunSahaifollowed by aninteresting debate onthefuture ofreconstructive publications, politicsandtraining. The remainder ofthemorningwillbe devoted to adiscussion of developments over thelast year ineachofthefollowing areas; research andclinical trials, meeting. Marcus Drake, Vibhash Mishra, Tina RashidandRoland Morley willprovide asummary with thenewly conceived “Updates” session, whichIhopewillbecome aregular feature for this annual meeting.The agendaincludesourannualsubsectionmeetingonMonday whichwillstart representative) have puttogether aneducational, topical andvaried programme for thisyear’s (Nottingham), Rizwan Hamid(London), ArunSahai(London) andSophiaCashman (SpR Greenwell (London), MoBelal(Birmingham),SuzanneBiers(Cambridge), Richard Parkinson Reid (Sheffield),Nikesh Thiruchelvam (Cambridge), Garthwaite Mary (Middlesbrough), Tamsin I amdelighted to welcome you to FNUUat BAUS 2018. The FNUUSubsectionCommittee; Sheilagh Mr ChrisHarding, Chairman,SectionofFemale, Neurological and Urodynamic Urology Introduction 1500-1700 Hall 1A 0900-1445 Room 3A Urodynamic Urology AnnualMeeting BAUS SectionofFemale, Neurological and Monday 25June & Female, Neurological andUrodynamic Urology Joint Session: Andrology andGenito-Urethral Surgery 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 29
Section of Female, Neurological and Urodynamic Urology 1200-1230 Hall 1A 1010-1030 Room 3A 0900-0910 Room 3A 1100-1200 Room 3A 1030-1100 0910-1010 Room 3A 1200-1330 1140-1200 1120-1140 0955-1010 0940-0955 0925-0940 Chair’s Chair’s Welcome 1100-1120 Malde, Guy’s Hospital,London Chairs: MrChrisHarding, Freeman Hospital,Newcastle-upon-Tyne &MrSachin Reconstructive Urology Mr ArunSahai,Guy’s Hospital,London Perspectives onNocturia 0910-0925 Parkinson, NottinghamCityHospital Chairs: Miss SuzanneBiers,Addenbrooke’s Hospital,Cambridge&MrRichard FNUU Updates Mr ChrisHarding, Freeman Hospital,Newcastle-upon-Tyne See page17for details Satellite Session –Boston Scientific
Refreshment Break, ExhibitionandePoster Viewing inHall2 Lunch Break, Exhibition andePoster Viewing inHall2 Miss Tamsin Greenwell, University College Hospital,London The Casefor OpenReconstruction Mr RajeshKavia, Northwick Park Hospital,Harrow Ileal Conduit vs BladderReconstruction Mr Roland Morley, CharingCross Hospital,London FNUU Training Update Miss Tina Rashid,CharingCross Hospital,London FNUU Politics Update Mr Vibhash Mishra, Royal Free Hospital,London FNUU PublicationsUpdate Professor Marcus Drake, SouthmeadHospital,Bristol FNUU Trials &Research Update Mr NikhilVasdev, Lister Hospital,Stevenage The Casefor Robotic Reconstruction
25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING
30
Section of Female, Neurological and Urodynamic Urology 1500-1700 Hall 1A 1430-1500 1330-1430 Room 3A 1700-1800 Hall 1A 1640-1700 1620-1640 1600-1700 1530-1600 1400-1430 State oftheArtLectures Mr AsifMuneer,University College Hospital,London Mr ChrisHarding, Freeman Hospital,Newcastle-upon-Tyne Mrs Mahreen Pakzad, University College Hospital,London 1600-1620 1500-1530 Rees, University HospitalSouthampton Chairs: MsSheilaghReid, Royal Hallamshire Hospital,Sheffield &MrRowland and Female, Neurological &Urodynamic Urology Joint Session: Andrology &Genito-Urethral Surgery 1330-1400 Greenwell, University College Hospital,London Chairs: MrMoBelal,QueenElizabethHospital,Birmingham&Miss Tamsin See page17for details Astellas Satellite Session Panel: Management Refreshments, ExhibitionandePoster Viewing inHall2 Cauda Equina Syndrome –CasePresentations /MDT Mr Marc Lucky , University HospitalAintree Erectile Dysfunction inNeurological Disease Mr AmmarAlhasso, Western General Hospital,Edinburgh Bladder Urological ManagementofCaudaEquina Syndrome Miss Tamsin Greenwell, University College Hospital,London and Outcomes Incontinence Surgery after Radiotherapy: Options Pune, India Dr Sanjay Kulkarni , Kulkarni Reconstructive Urology Center, Urethroplasty Training OutsideEurope Professor Frank van derAa,University ofLeuven, Belgium Current Perspectives inSUISurgery Professor Howard Goldman,Cleveland Clinic,Ohio, USA New Devices andNew Technologies for OAB 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 31
Section of Female, Neurological and Urodynamic Urology 1030-1200 Room 4 Monday 25June See page57 for theePosters Chairs: Matthew Nielsen&Alex Colquhoun ePoster Session 1:BladderCancer 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 32
Programme: Monday 25 June 0800-0830 Hall 1A Tuesday 26June 0900-1000 Room 3A/B 0845-0930 Hall 1A 0830-1000 Room 12 0830-1000 Room 4 Mr BillDunsmuir,Ashford andSt Peter’s Hospitals,Chertsey What MighttheFuture Look Like? Oncology Chair Ms JoCresswell, JamesCook University Hospital,Middlesbrough andSectionof The Reality at theCoalface Imperial Healthcare NHSTrust Professor HashimAhmed,ChairofNHSEnglandCEGfor Prostate Cancer and The NHSPerspective Chair: MrKen Anson,St George’s Hospital,London MDTs inUrology -where are we in2018? See page62for theePosters Chairs: RajPersad &Ayman Younis Cancer andMaleInfertility ePoster Session 3:Andrology, Reconstruction, Penile See page60for theePosters Chairs: Luke Forster &NikhilVasdev Quality Improvement ePoster Session 2:Management,Governance and See page18for details Prostate Cancer UKSatellite Session University College Hospital,London Chairs: MrRichard Napier-Hemy, Manchester Royal Infirmary&MrDaron Smith, My role andwhat itadds The Management oftheObstructed Infected Kidney: Mr Jake Patterson , Royal Hallamshire Hospital,Sheffield Retrograde Drainage andTimeframes of Leicester NHS Trust Ms Rosemina Ahmad,Consultant Radiologist, University Hospitals Diagnosis andNephrostomy Drainage 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 33
Programme: Tuesday 26 June 1000-1030 Hall 1A 0930-1000 Hall 1A 1015-1230 Hall 11A Dr Bruce Macrae, Consultant Microbiologist, University College Hospital,London Microbiological Aspects AGM 2. 1. Aim trainees inUrology! as acareer andtraining to improve any deficiencies. We need to keep thebest mentoring indeciding theirnext career move, re-inspiring themto pursueurology This group oftrainees have great potential butmay needsupport,advice and poor performance ontheday. communication skills,research/audit andqualityimprovement achievements or National Selectionday. This may bebecauseoflackurology experience, Each year there are goodcandidates whoare unsuccessful at theUrology ST3 Representative Organiser: MrLuke Forster, SPR London, SURG/BAUS SectionofTrainees Core those unsuccessful inUrology ST3 National Selection Bouncing Back:Support,Mentorship andadvice for Introduced by: MrKieran O’Flynn,BAUS President Mr Jonathan Goddard, Leicester General Hospital 70th Anniversary oftheNHS Questions andAnswers Dr Anthony Wilson , Consultant inCriticalCare, Manchester Royal Infirmary ITU Management London Professor Mervyn Singer,Professor ofIntensive Care Medicine, University College Basic SepsisScience Pune, India Presented to: DrSanjay Kulkarni, Kulkarni Reconstructive Urology Center, prominence inthefieldofmedicine related to urology either intheUKorabroad.” Honorary Membershipis given to “personswhohave achieved outstanding BAUS Honorary Membership Presented to: MrAsifMuneer , University College Hospital,London appointment whohave madeasignificantandlasting contribution to urology. This award isgiven to BAUS Memberswithin10years oftheirfirst consultant Karl Storz Harold HopkinsGoldenTelescope Award of theAGM orhandedto theRegistration Deskby 1700 onMonday 25June. Any otherbusiness –ifpossible, written questions shouldbesubmitted inadvance The AGM Agenda willbe available to Membersviathe BAUS website. Chair: MrKieran O’Flynn,BAUS President Keep thebest quality candidates interested inUrology asacareer Offer support to trainees unsuccessful inNational selection at adifficulttime 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 34
Programme: Tuesday 26 June 1030-1200 Room 4 1030-1200 Room 3A/B 1000-1100 1030-1200 Room 12 1100-1200 Hall 1A Urodynamic Urology 1 ePoster Session 5:Female, Neurological & See page64for theePosters Chairs: BenChew &Matt Bultitude Disorders ePoster Session 4:Stones, ImagingandUpperTract Discussion Mr Paul Cathcart, Guy’s &St Thomas’ Hospital,London National Prostate Cancer Audit Mr Jonathan Makanjuola, KingsCollege Hospital,London Technological Aidsto Patient DecisionMaking Mr Vincent JGnanapragasam, CambridgeUniversity The PREDICT: Prostate CambridgeModel Individualising Prognostic Prediction inProstate Cancer: Mr Nick Burns-Cox, Musgrove Park Hospital,Taunton Option Grids Shared DecisionMaking andDecisionAidsinUro-oncology: Institution, Baltimore, USA Professor AlanPartin, The Brady Urological Institute, The JohnsHopkinsMedical Prostate Diagnostics andPrognostics in2017 The Section ofOncology Guest Lecture: Raigmore Hospital,Inverness, Scotland Chairs: MrBenChallacombe, Guy’s Hospital,London & Mr David Douglas, Prostate Cancer: Navigating Decision-Making Southend University Hospital Professor Tony Young, National Clinical Lead for Innovation NHSEngland& Introduction andWelcome Southend University Hospital Chair: Professor Tony Young, National ClinicalLead for Innovation NHSEngland& Innovations See page67 for theePosters Chairs: AngelaBirnie&AsedAli Refreshment Break, ExhibitionandePoster Viewing inHall2 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 35
Programme: Tuesday 26 June 1200-1245 Hall 1A 1245-1345 1245-1330 Hall 1A Dr JamesMault,CMOat Qualcom Life How Technology isDisruptingMedicineGlobally Citation by: MrKieran O’Flynn,BAUS President Presented to: Professor NoelClarke, The Christie Hospital,Manchester with thediefor themedalin1948. urology. MrBernard Ward (Vice President, 1945-1947) presented theAssociation Commonwealth whohasmadeanotablecontribution to theadvancement of The St. Peter’s Medalisawarded to any subjectoftheBritishIslesor St Peter’sMedal Citation by: MrBenChallacombe, Guy’s Hospital,London Hopkins MedicalInstitution, Baltimore, USA Presented to: Professor AlanPartin, The Brady Urological Institute, The Johns 1989. (President, 1988-1990) presented theAssociation withthediefor themedalin Council particularlywishesto appreciate andhonour. MrRichard Turner Warwick from overseas whosecontributions to BAUS inparticular, orto urology ingeneral, The St. Paul’s Medalisawarded by BAUS Council to distinguished colleagues St Paul’s Medal Mr Kieran O’Flynn,BAUS President President’s Address President’s Address &Presidential Handover Questions andAnswers Mr SamFolkard, MrWilliam Gallagher, DrHarryThirkettle &DrElliotStreet 4 x1-minute NHSEnglandClinicalEntrepreneur Pitches Ms NadineHachach-Haram, Co-Founder Proxime Transforming Surgery through Augmented Reality Mr JaniAhonala,CEONoona The Cancer Clinicat your Fingertips Southend University Hospital Professor Tony Young, National ClinicalLead for Innovation NHSEngland& Innovation to Transform theNHS See page18for details Olympus Satellite Session Investure ofMrDuncanSummerton asPresident ofBAUS Presidential Handover Lunch, ExhibitionandePoster Viewing inHall2 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 36
Programme: Tuesday 26 June 1330-1630 Room 11A 1345-1445 Hall 1A 1625-1630 1410-1500 1345-1410 1335-1345 BAUS Meetingfor Core Trainees inUrology 1330-1335 Introduced by: Professor KrishnaSethia,Norfolk andNorwichHospital the University ofCalifornia, SanFrancisco, USA Professor Robert Wachter, Professor andChairoftheDepartmentMedicineat When… andHow? Promise ofDigital Health: Are We There Yet? If Not, BJU International Guest Lecture: Achieving the 1605-1625 1545-1605 1500-1545
section andcareer options BAUS sub-specialtysections:What’s happeninginthe Welcome to Urology Introduction Concluding Remarks Advancement intheNHS-AVision oftheNext Decade Opportunities Innovation andTechnological How to getaheadinUrology BAUS FY&CTAudit /QuIPCompetition posters BAUS FY&CTAudit /QuIPCompetition presentations Mr DominicHodgson, QueenAlexandra Hospital Mr Luke Forster, Whipps Cross Hospital,London ePoster presentations (see pages83-84) Oral presentations (see page83) England Foundation Trust &National ClinicalLead for Innovation at NHS Professor Tony Young, SouthendUniversity HospitalNHS Southmead Hospital,Bristol Mr Sunjay Jain,St James’s University Hospital& Mr JoeJelski, Oncology Mr Richard Parkinson, NottinghamCityHospital Female, Neurological &Urodynamic Urology Mr JonAning, Freeman Hospital,Newcastle uponTyne Academic Urology Miss PhillippaSangster, University College Hospital,London Andrology &Genito-Urethral Surgery Mr Jonathan Glass, Guy’s andSt Thomas’ Hospital,London Endourology Mr Kieran O’Flynn, BAUS President Mr DominicHodgson, QueenAlexandra Hospital,Portsmouth 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 37
Programme: Tuesday 26 June 1345-1445 Room 3A/B 1445-1530 Hall 1A 1400-1500 Room 12 1400-1545 Room 4 Dysfunction Improve Life Expectancy? Preventative Andrology –CanTreating MaleSexual Chair: MrJamesGreen, Bart’s HealthNHSTrust, ClinicalLead for EQuIP Research Using Implementation Science andEducational Embedding Total QualityImprovement inUrology: See page73 for theePosters Chairs: David Thomas &Andrew Moon ePoster Session 7:General Urology 1 See page69 for theePosters Chairs: AlanPartin &Prasanna Sooriakumaran ePoster Session 6:Prostate Cancer Professor GeoffHackett, GoodHopeHospital,Birmingham Mortality –What istheEvidence Effect of Testosterone Replacement on Long-term Morbidityand Mr ArieParnham, The Christie Hospital,Manchester Health andMortalityRisk Endothelial Dysfunction andPDE5iuse–Cardiovascular Risk, Italy Associate Professor Andrea Salonia,Università Vita-Salute SanRaffaele, Milan, Male Infertility asaBarometer for HealthandDisease Pearcy Chairs: MrMajShabbir,Guy’s &St Thomas’ Hospital,London andMrRichard Mr Roland Morley, ImperialCollege Healthcare NHSTrust, ChairofUrology SAC The Educational Angle King’s Improvement Science Power Tracey The ManagementAngle Katrine Kirk,Patient EngagementExpert The Patient’s Perspective Acute Medicine, QueenElizabethUniversity Hospital,Glasgow Dr Katie Percival, CT1Doctor inAcute Care Common Stem (ACCS) - A Trainee’s Story , Derriford Hospital,Plymouth , ManagingDirector ofMaudsley International, Programme Lead for 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 38
Programme: Tuesday 26 June 1530-1600 Hall 1A 1615-1700 Hall 1A 1600-1615 1445-1545 Room 3A/B 1530-1545 1515-1530 1500-1515 EQuIP Health Services &Population Research, King’s College London. Academic Lead for Professor NickSevdalis, Professor ofImplementation Science &Patient Safety, The Scientific Angle University Challenge:Consultants vs SURG Lecture by: MrSimonHarrison,PinderfieldsGeneral Hospital, Wakefield Introduced by: MrIanPearce , Manchester Royal Infirmary Urology JCU Guest Lecture: GettingItRightFirst Time in 1445-1500 Cashman, Luton andDunstable Hospital Chairs: Professor Howard Goldman,Cleveland Clinic,Ohio, USA &Miss Sophia Urinary Tract Infections Mr Luke Forster, Whipps Cross Hospital,London The Trainee Angle Miss HelenTeixeira, Maidstone andTunbridge Wells Mr IanRudd,St George’s Hospital,London Miss Sarah Tang, The Whittington Hospital,London Mr JoeJelski,SouthmeadHospital,Bristol (Team Captain) SURG Team: Mrs Caroline Moore, University College Hospital,London Mr Richard Napier-Hemy, Manchester Royal Infirmary Ms JoCresswell, JamesCook University Hospital,Middlesbrough Professor RajPersad, SouthmeadHospital,Bristol (Team Captain) Consultant’s Team: Chair: MrDuncanSummerton, Leicester General Hospital Refreshment Break, ExhibitionandePoster Viewing inHall2 Procedures…. Potions…… Pills….. Diagnosis ofUTI–Controversies Mr IanBeckley, PinderfieldsHospital, Wakefield Professor Frank van derAa,University ofLeuven, Belgium Tyne Mr ChrisHarding, SFNUUChair, Freeman Hospital, Newcastle-upon- Mr AsedAli,PinderfieldsHospital, Wakefield 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 39
Programme: Tuesday 26 June 1800-1930 Room 3A/B 1715-1800 Hall 1A 1700-1715 1730-1800 Room 3A/B professional &theteam SpRs? 1915 -1930 Foundation Trust Simulation Training: MrKamran Ahmed,University College London HospitalsNHS Paediatrics: MrRoland Morley , ImperialCollege Healthcare NHSTrust FNUU: Miss SuzanneBiers,CambridgeUniversity HospitalsNHSFoundation Trust Trust Andrology: MrAsifMuneer , University College London HospitalsNHSFoundation NHS Trust Specialist Advisory Committee: MrRoland Morley, ImperialCollege Healthcare (5 minutes maximumperpanelmemberto allow audience Q&A) 1845 -1915 National ClinicalLead for Innovation Professor Tony Young, SouthendUniversity HospitalNHSFoundation Trust & 1830 -1845 Trust Awarded to MrOliver Wiseman, CambridgeUniversity HospitalsNHSFoundation 1815 -1830 Miss SophiaCashman,Luton &Dunstable Hospital/SURG FNUURepresentative Mr Jonathan Noël,Royal MarsdenNHSFoundation Trust/SURG Chair 1800 -1815 Meeting ofSURGandBAUS Trainee Members SURG AGM See page19for thedetails Bayer Satellite Session Foundation Trust Miss Alice Hartley, Newcastle University andCityHospitalsSunderlandNHS Refreshment Break, ExhibitionandePoster Viewing inHall2 Training Updates &Indicative NumberChallenges Silver Cystoscope &Urological Training: what matters to Undermining &bullying:theeffect onthepatient, the Introduction by MeetingChairs Innovation &Entrepreneurship inUrology 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 40
Programme: Tuesday 26 June 0800-0900 Hall 1A Wednesday 27 June
0900-0930 Hall 1A 0800-0900 Room 3A/B 1000-1030 Hall 1A 0930-1000 Hall 1A Mr Veeru Kasivisvanathan, University College Hospital,London Harrogate District Hospital Chairs: MrJohnMcGrath, Royal Devon &Exeter NHSTrust &MrsRachelMorrison, Haematuria: Controversies inEveryday Practice Seconder: MrMarkSpeakman,Taunton &SomersetNHSTrust Opposer: MrJonathan Glass, Guy’s &St Thomas’ HospitalTrust Seconder: David Cranston, The Churchill Hospital,Oxford Proposer: MrJohnReynard, The Churchill Hospital,Oxford Chair: MrKieran O’Flynn,BAUS President circumcision are consented for death Debate: This housebelieves itiscorrect that patients having a Consenting to Death See page20 for details Astellas Oncology Satellite Session Professor Kevin Turner, Royal BournemouthHospital&University Introduced by MrKieran O’Flynn,BAUS President AUR –Adverse Events, Urologists andResilience Mr David Sellu, Honorary Consultant Surgeon, St Mark’s Hospital,London My Journey through aGross Negligence Manslaughter Conviction Introduced by MrKieran O’Flynn,BAUS President BAUS Guest Lecture IDENTIFY andtheBURST Collaborative Investigated for Non-Visible Haematuria? Can Ultrasound Renal Tract Replace CTUrogram inPatients Dr Matthew Nielsen,UNCLineberger Cancer Center, NorthCarolina, USA Haematuria -CTfor All?ARiskstratified protocol Mr Wei ShenTan , University College Hospital,London DETECT andIDENTIFY: Current UKPractice 25-27 June 2018 - Liverpool BT Convention Centre
BAUS ANNUAL MEETING 41
Programme: Wednesday 27 June 1100-1200 Room 4 1100-1130 Hall 1A 1030-1100 1100-1200 Room 3A/B 1100-1230 Room 12 Questions andAnswers Mr Craig McIlhenny, Forth Valley Royal Hospital Teamwork Mr JohnMcGrath, Royal Devon &Exeter NHSTrust Enhanced Recovery Ms Archie Fernando, Guy’s &St Thomas’ HospitalTrust Mindfulness andSelf-Control Dr JeanNehme,Co-founder andCEO, Touch Surgery Surgical Rehearsal Dr David Walker, University College Hospital,London Peri-operative Optimisation Churchill Hospital,Oxford Chairs: Jonathan Glass, Guy’s &St Thomas’ HospitalTrust &MrBenTurney , Optimising your Patient, OptimisingYourself feasibility ofnovel imagingtechniques to screen for prostate cancer The PROSTAGRAM trial:Aprospective cross-sectional study assessing the For thefollowing research: Trust Mr David Eldred-Evans, Academic ClinicalResearch Fellow, ImperialCollege NHS Award oftheTUFResearch ScholarMedal Introduced by: Louise deWinter, The Urology Foundation ChiefExecutive Professor Roger Kirby, The Prostate Centre, London A Journey Through my Prostate The Urology Foundation Guest Lecture See page80 for theePosters Chairs: ShahzadShah& Neil Harris Urodynamic Urology 2 ePoster Session 10:Female, Neurological & See page75 for theePosters Chairs: MarkSpeakman&NickCampain ePoster Session 8: General Urology 2 Refreshment Break, ExhibitionandePoster Viewing inHall2 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 42
Programme: Wednesday 27 June 1130-1230 Hall 1A 1230-1315 Room 3A/B 1200-1330 Room 4 1200-1230 Room 3A/B 1230-1400 Differences Global Urological Practice –Similaritiesand Dudley Mrs SuzieVenn, St Richard’s Hospital&MrPaul Russells Anderson, HallHospital, Urolink Update Hospital, Dudley Chairs: MrsSuzieVenn, St Richard’s Hospital& Mr Paul Russells Anderson, Hall Urolink See page77for theePosters Chairs: David Nicol &Archie Fernando ePoster Session 9:Renal Cancer andTestis Cancer General Hospital,Canada Associate Professor BenChew, University ofBritishColumbia &Vancouver The Fate ofFragments andtheScience ofStents Dr Sanjay Kulkarni, Kulkarni Reconstructive Urology Center, Pune, India Sanjay Kulkarni: IndianPerspective Institution, Baltimore, USA Professor AlanPartin, The Brady Urological Institute, The JohnsHopkinsMedical US Perspective Professor JamesN’Dow, University ofAberdeen A Comparison oftheUKandEU Hospital Chair: MrDuncanSummerton, Vice-President ofBAUS &Leicester General Dr AbubacarrJah,Sharab MedicalCentre, Serrekunda, The Gambia Training LMICUrologists intheUK Dr CharlesMabedi,Kamuzu Central Hospital, Lilongwe, Malawi Urological Training inAfrica Refreshment Break, ExhibitionandePoster Viewing inHall2 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 43
Programme: Wednesday 27 June 1400-1615 Hall 1A 1615-1630 Hall 1A Highlights oftheYear, BAUS 2018 &Breaking News Mr DuncanSummerton, Vice-President ofBAUS &Leicester General Hospital 2019 Closing remarks/overview andinvitation to BAUS Mr Veeru Kasivisvanathan, University College Hospital,London Breaking News: Precision Trial Mr Tom Walton, NottinghamCityHospital Oncology Mr ArieParnham, The Christie Hospital,Manchester Andrology &Genito-Urethral Surgery Mr MoBelal,QueenElizabethHospital,Birmingham Female, Neurological andUrodynamic Urology Mr Frank Keeley, SouthmeadHospital,Bristol Endourology Chair: Miss SuzanneBiers,Addenbrooke’s Hospital,Cambridge 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 44
Programme: Wednesday 27 June IT TAKES MEANINGFUL INNOVATION TO TRANSFORM PATIENTS’ LIVES. WE PUT MORE INTO THE SCIENCE SO YOU CAN MAKE MORE OF A DIFFERENCE.
To learn more about our meaningful innovation, come and see us at our booth.
Illustrations are not indicative of clinical performance. For illustration purposes only. CAUTION: The law restricts these devices to sales by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for the use only in countries with applicable health authority product registrations.
UROPH-394604-AA-MAY 2016 © 2017 Boston Scientific Corporation or its affiliates. All rights reserved. www.bostonscientific.eu he was anAcademic All-American football player. chemistry from the University ofMississippi where Dr. Partin received hisundergraduate degree in disease inmen. invasive techniques for treatment ofthiscommon hyperplasia withanemphasisonminimally clinical interest intreatment ofbenignprostatic In addition,Dr. Partin hasanacademicand in detection—and staging ofprostate cancer. investigation ofnew proteins—which may help of prostate cancer as well asbasicscience soon to become available for thediagnosis new “PSA-like” serumtests, someofwhichare Dr. Partin’s laboratories have investigated many by bothpatients andphysicians. so that rational treatment decisions canbemade predicting theaggressiveness ofprostate cancers and testing new andexisting methodsfor clinical andsurgical interests focus ondeveloping his research famous. Dr. Partin’s laboratories and likelihood ofbeingcured by treatment, made can predict with95 percent accuracy aman’s cancer. The creation ofThe Partin Tables, which and makingpredictions for menwithprostate Dr. Partin isanexpert inassessing prognosis chief ofThe JohnsHopkinsHospital. at theBrady Urological Institute andurologist-in- was nameddirector oftheDepartmentUrology Cystoscope” award in2001. In2004,Dr. Partin Scholars inUrology Award in1996,andthe“Gold- Hopkins Young Investigators Award, thePfizer been honored withmany awards, includingthe of theCampbell-Walsh urology text. Hehas in-chief ofUrology CaseReports andeditor on numerous editorial boards andiseditor- author ofmore than500scientificarticles,serves Alan W. Partin, M.D., Ph.D., istheauthor orco- Johns HopkinsMedicine Urological Institute The JamesBuchananBrady Urologist-in-Chief Chairman Professor The Jakurski Family Director and Alan W. Partin, M.D., PH.D St Paul’s MedalWinner Speaker Biographies doctoral training. Hopkins University where hecontinued hispost- pharmacology andmolecularsciences from Johns He received hismedicaldegree andhisPh.D. in Group between 2003 and2009, was integrally Cancer Research Institute Prostate Clinical Studies In research hewas ChairmanoftheUKNational 2002 and2010. and Cheshire Urological Cancer Network between 2002 to 2005andheChaired theManchester delivery ofUrological Cancer inEngland from the “Improving Outcomes Guidance”, aplanfor involved inthedevelopment andpublication of section ofOncology. Hewas oneof2Urologists one ofthefounding group developing theBAUS served 2terms ontheBAUS executive andwas and Director ofSurgery at theChristie Hospital, Director ofUrology at Salford Royal Hospitals Professor Clarke hasheldthepositionsof tumours. provision for complex andrare abdomino-pelvic providing UKregional andsupra-regional surgical prostate, bladder, kidney andtestis inadditionto in thediagnosisandtreatment ofcancers ofthe nationally andinternationally recognised expert Cancer treatment inhealthcare systems. Heisa Genito-Urinary malignancy andthedelivery of and retroperitoneal surgery, research into secondary andtertiary referral complex pelvic in 1991.Since that timehehasspecialisedin and hisurological accreditation andFRCS(Urol) FRCS(Eng) in1985,hisChMManchester 1990 He completed hisMBBSinLondon in1981,his Oncology at Manchester University since 2007. Honorary Professor ofUrological Manchester, since 1993, and and Salford Royal Hospitals, Urological Surgeon at theChristie Noel Clarke hasbeenaConsultant MBBS ChMFRCS(Urol) Professor NoelWClarke St Peter’s MedalWinner 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 46
Speaker Biographies Examinations (JCIE) servingfrom 2010 to 2015. member ofthe JointCommittee for Intercollegiate Intercollegiate Surgical Board inUrology anda Urol) andwent onto become chairmanof the Fellowship examination inUrology (FRCS to 2010 hewas anexaminer for theIntercollegiate the RCSEd Examinations Committee. From 2005 Membership Exam (FRCS/MRCS)andserved on He was an examiner for theIntercollegiate member oftheEast ofScotland training rotation. Urology training inAberdeen andwas afounder and becamethelocalprogram director for He was always interested intraining and teaching for ten years. of theNHSGrampian ClinicalEthicsCommittee involvement inmedicalethicsandwas chairman Medical Director. Hehadalong-standing of Service for Urology to therole ofAssociate a numberofmanagementroles locally, from Head Consultant post inAberdeen in1993. Hehasheld and Aberdeen before takingupa then trained inBelfast, Dumfries James’s HospitalinDublin.He and didhishousemanjobsinSt Trinity College, Dublinin1980 Sam McClinton graduated from Professor SamMcClinton BAUS GoldMedalWinner medical andscientificdisciplines. >30 PhD/MD students from awiderange of cancer duringthecourse ofsupervising/training and 9bookchapters onurology andurological cancer. Hehasauthored 225peer-reviewed papers science andPhaseI,II,IIItrialsinurological research interests encompass basic/translational coordination anddata analysis. Professor Clarke’s national andinternational cancer trialplanning, cancer trialsandhasbeeninvolved extensively in Radicals trials,two oftheworld’s largest prostate and Wales. HeisaCo-PI oftheSTAMPEDE and for theNational Prostate Cancer Audit inEngland is thejointclinicalleadandBAUS representative of Excellence for prostate cancer research. He the Manchester /Belfast FASTMAN national centre the pan-Manchester biobankandclinicalleadfor Manchester University GUCancer Research Group, EORTC GUgroup. Heiscurrently Director ofthe RADICALS andPATCH trialsandCo-Chaired the involved inthedevelopment oftheSTAMPEDE, Royal Infirmary(2015). theatres andaDaVinci robot system at Aberdeen more recently fundednew integrated operating Centre that was openedinJanuary2008and and developed anintegrated UCAN Cancer Care UCAN hasraised £5.6millionandhasfunded cancers andsupport theirfamilies. To date the delivery ofcare for patients withurological charity, calledUCAN,whichaimed to improve He was co-founder andpast Chairman ofalocal and theresults were publishedintheLancet 2016. first ofthese(SUSPEND) hasnow been completed randomised controlled trialsinEndourology. The Assessment (NIHRHTA) national multicentre Institute for HealthResearch HealthTechnology He istheChiefInvestigator ofthree National elected astheChairmanofSection. the BAUS SectionofEndourology andwas then Treasurer). Hesubsequentlybecamesecretary of for Endourology (takingontherole asitsfirst Council andamemberoftheBritishSociety of Scotland. Hewas anelected member ofBAUS Advisor for Urology to theChiefMedicalOfficer the Scottish Urology Societyandwas Specialty East ofScotland, was elected asPresident of He was theBAUS regional representative for the 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 47
Speaker Biographies Join the debate Monday 25 June • 17.00–18.00 • Hall 1A
This house believes that five years after the launch of an alternative treatment class, patients with OAB are still not benefitting from increased choice
Chairman Mr Christopher Harding Join our esteemed faculty as they make Urologist, Newcastle a case for the treatment pathway that Speakers Mr Nikesh Thiruchelvam they believe would most likely benefit Urologist, Cambridge patients with overactive bladder. Mr Steve Foley Urologist, Reading In the end, only you can decide.
This promotional symposium has been fully funded and organised by Astellas Pharma Ltd and Astellas products will be discussed.
Prescribing information: Betmiga™ (mirabegron) For full prescribing information, refer to the Summary of Product Characteristics (SPC) taking antimuscarinics medicinal products for OAB: Urinary retention in patients with bladder antagonist) study were similar in type and severity to those observed in the three 12-week phase Presentation: Betmiga prolonged-release tablets containing 25 mg or 50 mg mirabegron. outlet obstruction (BOO) and in patients taking antimuscarinic medicinal products for the 3 double blind, placebo controlled studies. Adverse reactions: The following list reflects the Indication: Symptomatic treatment of urgency, increased micturition frequency and/or urgency treatment of OAB has been reported in postmarketing experience in patients taking mirabegron. adverse reactions observed with mirabegron in the three 12-week phase 3 double blind, placebo incontinence as may occur in adult patients with overactive bladder (OAB) syndrome. A controlled clinical safety study in patients with BOO did not demonstrate increased urinary controlled studies. The frequency of adverse reactions is defined as follows: very common Posology and administration: The recommended dose is 50 mg orally once daily in adults retention in patients treated with Betmiga; however, Betmiga should be administered with (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (including elderly patients). Mirabegron should not be used in paediatrics. A reduced dose of caution to patients with clinically significant BOO. Betmiga should also be administered with (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000) and not known (cannot be established 25 mg once daily is recommended for special populations (please see the full SPC for information caution to patients taking antimuscarinic medicinal products for the treatment of OAB. from the available data). Within each frequency grouping, adverse reactions are presented in on special populations). The tablet should be taken with liquids, swallowed whole and is not to Interactions: Caution is advised if mirabegron is co-administered with medicinal products with order of decreasing seriousness. The adverse events are grouped by MedDRA system organ class. be chewed, divided, or crushed. The tablet may be taken with or without food. a narrow therapeutic index and significantly metabolised by CYP2D6. Caution is also advised if Infections and infestations: Common: Urinary tract infection, Uncommon: Vaginal infection, Contraindications: Hypersensitivity to the active substance or to any of the excipients listed mirabegron is co-administered with CYP2D6 substrates that are individually dose titrated. Cystitis. Psychiatric disorders: Not known (cannot be estimated from the available data): in section 6.1 of the SPC. Severe uncontrolled hypertension defined as systolic blood pressure In patients with mild to moderate renal impairment or mild hepatic impairment, concomitantly Insomnia*. Nervous system disorders: Common: Headache*, Dizziness*. Eye disorders: Rare: ≥ 180 mm Hg and/or diastolic blood pressure ≥ 110 mm Hg. receiving strong CYP3A inhibitors, the recommended dose is 25 mg once daily. For patients who Eyelid oedema. Cardiac disorders: Common: Tachycardia, Uncommon: Palpitation, Atrial Warnings and Precautions: Renal impairment: Betmiga has not been studied in patients are initiating a combination of mirabegron and digoxin (P-gp substrate), the lowest dose for fibrillation. Vascular disorders: Very rare: Hypertensive crisis*. Gastrointestinal disorders: with end stage renal disease (GFR < 15 mL/min/1.73 m2 or patients requiring haemodialysis) digoxin should be prescribed initially (see the SPC for full prescribing information). Common: Nausea*, Constipation*, Diarrhoea*, Uncommon: Dyspepsia, Gastritis, Rare: and, therefore, it is not recommended for use in this patient population. Data are limited in The potential for inhibition of P-gp by mirabegron should be considered when Betmiga is Lip oedema. Skin and subcutaneous tissue disorders: Uncommon: Urticaria, Rash, Rash macular, patients with severe renal impairment (GFR 15 to 29 mL/min/1.73 m2); based on a combined with sensitive P-gp substrates. Increases in mirabegron exposure due to drug-drug Rash papular, Pruritus, Rare: Leukocytoclastic vasculitis, Purpura, Angioedema*. Musculoskeletal pharmacokinetic study (see section 5.2 of the SPC) a dose reduction to 25 mg is recommended interactions may be associated with increases in pulse rate. and connective tissue disorders: Uncommon: Joint swelling. Renal and urinary disorders: in this population. This medicinal product is not recommended for use in patients with severe Pregnancy and lactation: Betmiga is not recommended in women of childbearing potential Rare: Urinary retention*. Reproductive system and breast disorders: Uncommon: Vulvovaginal renal impairment (GFR 15 to 29 mL/min/1.73 m2) concomitantly receiving strong CYP3A not using contraception. This medicinal product is not recommended during pregnancy. Betmiga pruritus. Investigations: Uncommon: Blood pressure increased, GGT increased, AST increased, ALT inhibitors (see section 4.5 of the SPC). Hepatic impairment: Betmiga has not been studied in should not be administered during breast-feeding. increased.*signifies adverse reactions observed during post-marketing experience. Prescribers patients with severe hepatic impairment (Child-Pugh Class C) and, therefore, it is not Undesirable effects: Summary of the safety profile: The safety of Betmiga was evaluated in should consult the SPC in relation to other adverse reactions. recommended for use in this patient population. This medicinal product is not recommended for 8433 patients with OAB, of which 5648 received at least one dose of mirabegron in the phase Overdose: Treatment for overdose should be symptomatic and supportive. In the event of use in patients with moderate hepatic impairment (Child-Pugh B) concomitantly receiving strong 2/3 clinical program, and 622 patients received Betmiga for at least 1 year (365 days). In the overdose, pulse rate, blood pressure, and ECG monitoring is recommended. CYP3A inhibitors (see section 4.5 of the SPC). Hypertension: Mirabegron can increase blood three 12-week phase 3 double blind, placebo controlled studies, 88% of the patients completed Basic NHS Cost: Betmiga 50 mg x 30 = £29, Betmiga 25 mg x 30 tablets = £29 pressure. Blood pressure should be measured at baseline and periodically during treatment with treatment with this medicinal product, and 4% of the patients discontinued due to adverse events. Legal classification: POM mirabegron, especially in hypertensive patients. Data are limited in patients with stage 2 Most adverse reactions were mild to moderate in severity. The most common adverse reactions Marketing Authorisation number(s): EU/1/12/809/001 – 018 hypertension (systolic blood pressure ≥ 160 mm Hg or diastolic blood pressure ≥ 100 mm Hg). reported for patients treated with Betmiga 50 mg during the three 12-week phase 3 double blind, Marketing Authorisation Holder: Astellas Pharma Europe B.V. Sylviusweg 62. Patients with congenital or acquired QT prolongation: Betmiga, at therapeutic doses, has not placebo controlled studies are tachycardia and urinary tract infections. The frequency of 2333 BE Leiden. The Netherlands. demonstrated clinically relevant QT prolongation in clinical studies (see section 5.1 of the SPC). tachycardia was 1.2% in patients receiving Betmiga 50 mg. Tachycardia led to discontinuation in Date of Preparation of Prescribing information: December 2017 However, since patients with a known history of QT prolongation or patients who are taking 0.1% patients receiving Betmiga 50 mg. The frequency of urinary tract infections was 2.9% in Job bag number: PRE17013UK(1) Further information available from: Astellas Pharma Ltd, medicinal products known to prolong the QT interval were not included in these studies, the patients receiving Betmiga 50 mg. Urinary tract infections led to discontinuation in none of the 2000 Hillswood Drive, Chertsey, KT16 0RS. Medical Information: 0800 783 5018. effects of mirabegron in these patients is unknown. Caution should be exercised when patients receiving Betmiga 50 mg. Serious adverse reactions included atrial fibrillation (0.2%). For full prescribing information, please see the Summary of Product Characteristics, which may administering mirabegron in these patients. Patients with bladder outlet obstruction and patients Adverse reactions observed during the 1-year (long term) active controlled (muscarinic be found at www.medicines.org.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Astellas Pharma Ltd on 0800 783 5018
BET18005UK(1)d Date of preparation: May 2018 Exhibition Plan 550 650 350 432 234 744 746 748 334 834 540 542 336 640 230 430 330 740 742 830 422 130 222 730 822 622 324 530 532 128 418 126 520 522 322 218 220 620 320 414 416 720 722 618 124 510 512 514 516 214 410 412 716 316 614 616 216 717 25-27 June 2018 - Liverpool BT Convention Centre 810 122 312 407 408 610 612 314 712 718 210 212 900 120 502 504 506 500 118 404 406 308 709 206 208 608 606 808 806 710 306 BAUS ANNUAL MEETING 304 202 302 seating 200
Entrance 49
Exhibition Plan (Paragon Insurance Brokers) Incision Indemnity iMEDicare Ltd Ideal MedicalSolutions Hospital Services Limited Hitachi MedicalSystems UKLtd History ofUrology Genesis MedicalLtd Fresenius Kabi Fight BladderCancer Ferring Pharmaceuticals Exact Imaging Evolan PharmaAB Erbe MeedicalUK ePosters 640 D&k Technologies Cook Medical Contura 610 Combat Medical Coloplast 622 Coffee bar Class Medical CJ Medical Catering Seating Catering BXTAccelyon Ltd British Association ofUrological Nurses Boston Scientific Bk Ultrasound BJU International Biocompatibles UKLtd Bespoke MedicalIndemnity Bayer 408 BAUS &JCU Augmenix UKLimited Astellas PharmaLtd Aspire PharmaLtd Aquilant Ltd Angiodynamics 742 Alpha Laboratories Ltd Allergan 522 Albyn MedicalLtd Accident &Emergency Agency Ltd Abbott Molecular Company Exhibition List 202, 302, 222,234, 432, 822&834 900 &350 Stand 406 200 304 430 540 608 806 808 620 206 308 208 330 709 530 520 220 730 542 336 532 722 410 510 710 120 514 616 316 412 124 612 128 122 118
ZSI, Zephyr Surgical Implants Working Area Visit Glasgow Urology News University ofEdinburgh UK MedicalLimited Trials 650 The Urology Foundation Syner-Med (PP)Ltd Synergo -MedicalEnterprises Surgical Holdings Smarttarget Limited Sigmacon (UK)Ltd Rocamed 718 Richard Wolf Prostate Cancer UK Promed Ltd Procept Biorobotics Premium MedicalProtection PNN MedicalA/S Partners For Endoscopy Limited Oneview Healthcare Oncology Systems Limited Nuada MedicalProstate Care Ltd Neotract 500 Mobile HealthSystems Mentoring 3 Mentoring 2 Mentoring 1 Meeting Room Medtronic 130 Mediplus 407 Mddus Logixx Pharma Laborie MedicalTechnologies Koelis 614 Equipment) Ltd KeyMed (Olympus Medical&Industrial Kebomed 422 Karl Storz Endoscopy (UK)Ltd Janssen 306 Invivo 504 Intuitive Surgical Company 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 312 &216 Stand 404 606 506 830 550 230 320 502 740 334 720 324 744 746 748 322 810 414 210 416 314 418 214 618 516 716 126 218 512 712 717 212 50
Exhibition Listing BAUS Events 2018 /19
6-7 September 2018 Keble College, Oxford BAUS Section of Endourology Annual Meeting The meeting will include plenary sessions covering the following:
• Ureteric Colic Management - What is the • The Best Evidence for What I Do best marker of success? • Paper Presentations & Video Tips of the Trade • A Question of Sport: Endoluminal Team • How Social Media Affects Endourology vs Exoluminal Team
• Complex Renal Mass in Solitary The Social Dinner will be held at Keble College on Functioning Kidney Thursday 6 September. • Cutting the Stone: Bladder Stone Registration is open via the BAUS website at www.baus.org.uk Management • Audit Updates
17-21 September 2018 FRCS (Urol) Revision Course This course is aimed at those clinicians who have passed the MCQ / EMQ part of the FRCS (Urol) exam, with the afternoon sessions being devoted to mock vivas and examination technique. The course is split into different types of activities: St Catherine’s College, • Seminars from experts Oxford • Mock viva examinations • Microteaching sessions Course fees Member Fees Non-Member Fees Dinner: On Thursday 20 September 2018, 5 Nights Sun-Fri = £1180 5 Nights Sun-Fri = £1405 there will be a course dinner in Oxford City 4 Nights Mon-Fri = £1080 4 Nights Mon-Fri = £1305 Centre. Non-Residential = £775 Non-Residential = £1000 All registrations (residential & non-residential) include breakfast, lunch & refreshments throughout the week. Registrations with accommodation include dinner Monday - Wednesday. Registration is open via the BAUS website at www.baus.org.uk
The British Association www.baus.org.uk of Urological Surgeons BAUS Events 2018 /19
9-10 November 2018 Clayton Hotel, Birmingham Consultant and Associate Urological Specialists Refresher Course also be a debate on prostate imaging and biopsy methods, This year, we are re-launching the popular the modern treatment of metastatic prostate cancer, and of refresher course for consultants, with a new the latest therapies for Non Muscle-invasive bladder cancer. programme informed by the feedback from As well as the clinical component , and due to popular the previous, very successful course run by demand, we will also cover the recent changes in urological Shamim Khan in 2016. Aimed at those who and surgical training, revalidation, job planning and provide wish to keep up to date with the latest issues pointers on how to avoid litigation and to start up and in contemporary urological practice - or manage a private practice. those who just want to make sure that they are All the talks will be delivered by proven UK experts and practising in a sensible and effective way - this accomplished speakers so that your time is spent in the most course will provide a broad update on many effective way possible with high quality assured. areas. As ever, there will be a chance for networking and informal The clinical topics covered will include discussion during session breaks and at the evening dinner overviews in the investigation and on Friday 9 November. Places are limited to BAUS Members management of stone disease, haematuria, only on a first-come, first–served basis. CME certificates will erectile dysfunction, urosepsis, novel BPH be issued. therapies and female incontinence. There will Registration will open shortly via the BAUS website at www.baus.org.uk
6-7 December 2018 BAUS Section of Oncology York University Annual Meeting Exhibition Centre Join us for the BAUS Oncology Meeting on ‘urological pelvic malignancy’ in the beautiful • The management of oligometastatic and recurrent prostate and historic City of York. This will be a meeting cancer with something for every Uro-oncologist • Invited plenary speakers from USA and Europe will and trainee interested in pelvic cancers. The contribute to an excellent British faculty meeting will include plenary sessions covering This year an ‘Interpreting MRI in early prostate cancer’ teaching the following: course, run by Caroline Moore will take place, which is a must • New approaches in the management of for all FRCS (Urol) candidates! Finally, there will be an update superficial bladder cancer on the BAUS Oncology audits as well as a range of Poster • Minimally invasive radical cystectomy and Sessions with prizes for Trainees. The Social Dinner will be held reconstruction techniques at the National Railway Museum on Thursday 6th December. • The optimal Imaging in prostate cancer The programme will be available via the BAUS website at staging www.baus.org.uk; we will look forward to seeing you there! • New approaches to robotic radical Abstract submission & Registration will open shortly via the BAUS prostatectomy website at www.baus.org.uk
The British Association www.baus.org.uk of Urological Surgeons BAUS Events 2018 /19
7-10 January 2019 Core Urology Course This is an introductory course for trainees embarking on a career in urology. The course runs over four days and consists of lectures from experts in all College Court, Leicester elements of urological practice. It provides an unrivalled opportunity to meet with experienced clinicians who can help with Hands-on Simulator Training your development as a urologist. The course is aimed at those of ST3 grade, or those intending Running concurrently with the portfolio reviews will be to apply for training in urology in the next hands-on training workshops, with simulators supplied by round of national selection. Kit Companies. This will be an excellent opportunity to trial equipment. Consultants will be based in the room to Portfolio Review Sessions guide you through the equipment. On Tuesday 8 January, there will be portfolio/ interview activity sessions with ST3s & Course fees Registrars. Member Fees Non-Member Fees This session is a chance for core trainees 4 nights’ accommodation - £820 4 nights’ accommodation - £980 to sit down, one-to-one, to review their 3 nights’ accommodation - £740 3 nights’ accommodation - £900 portfolios and for ST3s to offer any tips on Non-residential: £530 Non-residential: £690 improving their portfolio and interview skills. All delegates will receive lunch & refreshments throughout the week. Registrations with accommodation include breakfast; dinner will not be provided on Tuesday 8 January. Registration will open in September 2018 via the BAUS website at www.baus.org.uk
24-27 June 2019 SEC Glasgow BAUS Annual Meeting Call for Abstracts Submission of abstracts for the BAUS 2019 Annual Meeting will open November 2018 and are welcomed on a variety of topics.
Abstract submission will open in November 2018 and be available on the BAUS website at www.baus.org.uk
The British Association www.baus.org.uk of Urological Surgeons 2 1 6 minutes for thepresentation, 4minutes Q&Aandturnaround Each presenter willhave 10minutes: Chairs: Trinity Bivalacqua &JohnMcGrath Monday 25June, 0900-1000, Room 3B Best Academic Paper Session B H L R Burge F Edison E C N J Simmons L Akman J Hallet A Organisation (YURO), Australia, Gupta S Hayne D Kingdom, Shergill I 1 Assaf N 1 Khetrapal P 10 Al-Dhahir W A T College London, Dept.ofStatistical Science, London, United Kingdom, M Lamb B Kingdom , Wang L Simpson R P Ng G Hayat Z United Kingdom D of Urology, London, United Kingdom, stone passage inpatients presenting withacute ureteric colic? the effectiveness ofmedically expulsive therapy inimproving spontaneous MIMIC study: doesthesize andlocation ofureteric stones have animpact on recurrence inpatients after radical cystectomy for bladdercancer The utility ofplasmacell-free DNAmutations indetecting metastatic J A British Urology Researchers inSurgical Training, DepartmentofUrology, London, United Kingdom, University College HospitalUrology Department,London, United Kingdom, Barts Health,Whipps Cross andtheRoyal London, London, United Kingdom, 17 30 68 28 60 65 49 71 14 9 1 63 38 41 , Kelly J , CurryD , Lawrentschuk N , O’Connell H , CampbellA , JalilR , Chow K , SimsonN , Tam J , Bateman K , RujancichP , MasonH , Mason-BahrD , Jaffer A 25 , Seaward L 12 1 19 47 6 33 , Cumberbatch M 20 22 76 5 36 , Rezvani S 44 , Nzenza T , ShahT 8 , Ratan H Newcastle University, Dept.ofUrology, Newcastle, United Kingdom, , Pankhania R 1 14 Addenbrooke’s Hospital, Cambridge, United Kingdom, , HendryJ 61 , Morrison-JonesV , Pickard R , Feber A , SandhuS , Hussain Z 58 17 , DasGuptaR , Tudor E 55 68 1 , Young M 63 , Ross D , DongL 52 , KhadhouriS 49 , Mosey R 28 , DinW , Yousif M , Symes A , SInghH 66 31 71 41 , Wozniak S , Cronbach P , Lee S 1 , OlivierJ , Gao C , Gao 38 47 25 1 12 9 , SadienI , Bycroft J 61 23 , Abdelmoteleb H 74 58 , KhanS , RuljancichP 5 36 2 63 , Probert J 44 , Erotocritou P , Kerr L , Wong Y , ShengS , Cumberbatch M 17 , Nkwam N , Biyani C 69 , MurtaghK , MacKenzie K 34 52 72 28 14 49 , OsmanB , Al-Qassim Z 1 , O’Rourke J , Hussain A , O’Keefe A , Hatem E , HoC 1 , Lavan L , IvinN 55 42 , Cottrell A 4 , Tay J Information Services Division,University College London (UCL),United 66 10 20 23 48 31 , ClementsJ , Demirel S 38 , McIlhenny C , Laird A , MiakhilI , BdeshaA 2 74 , Tan W 15 , Tailor K 61 63 7 , HusainJ , Parwaiz I 8 , Gallagher M , Gallagher University College London Hospital,Dept.ofUrology, London, United 37 , Matanhelia M , Maw J 12 42 , Grice P 45 69 50 , BegumR 28 , CannonA 72 6 , CarrieA , Kynaston H , Rowbotham C 2 , Arya M , SmithD 18 52 , ManningT , GohM 26 34 , Reid K 55 , Tay L 21 1 59 , Hawary A , Rodney S , Foley R , Withington J 48 , SharmaA 39 , Pang K 10 8 , SharmaS 31 , SaleemiA , AliAbdaalC , Graham S 74 67 , Tait C 37 15 , Kum F , HannG 23 , Davenport K , KhanM 28 53 72 , HarrisA 25-27 June 2018 - Liverpool BT Convention Centre 45 13 18 7 62 , Tregunna R , Ward A , MbuviJ , Kasivisvanathan V , HamadS 42 , MillerM , Bordenave M , Premakumar Y 64 , Coode-Bate J 35 69 3 59 , Moyles 32 , Peacocke A , AkintimehinA 1 , Yassaie O 26 , Patterson J , LambB 21 , Sakthivel A 75 , Eldred-Evans D 50 48 , PhippsS 67 , Symes R 37 10 39 , Gilmore C , Wong C , Nethercliffe J 56 , Kashora F , Koschel S 24 , LukA 53 73 , Ajayi L , Rogers A 45 8 , Parys B 9 , Stewart H 13 , AlHayek S , BediN Austin Hospital,Heidelberg, Australia, 15 , ShettyA 64 29 , Cameron F 1 , BriggsT , QuinlanD , Ibrahim H 3 70 18 40 Australian Young Urology Researchers 21 75 4 , Oyekan A , Weeratunga G 51 59 , Ngweso S , Pearce I 43 , CashmanS 32 56 62 BAUS ANNUAL MEETING , FrymannR , Al-ShakhshirS , Adams R 67 , Natarajan M , Suraparaju L , MinJ , Ager M 11 2 35 53 38 UCL Cancer Institute, London, , Gray S , BadgeryH 46 1 24 , KhanA , McKay A , Nehikhare O 11 , Kavia R 6 , Rodger F 73 13 Bendigo Health,Australia, 48 Whittington Hospital,Dept. 27 8 , Swallow D , SamsudinA 1 , Christidis D , OlaniyiP , BultitudeM , Thompson J 64 29 16 57 40 , ShinglesC , Evans S , McGrath S , Ness D 62 19 67 , Steen C 22 60 , Sriprasad S , EllisG , Ayres B 35 1 , Nyandoro M 75 , NambiarA 46 , Mirza A , Rezacova M 54 , AhmedI , MalkiM 11 43 70 , Graham J 25 , Brennan J 33 , IrvingS 51 , Udovicich 49 , DochertyE , O’BrienJ 38 13 , BelalM 65 , Stammeijer 57 , Abboudi , McCauley 7 9 , Gowardhan 73 27 , Derbyshire 41 , Liew M , Bolton 1 , Stonier 62 , Hughes- , Sridhar , Alberto 16 30 60 2 , Morrow , Kozan University , O’Brien 47 , Acher 76 19 , 43 , , 1 54 , 22 36 51 , 11 33 , , , , 58 , , 25 , , 54
Best Academic Paper Session 4 3 5 Infirmary, United Kingdom, University Hospital,Great Yarmouth, United Kingdom, Carlisle, United Kingdom, Hospitals, Addenbrookes Hospital, Cambridge, United Kingdom, Sheffield, United Kingdom, United Kingdom, Hospital, Mersey, United Kingdom, United Kingdom, Hospital, United Kingdom, Wigan, United Kingdom, United Kingdom, Northern Ireland, Hospital, United Kingdom, Australia , Kingdom , United Kingdom, Hospital, United Kingdom, Kingdom , Institute ofCancer Research, London, United Kingdom, Netherlands, Hospital, Oxford, United Kingdom, Patki P Weston SuperMare, United Kingdom, College Hospital,London ,United Kingdom, Winterbottom A Hospital ,United Kingdom Birtle A 1 Tran M 1 Howles S 12 Centre ,Glasgow, United Kingdom, 3 1 Bath, United Kingdom, Hospital, London, United Kingdom, J Valley Royal Hospital,United Kingdom, University HospitalNHSFoundation Trust, United Kingdom, Orthopaedics, Rheumatology andMusculoskeletal Sciences, University ofOxford, United Kingdom Trust ,Birmingham,United Kingdom, Kidney Cancer, Royal Free Hospital,London, United Kingdom, Dorchester, United Kingdom, United Kingdom, volume Optimal surgical treatment ofT1renal tumours correlates withnephrectomy susceptibility loci A Genome-wide association study ofkidney stone diseasereveals 5novel chemotherapy versus surveillance inuppertract urothelial cancer (UTUC) Results ofPOUT-AphaseIIIrandomised trialofperi-operative Kingdom, United Kingdom, Kingdom , United Kingdom, United Kingdom, Hospital, United Kingdom, Birmingham, United Kingdom, Kingdom UCL DivisionofSurgery andInterventional Science, London, United Kingdom, Nuffield DepartmentofSurgical Sciences, University of Oxford, United Kingdom, Royal Preston Hospital, United Kingdom, University HospitalsLeicester, United Kingdom, Box HillHospital,Melbourne, Australia, 8 , HillM 1,2 2 , MumtazF 1 , AbenK , JohnsonM 9 13 42 , Donovan J 66 46 44 1 St Barts&theLondon NHSTrust, United Kingdom, , Wiberg A Musgrove Park Hospital,Taunton, United Kingdom, Torbay andSouthDevon NHSFoundation Trust ,United Kingdom, Northwick Park /Central Middlesex Hospital,United Kingdom, North Manchester General Hospital,United Kingdom, 4 Netherlands Cancer Institute, Netherlands, 64 68 32 28 70 62 50 48 40 St Vincent’s University Hospital,Dublin,Ireland, University HospitalofSouthManchester, United Kingdom, 14 James Cook University Hospital,Middlesbrough, United Kingdom, Princess Alexandra Hospital,Harlow, United Kingdom, St George’s Hospital,London, United Kingdom, Wellington Hospital,New Zealand, Peterborough CityHospital,United Kingdom, Queen Alexandra Hospital,Portsmouth, United Kingdom, 3 Manchester Royal Infirmary, United Kingdom, , Neves J , Lewis R 2 , Barod R 2 58 2 , Kocklebergh R 10 , Furness D Salford Royal Hospital,Greater Manchester, United Kingdom, 75 19 , French A Darent Valley Hospital,Dartford, United Kingdom, Worthing Hospital,Western Sussex NHSTrust, United Kingdom, 6 60 56 54 38 26 University ofBirmingham,United Kingdom, Lister Hospital,Stevenage, United Kingdom, Royal Free Hospital,London ,United Kingdom, Royal Alexandria Hospital,Paisley, United Kingdom, Southend University Hospital,United Kingdom, Great Western Hospital,Swindon, United Kingdom, 21 1 9 Edinburgh, United Kingdom, 52 , Fowler S , HallE Queen ElizabethHospital,KingsLynn, United Kingdom, 2 , Aitchison M 8 17 8 Guy’s HospitalandKing’s College London, United Kingdom 15 Cardiff University, United Kingdom, Craigavon Area Hospital,NorthernIreland, Cheltenham General Hospital,Cheltenham, United Kingdom, 2 30 11 , Turney B 73 , HarrisC 24 Heidelberg Repatriation Hospital,Australia, 9 Whiston Hospital,Merseyside, United Kingdom, 13 Freeman hospital,Newcastle, United Kingdom, Broomfield Hospital,Chelmsford, United Kingdom, 2 Newcastle uponTyne Hospitals NHSTrust, United Kingdom, 5 3 , Sullivan M , Keeley F 36 Kingston Hospital,Surrey ,United Kingdom, 4 North Bristol NHSTrust, United Kingdom, 2 12 , Bex A 1 , Powles T 25-27 June 2018 - Liverpool BT Convention Centre 71 34 4 10 Western Health,Australia, , Catto J Kettering General Hospital,United Kingdom, University ofBristol, United Kingdom, 5 7 , Stewart G BAUS, United Kingdom, 2,4 12 22 Consumer Representative, London, United Fiona Stanley Hospital,Western Australia, 3 14 13 Netherlands Comprehensive Cancer Centre, Fight Bladder Cancer, Chinnor, United , Todd R 43 7 Oxford University Hospitals,Churchill Norfolk andNorwichHospital,United 41 5 49 45 , Bryan R Maroondah Hospital,Eastern Health, 65 Princess Royal Hospital,Haywards Heath, Northampton General Hospital,United 63 Sunderland Royal Hospital,United St James’s University Hospital,Leeds, 6 , Challacombe B 9 7 Clinical Trials andStatistics Unit, Beatson West ofScotland Cancer 39 9 BAUS ANNUAL MEETING 29 , Tregellas L Luton andDunstable Hospital, Heart ofEnglandNHSFoundation 47 61 20 57 6 69 Nottingham University Hospitals, 51 , JonesR Southmead Hospital,Severn, 2 Royal United Hospitals, Dorset County Hospital, University HospitalWales, Specialist Centre for 18 67 Queen ElizabethHospital, Cumberland Infirmary, Ulster Hospital,Belfast, 55 2 6 Nuffield Departmentof 27 72 Cambridge University Royal Devon andExeter 31 Guys Hospital,London, Weston General Hospital, High Wycombe Hospital, 33 59 74 James Paget Sheffield Teaching 9 7 53 25 Wigan Infirmary, , Wilson C , Chester 8 Rotherham General Glasgow Royal 5 , Mahrous A 37 76 The University of 14 Leicester General Wrexham Maelor Charing Cross 11 Southend 16 Chester 10 35 , King’s 23 Forth 2 , 55
Best Academic Paper Session 6 P 1 Trail M Microbiology andVirology, Western General Hospital,Edinburgh, United Kingdom ‘infection’? Results ofaprospective clinicalstudy Is itsafe to carryoutflexible cystoscopy whenurinarydipstick ispositive for Department ofUrology, Western General Hospital,Edinburgh, United Kingdom, 1 1 , CullenJM 1 , DickL 1 , Fulton E 1 , MacGregor E 25-27 June 2018 - Liverpool BT Convention Centre 1 , Clayton F 1 , Kalima P BAUS ANNUAL MEETING 2 Department ofMedical 2 , Donat R 1 , Mariappan 56
Best Academic Paper Session P1-4 P1-2 P1-1 3 minutes for thepresentation, 2minutes Q&Aandturnaround Each presenter willhave 5minutes: Chairs: Matthew Nielsen&Alex Colquhoun Monday 25June25,1030 -1200, Room 4 Bladder Cancer ePoster Session 1: 3 minutes for thepresentation, 2minutes Q&Aandturnaround Each presenter willhave 5minutes: ePoster Sessions P1-6 P1-5 of Sheffield,United Kingdom, United Kingdom, Statistics Unit,Institute ofCancer Research, London, United Kingdom, Winterbottom A Cancer Centre, Glasgow, United Kingdom, Birtle A 1 Trail M 1 Panwar P 1 Omar K 1 Tan W 11 3 1 DETECT investigators J urogram? ureteroscopy inpatients withsuspected uppertract urothelial cancer onCT Is itsafe to proceed directly to nephro-ureterectomy withoutdiagnostic nephroureterectomy: asinglecentre experience of uppertract urothelial tumourstreated by laparoscopic radical Role ofpreoperative urinarycytology andureteroscopy inthemanagement cystectomy: open,robotic andlaparoscopic (CORAL) trial Long term oncological outcomes following therandomised controlled study of3556 patients Who shouldbeinvestigated for haematuria? Aprospective observational chemotherapy versus surveillance inuppertract urothelial cancer (UTUC) Results ofPOUT-AphaseIIIrandomised trialofperi-operative O’Donnell M Kingdom NHS Lothian University Hospitals,Edinburgh, United Kingdom University HospitalsofNorthMidlands,Stoke onTrent, United Kingdom Guy’s Hospital,London, United Kingdom, University College London, London, United Kingdom Royal Preston Hospital,United Kingdom, University HospitalsLeicester, United Kingdom, Southend University HospitalNHSFoundation Trust, United Kingdom, 8 , HillM 1 1 , Feber A , Waheed-Rahman S 1 1 , NairR , JohnsonM 9 , Donovan J 1 , Thursby H 1 , Leung S 13 1 St Barts&The London NHSTrust, United Kingdom, , Thurairaja R 1 , SapongR 14 , Lewis R 2 , Kocklebergh R 10 1 , Kalyanasundaram K 1 , French A , Laird A 6 University ofBirmingham,United Kingdom, 9 , HallE 1 1 , Khetrapal P , Broadhurst W 1 , Rimington P 1 11 , HarrisC 9 2 2 Newcastle uponTyne HospitalsNHSTrust, United Kingdom, 8 Eastbourne District General Hospital,United Kingdom 3 Cardiff University, Cardiff, United Kingdom, , Keeley F 1 , Rodney S 4 North Bristol NHSTrust, United Kingdom, 12 1 2 , GolashA 1 , PhippsS , DasguptaP , Powles T 25-27 June 2018 - Liverpool BT Convention Centre 4 , Catto J 1 , Williams N 1 1 , Fernando H 13 , Thomas B , Todd R 1 5 , KhanS , Bryan R 14 10 12 Fight BladderCancer, Chinnor, United University ofBristol, United Kingdom, Consumer Representative, London, 9 BAUS ANNUAL MEETING 7 , Tregellas L 1 , Brew-Graves C Beatson West ofScotland 1 1 , Cutress M 6 1 , JonesR 9 Clinical Trials and 9 7 1 , Wilson C , Chester , McNeillA 5 The University 1 , Kelly J 10 1 , , 1 , 57
ePosters: 1 P1-13 P1-12 P1-11 P1-10 P1- 9 P1-8 P1-7 Cancer Research, London, United Kingdom Kingdom, County Hospital,Guildford, United Kingdom Hospitals NHSFoundation Trust, Cheltenham, United Kingdom, United Kingdom, 1 Mostafid H 3 1 Ashton A 1 Ayres B 1 Austin T 1 Dooher M 1 Bedi N,Stefanova I,ShamsuddinA 1 Tan W Representative, Hampshire, United Kingdom, Lewis R Hospitals NHSTrust, United Kingdom, Knowles M NHS Foundation Trust, Middlesbrough, United Kingdom, (NMIBC) versus surgical managementinlow risknon-muscleinvasive bladdercancer Results ofCALIBER:AphaseIIrandomised feasibility trialofchemoablation BCG-unresponsive non-muscleinvasive bladdercancer –Amulticentre study Hyperthermic intravesical chemotherapy usingthecombat BRSsystem for invasive bladdercancer that hasfailed BCG 10-year experience ofRITEthermochemotherapy for highrisknon-muscle standard protocol inasingleUKcentre -shouldthisbethe new standard? Day caseprimarytransurethral resection ofbladdertumour(TURBT) as TURBT training –acontrolled study evaluating outcomes The value ofphotodynamic diagnosis(PDD) incombination withdedicated urothelial tumours usingthe1470 nmdiodelaser:Ourexperience sofar Outpatient flexible cystoscopy andtransurethral laserablation (TULA) for visible haematuria? Can CTintravenous urogram bereplaced withrenal tract ultrasound for non- investigators Royal Surrey County Hospital NHSFoundation Trust, Guildford, United Kingdom, St Richard’s Hospital,Chichester, United Kingdom, St George’s Hospital,London, United Kingdom Urology Department,Portsmouth, United Kingdom Western General Hospital, Edinburgh, United Kingdom Northwick Park Hospital,London, United Kingdom University College London, United Kingdom Netherlands Cancer Institute –Antoni van Leeuwenhoek Hospital,Amsterdam, Netherlands, 1 , Feber A 12 1 , BackhouseC 1 9 , HallE , Robinson R Royal Devon andExeter NHSFoundation Trust, United Kingdom, 1 , deJongJ 1 , SimpsonH,GietzmannW, Smith H,MainsE,Mistry K,MariappanP 8 1 , Cresswell J , McGrath J 4 University College London HospitalsNHSFoundation Trust, United Kingdom, 12 1 , SarpongR 2 1 , HendricksenK , Forshaw C 1 , JohnB 9 , Cooke P 2 , GriffithsL 1 , Rodney S 1 , Thakkar R 11 10 Medway NHSTrust, Gillingham,United Kingdom, 1 , HodgsonD , MasoodS 3 , Kelly J 3 , Rosier M 6 1 University ofSheffield,United Kingdom, , Williams N 1 , Pulikal A 2 4 Erasmus MCCancer Institute, Rotterdam, Netherlands, , KnightA 25-27 June 2018 - Liverpool BT Convention Centre 11 , GoubarA 1 , HallS 2 3 , BoormansJ University HospitalsofLeicester NHSTrust, 1 , Brew-Graves C 1 , Perry M 1 , Wilby D 8 5 Leeds Teaching HospitalsNHSTrust, United , Catto J 12 , Penegar S 2 1 , Mostafid H , Bailey M 1 BAUS ANNUAL MEETING 6 , Davenport K 10 The Royal Wolverhampton 1 , Kelly J 12 2 South Tees Hospitals , Porta N 1 , Issa R 7 4 Gloucestershire 12 1 , DETECTI The Institute of 7 , Feber A 4 12 1 Royal Surrey , Wiley L 5 Patient 4 , 12 , 58
ePosters: 1 P1-3 P1-18 P1-17 P1-16 P1-15 P1-14 Hospital, Belfast, United Kingdom Surgeons, London, United Kingdom Trust, United Kingdom, United Kingdom 1 Ellis R 1 Khetrapal P 1 Moore M 3 1 Moore M 1 Varughese M 1 Malde S A United Kingdom Hospital, Sheffield,United Kingdom City Hospital,Nottingham,United Kingdom suspected upper tract urothelial cancer The utilityofpre-operative CTurography inthediagnosisofpatients with recurrence inpatients after radical cystectomy for bladdercancer The utilityofplasmacell-free DNAmutations indetecting metastatic BAUS sectionofoncology hydronephrosis ontheoutcome ofradical cystectomy (RC)onbehalfofthe 2015-2016: theimpactofpre-operative renal failure (RF) and/or British Association ofUrological Surgeons (BAUS) cystectomy database impact oncystectomy outcomes onbehalfoftheBAUS section ofoncology 2015-2016: Pre-operative cardiopulmonary exercise testing (CPET) andits British Association ofUrological Surgeons (BAUS) cystectomy database of diagnosisandmanagementwithintheUK Current radiotherapy practice ofmuscleinvasive bladdercancer: assessment of adherence to NICEguidelinesintheUK Discharge oflow-risk non-muscle-invasive bladdercancer: Anational survey Guildford, United Kingdom, Kingdom, NHS Foundation Trust, United Kingdom, Department ofUrology, Nottingham CityHospital,United Kingdom, University College HospitalUrology Department,London, United Kingdom, Royal Devon andExeter NHSFoundation Trust, Exeter, United Kingdom, Royal Devon AndExeter NHSFoundation Trust, United Kingdom, Beacon Centre, Musgrove Park Hospital,Taunton, United Kingdom, Guy’s andSt Thomas’ NHSFoundation Trust, London, United Kingdom, James Cook University Hospital,Middlesbrough, United Kingdom, 1 , Kelly J 1 , Scriven S 1 , Mostafid H 3 1 1 , Rowe E Rowe , E Rowe , James Cook University Hospital,Middlesbrough, United Kingdom, 1 , Feber A 1 , DongL 1 , Treece S,Drinkwater K 1 , Lloyd J 2 2 , Cresswell J , Cresswell J 1 5 2 South Tees HospitalsNHSFoundation Trust, United Kingdom, 2 , Mir-Kohler A , Wong Y 3 North Tyneside General Hospital,United Kingdom, 2 , Ratan H 2 3 3 , Tan W , Fowler S , Fowler S 3 1 Royal College ofRadiologists, London, United Kingdom, , BagnallP 1 3 , McAleeseJ 1 , Rodney S 4 4 , McGrath J , McGrath J 25-27 June 2018 - Liverpool BT Convention Centre 3 , Taylor J 1 , LambB 4 1 1 4 , Creswell J 2 North Bristol NHSTrust, United Kingdom, 4 2 British Association ofUrological Surgeons, Peterborough andStamford Hospitals 2 Department ofRadiology, Nottingham 1 , BriggsT 2 Royal Surrey County Hospital, 2 North Bristol NHSTrust, United BAUS ANNUAL MEETING 2 UCL Cancer Institute, London, 4 British Association ofUrological 5 4 , Catto J Salford Royal Foundation 1 , Thompson J 6 Royal Hallamshire 6 1 4 , Sridhar Belfast City 59
ePosters: 1 P2-1 Chairs: Luke Forster &NikhilVasdev Tuesday 26June, 0830-1000, Room 4 Improvement Management, Governance, Education andQuality ePoster Session 2: P2-5 P2-4 P2-3 P2-2 P2-8 P2-7 P2-6 1 Foster L 1 Megson M 1 Warner R 1 Malthouse T 3 1 Manson R 3 1 Manson R 1 Pallari E 1 Elves A quality improvement training modulefor urology trainees Development, delivery andtheory-driven evaluation ofanevidence-based The urology cancer MDT: what canbeimproved? Thames urology regional meeting community? Areview oftheoutcomes ofabstracts presented at theSouth Do regional meetingpresentations addvalue to thewiderscientific survey Urologist workload – an up to date picture. Results from the BAUS workforce Results from theBAUS workforce survey Subspecialty urology –canwe predict where gapswillbein7years’ time? follow upcare for citizens withprostate cancer A patient centred, self-managementappproviding digitalsupport and Mobile appsfor lower urinarytract symptoms education training (COMET) Urology low fidelitysimulation teaching -clinically observed medical London, United Kingdom, NHS HealthTrust, London, United Kingdom Department ofUrology, Whipps Cross University Hospital,London, United Kingdom George EliotHospital,Nuneaton, United Kingdom Whipps Cross University Hospital, London, United Kingdom, Brighton &Sussex University HospitalsNHS Trust, United Kingdom Queen ElizabethUniversity Hospital,Glasgow, United Kingdom, Queen ElizabethUniversity Hospital,Glasgow, United Kingdom, King’s College London, United Kingdom, Shrewsbury andTelford NHSTrust, United Kingdom, On behalfofBAUS and theSpecialist Advisory Committee inUrology, On behalfofBAUS and theSpecialist Advisory Committee inUrology, 1 , DunkS 1 1 , KhadjesariZ , Warner R 1 1,2,3 1 , Pottle E , Palmer M 1 , SinghS , Palmer M 1 , Sturch P, Symes A,LarnerT 1 , Perry S 2 1 , Bastianpillai C , Taylor C 3 1 , Biyani S School ofHealthSciences, University ofSurrey, United Kingdom 1 , SrihariN 3 , Green J 2 , JainS 1 1 2 , Green J , Pope R Leeds Teaching HospitalsNHSTrust, Leeds, United Kingdom, 1 2 , Sevdalis N 2 1 , KhanduriS 25-27 June 2018 - Liverpool BT Convention Centre 2 Dynamic Health Systems, United Kingdom 1 2 , Green J School ofMedicalEducation, King’s College 2 2 Glasgow Royal Infirmary, United Kingdom, Glasgow Royal Infirmary, United Kingdom, 1 , Redgrave R 3 BAUS ANNUAL MEETING 1 3 Barts 60
ePosters: 2 P2-16 P2-15 P2-14 P2-13 P2-12 P2-11 P2-10 P2-9 A 1 Habib A 1 Hall S 1 Hadjipavlou M 1 Kulkarni M 1 Gill N 1 Reid J 1 Donato P 1 Miah S Gibbons N capacity withcost savings Spare thescope. Guideline-basedflexible cystoscopy safely improves urology ward Collaborating withgeriatricians to improve care for frail patients ona throughout theUKover thelast decade Urologists beware -Astudy ofthepatterns oflitigation inurology abuse? Is the“two-week wait” cancer pathway inurology fit for use, oropen to cancer basedonPROMISdata Significant cost savings achievable withdiagnostic pathway for prostate a one-year period multiparametric MRIandprostate biopsies;assessment ofsustainability over A one-stop prostate cancer diagnostic clinicincorporating same-day removal Cost benefitanalysis ofadisposableflexible cystoscope for ureteric stent urology virtualclinic A prospective clinical,cost andenvironmental analysis ofaclinician-led London NorthWest University Healthcare NHSTrust, United Kingdom Royal Derby Hospital,United Kingdom The Urology Centre, London, United Kingdom Guy’s andSt Thomas’ Foundation Trust, London, United Kingdom Royal Gwent Hospital,Newport, United Kingdom The Royal Free Hospital,London, United Kingdom Redcliffe Hospital,Queensland, Australia Charing Cross Hospital,London, United Kingdom, 1 1 1 , Carter A 1 , Evans B , McCarthy F 1 , Dunford C 1 , Batura D 1 , Honore M 1 1 , Hrouda D , Addow A,Fernando A 1 , Fernando A 1 1 , Tuckwood L , Wilson J 1 1 , Eldred-Evan D , Hellawell G 1 , GoodeA 1 , RukinN 1 1 1 1 , Gordon A 1 1 , Marcus A , Bowes W 1 2 , Edison M 1 1 , Williams S , Train M 1 , Pokorny M 2 Imperial Collage, London, United Kingdom 25-27 June 2018 - Liverpool BT Convention Centre 1 , Gan C , Gan 1 , Grant L 1 1 1 , Aldiwani M 1 , Volanis D BAUS ANNUAL MEETING 1 , ShahT 1 , SmithG 1 , AhmedH 1 , SinghP 2 , 1 Roy , Roy
61
ePosters: 2 P3-7 P3-6 P3-5 P3-4 P3-3 P3-2 P3-1 Chairs: RajPersad &Ayman Younis Tuesday 26June, 0830-1000, Room 12 Infertility Andrology, Reconstruction, Penile Cancer andMale ePoster Session 3: London, NIHRBiomedicalResearch Centre, London, United Kingdom Surgery, BritishAssociation ofUrological Surgeons, London, United Kingdom 1 Kumar V 1 Ager M 1 Alnajjar H 1 Sujenthiran A 1 Skrodzka M 1 Skrodzka M 1 Bullock N Oncology, University College London Hospitals,London, United Kingdom, Education, University ofSouthWales, Pontypridd, United Kingdom, United Kingdom period in>100patients node biopsy (DSNB) inpenilecancer- aprospective study over an8-year Role ofmodernimaginginreducing false negative rate ofdynamicsentinel carcinoma ofthepenis ipsilateral groin isclinicallyandpathologically positive insquamouscell Management oftheclinicallynegative contralateral groin whenthe affect survival rates for patients withsquamous cell carcinoma ofthepenis? Does thetypeofsurgical procedure for inguinallymphnodemanagement invasive penilecancer Oncological outcomes of100glansresurfacing procedures for superficial Glanspexy for floppy glans-outcomes andpatient satisfaction ROLOCS (restoration ofthelost obscured coronal sulcus) procedure How to doacircumcision, whentheforeskin iswelded to theglans.The current practice The emergency managementofpriapismintheUnited Kingdom:asurvey of London, United Kingdom Norfolk andNorwichUniversity Hospital, Norwich,United Kingdom St George’s University Hospital,London, United Kingdom Department ofUrology, University College London Hospitals,London, United Kingdom, Kingston HospitalNHSFoundation Trust, London, United Kingdom, University College HospitalofLondon, London, United Kingdom University College HospitalofLondon, London, United Kingdom, Department ofUrology, Royal Glamorgan Hospital,Llantrisant,United Kingdom, 1 , Manjunath A 1 , Natarajan M 1 1 , BennettA , Christodoulidou M 1 1 , BlecherG , Ayers J 1 , Yan S 2 2 1 1 , Rea A , Ager M , Steggall M , Yan S 1 , SethiaK 1 , MoubasherA 1 2 , LamW , Hadway P 1 2 , NigamR , Corbishley C 1 2 , Brown G 1 , Tinwell B 1 , JohnsonM 1 2 , MaloneP , BritnellW 1,2,3 2 25-27 June 2018 - Liverpool BT Convention Centre , Tinwell B 1 , Corbishley C 1 , Garaffa G 1 , Mitra A 2 , MuneerA 2 2 , Ayres B,Watkin N The Royal Berkshire Hospital,Reading, 3 2 Section ofAndrology andGenito-Urethral St Georges Healthcare NHSTrust, 2 , Alifrangis C 1 , RalphD 1 , Ayres B 3 BAUS ANNUAL MEETING 1 UCLH andUniversity College , MaloneP 2 Faculty ofLife Sciences and 1 1 , Watkin N 2 , RalphD 1,2 2 Department of 1 1 , MuneerA 3 62
ePosters: 3 P3-14 P3-13 P3-12 P3-11 P3-10 P3-9 P3-8 S College London Hospital,United Kingdom 4 1 Vicens-Morton A 1 Hallerstrom M 1 Morris S extraction innon-obstructive azoospermia? I 1 Payne S 1 Payne S 1 Bugeja S 1 Bugeja S Fertility Clinic,London, United Kingdom, male infertility andpredict live birthsfollowing bothIVFandICSI Novel measures ofspermDNAdamageincrease itsusefulness to diagnose with non-mosaicklinefelter’s syndrome undergoing mTESE A UKmulticentre study analysing thesurgical spermretrieval rates inmen Kingdom Contemporary surgical management ofurethral diseaseintheUnited United Kingdom Aetiology, presentation andinitialevaluation ofurethral diseaseinthe undergoing different approaches to bulbarurethroplasty Evaluation ofpatient reported outcome methods(PROM)inpatients Bulbar urethral strictures after thetreatment ofprostate cancer (CaP) United Kingdom Denmark, Mohammadi AmrMoubasherB Urology Department-Guy´sandSt Thomas´ NHStrust, London, United Kingdom, University College London Hospital,United Kingdom Guy’s andSt. Thomas’ NHSFoundation Trust, London, United Kingdom, BAUS, London, United Kingdom, BAUS, London, United Kingdom, University College London Hospitals,NHSFoundation Trust, London, United Kingdom University College London Hospitals,NHSFoundation Trust, London, United Kingdom SpermComet -Fertility Unit,Belfast, United Kingdom, s there arole for salvage orredo micro-dissection testicular sperm 1 , RalphD 1 1 1 , Fowler S , Fowler S 6 , Yap T 1 1 , Ivaz S Imperial College Healthcare NHSTrust -Malefertility Unit,London, United Kingdom, , Ivaz S 1
1 , JohnsonM 1 , Alkematy K 1 1 , Frost A , Dragova M 1 , Nicopoullos J 1 1 , MundyT , MundyT 1 , Dragova M 1 , Sangster P 2 2 2 2 2 1 University College HospitalLondon, United Kingdom University College HospitalLondon, United Kingdom , CamposJuanatey F , BhandariC 1 , Hafez K 2 , Lewis S 3 Queens University Hospital-Fertility Unit,Belfast, United Kingdom, 1 , AndrichD 1 , RaheemA 1 , BhandariC 2 3 , Garraffa G , Lee K 25-27 June 2018 - Liverpool BT Convention Centre 5 Cryos Fertility -Department of Pathology, Aarhus, 4 1 , MundyA , LarsenP 1 , Frost A 1 , ZainalY 1 , Vincens A 2 , Sangster P 1 , AndrichD 5 1 , Ramsay J 1 , Poselay S 2 University College Hospital,London, BAUS ANNUAL MEETING 1 , Yap T 2 , ShabbirM 1 2 6 , MundyA The Lister Hospital 1 1 , MinhasS , JohnsonT , ShabbirM 1 , MinhasS 1 7 7 University , Yap T 1 1 , Minhas , 2 1
63
ePosters: 3 P4-4 P4-3 P4-2 P4-1 Chairs: BenChew &Matt Bultitude Tuesday 26June, 1030 -1200, Room 4 Stones, ImagingandUpperTract Disorders ePoster Session 4: B H L R Burge F Edison E C N J Simmons L Akman J Hallet A Gupta S Hayne D Shergill I Assaf N 1 Bhat A 1 Howles S 1 Kum F Al-Dhahir W T M Lamb B Wang L Simpson R P Ng G Hayat Z Orthopaedics, Rheumatology andMusculoskeletal Sciences, University ofOxford, United Kingdom D spontaneous stone passage in patients presenting withacute ureteric colic? impact ontheeffectiveness ofmedically expulsive therapy inimproving MIMIC Study: Doesthesize andlocation ofureteric stones have an Renal papillarybiopsy &lithogenesis-aninsight susceptibility loci A genome-wide association study ofkidney stone diseasereveals 5novel phenotype? Does thegenotypeinfirst-degree relatives with cystinuria relate to their J A Dr S.NMedicalCollege Jodhpur, India, Nuffield DepartmentofSurgical Sciences, University of Oxford, United Kingdom, Guy’s andSt. Thomas’ Hospitals,London, United Kingdom 17 30 68 28 60 65 49 71 14 9 63 38 41 , CurryD , Lawrentschuk N , O’Connell H , CampbellA , JalilR , Chow K , SimsonN , Tam J , Bateman K , RujancichP , MasonH , Mason-BahrD , Jaffer A 25 1 , Seaward L 1 , Wong K , AhmedB 12 1 19 47 6 33 , Cumberbatch M 20 22 76 36 , Rezvani S 44 , Nzenza T , ShahT , Ratan H 1 , Pankhania R , Wiberg A 14 , HendryJ 61 , Morrison-JonesV , Pickard R , SandhuS , Hussain Z 58 17 , DasGuptaR , Tudor E 55 68 , Young M 63 , Ross D 52 , KhadhouriS 49 , Mosey R 28 , DinW , Yousif M , Symes A , SInghH 66 31 71 41 1 , MeinR , Wozniak S , Cronbach P , Lee S 1 , OlivierJ , Gao C , Gao 1 , Bhat M 38 47 25 12 9 , SadienI , Bycroft J 61 23 , Abdelmoteleb H 74 58 , KhanS , RuljancichP 2 5 36 63 , Probert J , Furness D 44 , Erotocritou P , Kerr L , ShengS , Cumberbatch M 17 , Nkwam N , Biyani C 69 , MurtaghK , MacKenzie K 34 52 72 28 14 49 , OsmanB , Al-Qassim Z 1 1 , O’Rourke J , Hussain A , BultitudeM , O’Keefe A , Hatem E , HoC 1 , Lavan L , IvinN 55 42 1 , Bhat A , Cottrell A , Tay J 66 10 20 23 48 31 , ClementsJ , Demirel S 38 , McIlhenny C , Laird A , MiakhilI , BdeshaA 74 15 , Tailor K 61 63 2 , HusainJ , Parwaiz I 8 , Gallagher M , Gallagher , Turney B 37 , Matanhelia M 2 , Maw J 12 S.P.Medical College Bikaner, IndiaWITHDRAWN 42 , Grice P 45 69 50 2 , BegumR 28 , CannonA , Khandelwal N 72 6 , CarrieA , Kynaston H , Rowbotham C 2 , Arya M , SmithD 18 52 , ManningT , GohM 1 26 34 , Reid K , Thomas K 55 , Tay L 21 59 , Hawary A , Foley R , Withington J 48 , SharmaA 39 , Pang K 10 8 , SharmaS 31 , SaleemiA , AliAbdaalC , Graham S 74 67 , Tait C 37 15 1 , Kum F , HannG 23 , Davenport K , KhanM 28 53 72 , HarrisA 25-27 June 2018 - Liverpool BT Convention Centre 45 13 18 7 62 , Tregunna R , Ward A , MbuviJ , Kasivisvanathan V , HamadS 42 , MillerM , Bordenave M , Premakumar Y 64 , Coode-Bate J 35 69 3 59 , Moyles 1 32 , Peacocke A , AkintimehinA , Yassaie O 26 , Patterson J 2 21 , Sakthivel A 75 , Eldred-Evans D 50 48 , PhippsS 67 , Symes R 37 10 39 , Gilmore C , Wong C , Nethercliffe J 56 , Kashora F , Koschel S 24 , LukA 53 73 , Ajayi L , Rogers A 45 8 , Parys B , Stewart H 13 , AlHayek S , BediN 15 , ShettyA 64 29 , Cameron F , QuinlanD , Ibrahim H 70 18 40 21 75 4 , Oyekan A , Weeratunga G 51 59 , Ngweso S , Pearce I 43 , CashmanS 32 56 62 BAUS ANNUAL MEETING , FrymannR , Al-ShakhshirS , Adams R 67 , Natarajan M , Suraparaju L , MinJ , Ager M 11 35 53 38 , Gray S , BadgeryH 46 1 24 , KhanA , McKay A , Nehikhare O , Kavia R , Rodger F 73 13 48 27 8 , Swallow D , SamsudinA , Christidis D , OlaniyiP , BultitudeM 2 Nuffield Departmentof 64 29 16 57 40 , ShinglesC , Evans S , McGrath S , Ness D 62 19 67 , Steen C 22 60 , Sriprasad S , EllisG , Ayres B 35 1 , Nyandoro M 75 , NambiarA 46 , Mirza A , Rezacova M 54 , AhmedI , MalkiM 11 43 70 , Graham J 25 , Brennan J 33 , IrvingS 51 , Udovicich 49 , DochertyE , O’BrienJ 38 13 , BelalM 65 , Stammeijer 57 , Abboudi , McCauley 7 9 , Gowardhan 73 27 , Derbyshire 41 , Liew M , Bolton , Stonier 62 , Hughes- , Alberto 16 30 60 , Morrow , Kozan , O’Brien 47 , Acher 76 19 , 43 , , 1 54 , 22 36 51 , 11 33 , , , , 58 , , 25 , , 64
ePosters: 4 P4-8 P4-7 P4-6 P4-5 Hospital, Paisley, United Kingdom, Ireland, Portsmouth, United Kingdom, United Kingdom, Melbourne, Australia, United Kingdom, Kingdom, Hospital, United Kingdom, United Kingdom, London, United Kingdom, Alexandra Hospital,Harlow, United Kingdom, Organisation (YURO), Australia, Kingdom, United Kingdom, Kingdom, Infirmary, United Kingdom, Hospital, KingsLynn, United Kingdom, 3 1 Joshi H 1 Pietropaolo A 1 Sandoval BarbaH 1 Sandoval BarbaH 26 21 19 8 1 Kingdom, Cook University Hospital,Middlesbrough, United Kingdom, United Kingdom, College London, Dept.ofStatistical Science, United Kingdom, United Kingdom, Manchester, United Kingdom, Health, Whipps Cross andtheRoyal London, United Kingdom, Hospital, Stevenage, United Kingdom, Kingdom, Kingdom, new comprehensive patient reported outcome measure Urinary stones andintervention quality oflife (USIQOL):Development ofa prior urosepsis andemergency drainage Outcomes ofelective ureteroscopy andstone treatment in patients with Ureteric stones andacute kidney injury:What predicts progression? ureteric stone passage Proximal-to-distal ureteric ratio (PDUR):anovel predictor of spontaneous United Kingdom, United Kingdom, United Kingdom, Australia, Urology, London, United Kingdom, United Kingdom, University HospitalofWales, Cardiff, United Kingdom, University HospitalSouthampton NHSFoundation Trust, United Kingdom Queen ElizabethHospital,Birmingham,United Kingdom Queen ElizabethHospital,Birmingham,United Kingdom British Urology Researchers inSurgical Training, DepartmentofUrology, London, United Kingdom, Soutmead HospitalandBUI, Bristol, United Kingdom, Addenbrooke’s Hospital,Cambridge, United Kingdom, Edinburgh, United Kingdom, Darent Valley Hospital,Dartford, United Kingdom, Great Western Hospital,Swindon, United Kingdom, 65 1 , RajaA Sunderland Royal Hospital,United Kingdom, 72 76 69 63 36 30 5 Newcastle University, Dept.ofUrology, United Kingdom, Weston General Hospital, Weston SuperMare, United Kingdom, Wrexham MaelorHospital,United Kingdom St James’s University Hospital,Leeds, United Kingdom, Kingston Hospital,Surrey, United Kingdom, University HospitalWales, United Kingdom, Heidelberg Repatriation Hospital,Australia, 1 , Kyriakides R 74 67 61 49 45 43 34 24 17 15 2 Craigavon Area Hospital,NorthernIreland, Cheltenham General Hospital,Cheltenham, United Kingdom, Southmead Hospital,Severn, United Kingdom, Wigan Infirmary, United Kingdom, Ulster Hospital,Belfast, NorthernIreland, Freeman hospital,Newcastle, United Kingdom, Northampton General Hospital,United Kingdom, Norfolk andNorwichHospital,United Kingdom, Kettering General Hospital,United Kingdom, Princess Royal Hospital,Haywards Heath, United Kingdom, , Teleb H 1 1 13 , HaqueR , ScallanN Broomfield Hospital,Chelmsford, United Kingdom, 57 47 41 Royal United Hospitals,Bath, United Kingdom, Nottingham University Hospitals,United Kingdom, Maroondah Hospital,Eastern Health,Australia, 1 , Bratt D 59 22 51 Sheffield TeachingHospital,United Kingdom, Fiona Stanley Hospital,Western Australia, Queen ElizabethHospital,Birmingham,United Kingdom, 4 1 Information Services Division,University College London (UCL),United , JonesP 1 , KingT 1 , Chithiramohan A 55 7 University College London Hospital,Dept.of Urology, United Kingdom, Royal Devon andExeter Hospital,United Kingdom, 39 53 2 Luton andDunstable Hospital,United Kingdom, , Bolomytis S Rotherham General Hospital,United Kingdom, 1 , Subramonian K 1 , Geraghty R 29 Heart ofEnglandNHSFoundation Trust, Birmingham, United 20 25-27 June 2018 - Liverpool BT Convention Centre Dorset County Hospital,Dorchester, United Kingdom, 27 75 66 4 Guys Hospital,London, United Kingdom, Worthing Hospital,Western Sussex NHSTrust, United 2 Cardiff University, United Kingdom 37 9
31 St. JamesUniversity Hospital, Leeds, United Kingdom, 3 1 70 Torbay andSouthDevon NHSFoundation Trust, , Subramonian K Austin Hospital,Heidelberg, Australia, , PhilipJ High Wycombe Hospital,United Kingdom, Leicester General Hospital,United Kingdom, Wellington Hospital,New Zealand, 1 33 , Oliver R 68 James Paget University Hospital,Great Yarmouth, 18 University HospitalofSouthManchester, United 3 1 11 Cumberland Infirmary, Carlisle, United Kingdom, Australian Young Urology Researchers Bendigo Health,Australia, 35 King’s College Hospital,London, United 62 25 3 St George’s Hospital,London, United , Biyani C 44 64 Glasgow Royal Infirmary, United Kingdom, 6 46 Whittington Hospital,Dept.of North Manchester General Hospital, St Vincent’s University Hospital,Dublin, Northwick Park /Central Middlesex 1 , SomaniBK 23 14 BAUS ANNUAL MEETING 58 Charing Cross Hospital,London, Forth Valley Royal Hospital, 73 42 1 Salford Royal Hospital,Greater Whiston Hospital,Merseyside, Musgrove Park Hospital,Taunton, 60 2 50 Southend University Hospital, , Wood F 48 16 Queen Alexandra Hospital, Chester Hospital,Mersey, Peterborough CityHospital, 1 54 56 40 Royal Alexandria 52 Royal Free Hospital, 4 Manchester Royal 12 Queen Elizabeth Box HillHospital, 71 Western Health, 10 28 Barts Princess 2 32 University James 38 Lister 65
ePosters: 4 P4-12 P4-11 P4-10 P4-9 P4-14 P4-13 P4-16 P4-15 Cutner A Kingdom Burgess N 1 Althaus A 1 Kadhim H 1 Abushamma F 1 Oliver R 1 Hanah M 1 Raju J 1 Mikhail M 1 Finch W 5 Endometriosis Centre, University College London HospitalsNHSFoundation Trust, United Kingdom in theUK Risk factors for bloodtransfusion following percutaneous nephrolithotomy Local anaesthetic flexible ureterorenoscopy: painful for allinvolved? non-contrast CT KUB Calyceal diverticula (CD): diagnosisandmanagementoptionsintheera of with spinalcord injury(SCI) Outcomes ofureteroscopy (URS)for kidney stone disease(KSD) inpatients surgery instented patients The outcomes ofureterolysis duringcomplex rectovaginal endometriosis registry Is PCNLchangingintheUK–analysis of9500 casesfrom theBAUS PCNL Non-operative managementofpelvi-ureteric obstruction (PUJO) improvement project Fate oftheantegrade ureteric stent –An observational study andquality Kingdom, and NorwichUniversity Hospital,United Kingdom, Addenbrooke’s Hospital,Cambridge, United Kingdom, Department ofUrology, Eastbourne, United Kingdom North Bristol NHSTrust, United Kingdom Salisbury NHSFoundation Trust, United Kingdom Nottingham University Hospitals,United Kingdom, University HospitalsofNorthMidlands, Stoke-on-Trent, United Kingdom Institute ofUrology, University College London HospitalsNHSFoundation Trust, United Kingdom, Norfolk andNorwichUniversity Hospitals,United Kingdom, Oxford University Hospitals, United Kingdom, 1 , Thursby H 1 1 , New F 3 1 , ArmitageJ 2 , MannG BAUS, 1 , SmithD 1 1 , FisherG 3 , Withington J , Pai A , Wiseman O 1 , Ito H,Aboumarzouk O, Harding R,PhilipJ, Timoney A,Keeley F 4 Guy’s Hospital,London, United Kingdom 1 , Davies M 1 , Wai H 1 1 , Muthoveloe D 1 2 , ArumuhamV 2 , Withington J 1 1 , ChanK 2 , FinchW 1 , Brewin J 1 , MackieS 1 , George C 1 3 , Tasleem A , SmithD 4 , IrvingS 1 6 The BritishAssociation ofUrological Surgeons, London, United 4 1 , Watson G 2 University College Hospital,London, United Kingdom, Rotherham General Hospital,United Kingdom 1 4 , Fernando H 25-27 June 2018 - Liverpool BT Convention Centre 1 , Turney B , Fowler S 1 , ChoongS 2 Royal Free Hospital,London, United Kingdom, 2 Addenbrookes Hospital,Cambridge, United 1 5 3 , Fowler S , Burgess N 1 1 , AllenS , LiuS BAUS ANNUAL MEETING 1 6 1 , Vashisht A , ArmitageJ 1 , Wiseman O 2 1 , SaridoganE , IrvingS 2 2 UCLH 3 Norfolk 3 ,
2 , 66
ePosters: 4 P5-8 P5-7 P5-6 P5-5 P5-4 P5-3 P5-2 P5-1 Chairs: AngelaBirnie&AsedAli Tuesday 26June, Room 12,1030 -1200 Female, Neurological andUrodynamic Urology 1 ePoster Session 5: 1 Mironska E 1 Phillips R 1 Harbias A 1 Martyn-Hemphill C 1 Jenks J 1 Moghul M 1 Rizvi I 1 Fenner V Hospital, Sheffield,United Kingdom pelvic floor Exploring theuseofpatients own fat to stimulate tissue regeneration inthe human urothelial cell cultures? Does chondroitin sulphate play anactive role inbarrierformation by normal Time to re-think urinaryretention inwomen? syndrome The urological assessment ofpatients with postural orthostatic tachycardia idiopathic detrusoroveractivity The clinicalandcost effectiveness ofacupuncture for symptomatic study Percutaneous tibialnerve stimulation inoveractive bladder-Aprospective repair? Is routine Martiusflap interposition required in female urethral diverticula outcomes ofcomplete excision Paraurethral cysts inadultwomen –symptoms, urodynamic findingsand Birch Unitfor Molecular Carcinogenesis, University ofYork, United Kingdom Department ofMaterials Science andEngineering,University of Sheffield,United Kingdom, Pinderfields Hospital, Wakefield, United Kingdom, Manchester Foundation Trust -University HospitalSouthManchester, United Kingdom Kings College Hospital,London, United Kingdom University College Hospitalat Westmoreland Street, London, United Kingdom North Middlesex Hospital,London, United Kingdom Queen ElizabethHospital,Birmingham,United Kingdom University College Hospitalat Westmoreland Street, United Kingdom 1 , SulimanA 1 , Paras J 1 1 , Kocadeg H , SmithN 1 1 , Green L , Olateju A 1 , Roman S 1 , ItamS 1 , AlmallahZ 2 1 1 , Feuer J , Southgate J , Dadswell R 1 , MontagueR 1 , ChappleC 1 , O’Connor E 1 , Pakzad M 1 , Taylor C 1 , BelalM 1 , McDonaldJ 3 2 , MacNeilS 1 , Gunendran T 1 1 , OckrimJ , Pakzad M 1 1 2 Hull &East Yorkshire Hospitals, United Kingdom, 25-27 June 2018 - Liverpool BT Convention Centre 1 1 1 , HamidR 1 , HamidR 1 1 , Greenwell T 1 , OckrimJ BAUS ANNUAL MEETING 1 , Greenwell T 1 2 Royal Hallamshire 1 3 Jack 67
ePosters: 5 P5-11 P5-10 P5-9 P5-14 P5-13 P5-12 P5-15 1 Fenner V 1 Downey A 1 Croghan S 1 Seth J 1 Fenner V 1 Itam S 1 Mackenzie K Foundation Trust, London, United Kingdom London, United Kingdom prostatectomy incontinence A cadaveric pilotstudy ofbulkamid injectionsfor thetreatment ofpost following maleslingsurgery scoring systems demonstrate poorreliability ofpadweight assessments Patient globalimpression ofchange(PGIC)andICIQ−urinaryincontinence measures radical prostatectomy usingurodynamics andpatient reported outcome Detailed characterisation ofsevere incontinence after robotic-assisted Efficacy oftheautologous fascial slingintheneuropathic population transobturator tapes Still safe andsuccessful? Long term results of100consecutive for POP? Autologous rectus fascia pelvicorgan prolapse repair: ameshfree solution incontinence -outcomes ofimplantation urodynamically proven stress urinaryincontinence andmixed urinary Bladder neckartificialurinarysphincter (BN AUS) for recurrent A University College Hospitalat Westmoreland Street, London, United Kingdom Princess Royal SpinalInjuriesUnit,Sheffield,United Kingdom St. Vincent’s HospitalGroup, Dublin,Ireland University College London Hospital,United Kingdom University College Hospitalat Westmoreland Street, London, United Kingdom, University College Hospitalat Westmoreland Street, London, United Kingdom, Newcastle UponTyne HospitalsNHSFoundation Trust, United Kingdom 1 1 1 , Toia B , SethJ 1 1 , Kocadeg H , O’Connor E 1 1 , Reid S , MacCraith E 1 , Davis J 1 1 , Ecclestone H , SolomonE 1 1 , Harding C 1 1 , SolomonE , BenamerD 1 , Costigan G,NiallO 2 , Pakzad M 1 , Pakzad M 1 , AningJ 2 1 , OckrimJ , O’Connor E 1 , HamidR 1 , HamidR 1 1 , Lennon G 25-27 June 2018 - Liverpool BT Convention Centre 1 , Greenwell T 1 1 , AndrichD , Greenwell T 1 , Greenwell T 1 1 1 , OckrimJ 1 , OckrimJ 1 BAUS ANNUAL MEETING , OckrimJ 2 2 Guy’s andSt Thomas’ NHS St Guy’s andThomas’ Hospital, 1 , Greenwell T 1 1 1 , Mundy 68
ePosters: 5 P6-4 P6-3 P6-2 P6-1 Chairs: AlanPartin &Prasanna Sooriakumaran Tuesday 26June, 1400-1545Room 4 Prostate Cancer ePoster Session 6: P6-5 A Kingdom, General Hospital,Canada, Allen C Health Sciences Centre, Canada, Freeman A Germany, Italy, A 12 1 Kasivisvanathan V 1 Miah S 1 Shah J 4 1 Pchejetski D 1 Papaevangelou E London NHSFoundation Trust, United Kingdom, Helsinki University Hospital,Finland, University ofEast Anglia,Norwich,United Kingdom, Presbyterian Hospital,USA, Jordan Pharmacology andBiomedicalSciences, Faculty ofPharmacy andMedicalSciences, Petra University, Amman, Hospitals NHSFoundation Trust, United Kingdom, targeted biopsies evaluation showing low diagnostic yieldofsignificantcancer innon- Image fusiontargeted prostate biopsy in740 menat risk:amulticentre An innovative prostate cancer screening clinicinthecommunity conformations White bloodcells from prostate cancer patients carrydistinct chromosome model ofprostate cancer An intratumoural cytotopic immunotherapy approach inasyngeneic murine sampling usingimage-guidance ornot?(NCT02380027) The PRECISIONstudy: Prostate evaluation for clinicallyimportantdisease, Sinclair A Clinic, Rochester, MN,USA, London, United Kingdom, F Moore C University College London andUniversity College HospitalLondon, United Kingdom, Charing Cross Hospital,London, United Kingdom, Burton HospitalsNHSFoundation Trust, Burton UponTrent, Staffordshire, United Kingdom Charing Cross Hospital,ImperialCollege Healthcare NHSTrust, London, United Kingdom, King’s College London, United Kingdom Department ofSurgery andCancer, ImperialCollege London, London, United Kingdom, University ofChicago, USA, 15 23 7 , BudäusL , Villeirs G , HuJ 8 Martini Klinik,Germany, 1 1 , MinnsS , Eldred-Evans D 4 , AhmedH 1 23 24 18 3 University HospitalBern,Switzerland, Hospices Civilsde Lyon, Centre Hospitalier Lyon Sud,France, , Margolis D , Burke D 1 , MorrisS 2 16 8 , ShahT , Hellawell G , Virdi J 1 1 , Smolarek D 2 1 , Rannikko A 3 , Bhardwa J 1 17 1,4 , Punwani S 24 , Boxler S 4 16 , Alshaker H University College London Hospital,United Kingdom , Crouzet S Ghent University Hospital,Belgium, 6 2 25 University ofOuluandUniversity Hospital,Finland, , ShahT 13 Hospices Civilsde Lyon oftheHôpitalEdouard Herriot, France, 9 9 Whittington HealthNHSTrust, United Kingdom, London NorthWest Healthcare NHSTrust, United Kingdom, , Hindley R 27 New York University LangoneMedicalCentre, USA, 1 , ElhageO 3 18 2 3 Centro deUrologia CDU, Argentina, , Borghi M 1 , Karim O 1 , Robert G , Hosking-JervisF , Williams N 25 5 , Ramadass A , KlotzL 10 , Roobol M 1 , SmithR 21 3 19 3 , Montgomery B Radboud UMC,theNetherlands, 19 11 , Panebianco V 2 Bordeaux Pellegrin University Hospital,France, Imperial College, London, United Kingdom, Erasmus University MedicalCenter, theNetherlands, 26 , SinghP 30 3 25-27 June 2018 - Liverpool BT Convention Centre , Taneja S Oxford BioDynamicsLimited, United Kingdom, , Brew-Graves C 3 11 , Hunter E , Eggener S 1 2 , DasguptaP , LaniadoM 20 17 , Venderink W 27 Princess Alexandra HospitalNHSTrust, United , Pinto P 4 3 , MynderseL , BottS 3 , Akoulitchev A 12 24 30 , GheiM 4 3 BAUS ANNUAL MEETING Weill Cornell MedicineNew York- Sapienza University, Italy, , Hindley R , Takwoingi Y 1 , Galustian C 28 , GillI 3 14 , BarberN CHU Lille, France, 21 , HadaschikB 13 22 29 5 , Villers A University HospitalEssen, , Vaarala M 7 , AllenC 2 San Raffaele Hospital, 28 Helsinki University and 3 National Institute , DohertyA 3 5 , Winkler M Department of 2 1 31 School ofMedicine, 3 10 , Emberton M , Winkler M Hampshire 26 Sunnybrook 3 1 14 , GigantiF Nuada Medical, , Bladou 22 6 15 20 , Briganti , Ruffion Jewish Royal Free 5 Mayo 3 1,4 , 1 , 1 1 , , 69
ePosters: 6 P6-12 P6-11 P6-10 P6-9 P6-8 P6-7 P6-6 Dudderidge T Birmingham, United Kingdom United Kingdom, Verrill C Popert R 1 Leslie T 1 Hanna M 1 Chahal R 5 1 Thurtle D 1 Kum F 1 Donato P 1 D Galvin for Health,Bethesda,USA, Kumar M Kingdom, USA, Department ofSurgery, Chicago, United States ofAmerica, the feasibility study prostatectomy (PART) inintermediate riskprostate cancer –initialdata from A phaseIIIstudy comparing partialprostate ablation versus radical HIFU ablation over 8years A singlecentre experience intreating localisedprostate cancer withfocal undergoing robotic prostatectomy: acontemporary UKbasedcalculator Predicting riskfor pathological stage andprognostic grade inpatients survival innewly diagnosedprimarynon-metastatic prostate cancer PREDICT: prostate –anovel individualisedprognostic modelthat estimates setting: How doesthiscompare to conventional biopsy methods? Outcomes oflocalanaesthetic transperineal biopsiesintheoutpatient whole glandhistology compared to multiparametric MRI in primarytumourassessment: improved detection ofmultifocal diseaseon Role prostate-specific of68Ga membrane antigen-targeted PET/CT imaging diagnosed at biopsy withgleason6 The 4Kscore predicts adverse pathology at radical prostatectomy inmen Cambridge, United Kingdom, Kingdom Kingdom, Medicine, Brisbane, Australia London, United Kingdom Oxford University HospitalsNHSFoundation Trust, United Kingdom, Basingstoke andNorthHampshire Hospital,United Kingdom, Bradford Teaching HospitalsFoundation Trust, United Kingdom, Cambridge University HospitalsNHSFT, United Kingdom, Guy’s andSt. Thomas’ Hospitals,London, United Kingdom, Royal BrisbaneandWomen’s Hospital,Queensland,Australia, University ClinicEppendorf, Martini-KlinikProstate Cancer Centre, Hamburg, Germany, Department ofUrology, Singapore General Hospital, 30 University College London Surgical andInterventional Trials Unit,United Kingdom, 1 , MaliyilJ 1 2 , ElliottD , Fitzpatrick R 3 3 4 1 1 6 1 , Johnston M NUTHFT, Newcastle, United Kingdom, National Cancer Registry andAnalysis Service, HealthEngland,Fulbourn,United Public Kingdom, , HaeseA 1 , SinghR 1,2 , Faisal M , Roberts M , Greenberg D 5 , Hindley R 6 WUTH, Wirral, United Kingdom, 2 , Kulkarni M 3 , Davies L 1 , Addla S 1 7 , HouD 1,2 1 , Thorman H 2 , Coughlin G 29 , GleesonF University SouthernCalifornia Institute ofUrology, Keck SchoolofMedicine, 4 3 6 , HuangH Centre for Cancer GeneticEpidemiology, University ofCambridge, United , Sooriakumaran P 2 , Eggener S 1 2 , Yates D , BurnsR 1 , Faure-Walker N 2 1 1 , Rosario D , BottS , DunglisonN 5 , Lee L 2 2 , HeerR , Le Conte S 2 4 2 RLBUHT, Liverpool, United Kingdom, 5 7 , Emara A , Pharoah P University ofBradford, United Kingdom 7 , AhmedH 25-27 June 2018 - Liverpool BT Convention Centre 3 1 4 , ElhageO , Conford P , Catto J 1 , EslerR 2 Academic Urology Group, University of 2 2 3 , Thomson C King’s College London SchoolofMedicine, Mater andSt Vincent’s Hospitals,Dublin,Ireland 2 1 2 , Hindley R Frimley Park Hospital,Camberley, United The University ofQueensland,Faculty of 3 4 2 8 , Gnanapragasam V Sheffield TeachingHospitals,United , Bryant R , Donovan J 1,2 1 4 , Yaxley J , Challacombe B , Weston R 2 Nuffield Department ofSurgical BAUS ANNUAL MEETING 2 1 , Gray R 2 , LambA 1,2 3 , HamdyF 4 , RamaniV 2 , Wolstenholme J 1,2 2 5 University ofChicago, CNFT, Manchester, 1,2 , Cathcart P 2 , Brewster S 31 University of 2 5 , LauM 1 , 1 5 , , 2 , 70
ePosters: 6 P6-15 P6-14 P6-13 P6-19 P6-18 P6-17 Hospitals NHSFoundation Trust, London, United Kingdom, C London Hospital,United Kingdom, of Bristol, United Kingdom, United Kingdom, 4 1 Sujenthiran A 5 Sciences, University ofOxford, United Kingdom, 1 1 Panayi Z 1 Moschonas D 1 Cahill D1,KimL 1 Ashton R 7 Langley R United Kingdom, Aggarwal A Tropical Medicine, United Kingdom, London, United Kingdom, Kockelbergh R Cancer Centre, Glasgow, United Kingdom, cardiovascular status inmenafter robotic-assisted radical prostatectomy Prospective pilotstudy ofpatient-reported fatigue, physical activityand agonists inadvanced prostate cancer of transdermal oestradiol versus luteinising hormone-releasing hormone randomised comparison evaluating cardiovascular morbidity andmortality PATCH -Prostate adenocarcinoma: transcutaneous hormones.A population-based study evaluating theimpactoftimingandmodality Toxicity ofradiotherapy following radical prostatectomy: anational selection’ Extended pelviclymphnodedissection: Long way to ‘optimal case Retzius-sparing robotic radical prostatectomy for high-riskprostate cancer robotically assisted radical prostatectomy Association between maximalurethral lengthandcontinence following Kingdom, Department ofUrology, United Kingdom, Foundation Trust, Basingstoke, United Kingdom, Newcastle UponTyne, United Kingdom MRC ClinicalTrials UnitAt UCL,London, United Kingdom, Clinical Effectiveness Unit, Royal College ofSurgeons, London, United Kingdom, Wirral University Teaching Hospital,Liverpool, United Kingdom The Royal Surrey County Hospital,Guildford, United Kingdom The Royal MarsdenHospital,London, United Kingdom Northumbria University, Newcastle UponTyne, United Kingdom, University HospitalsofLeicester, United Kingdom, University HospitalSouthampton NHSFoundation Trust, United Kingdom, National HeartandLungInstitute, ImperialCollege London, United Kingdom, 1 , Parmar M 11 1 , JonesR,Riley G,Kumar M,Nambirajan T 1 Frimley HealthNHSFoundation Trust, Wexham Park Hospital,United Kingdom, , Tew G 1 , DuongT 3 1 , GilbertD 1 1 , Kusuma M , Parry M 7 10 8 , GodslandI 1 Department ofSurgery &Cancer, ImperialCollege London, United Kingdom , Patel A Scunthorpe General Hospital, NorthLincolnshire andGoole NHSTrust, Scunthorpe, United 1 , Saxton J 1 , Clarke N 9 Mid-Yorkshire HospitalsNHSTrust, PinderfieldsGeneral Hospital, Wakefield, 1 1 , Nossiter J 4 , AbelP 1 Department ofOncology &Metabolism,University ofSheffield,United Kingdom, , JalladS 1 , Pavlakis P 10 1 , AningJ , Sundaram S 5 2 Salford Royal NHSFoundation Trust, Manchester, United Kingdom 3 , Kynaston H Guy’s &St Thomas’ Hospital,London, United Kingdom, 1 , Taghavi AzarSharabiani M 1 , Cathcart P 3 Cardiff SchoolofMedicine, Cardiff University, United Kingdom, 6 2 The Institute ofCancer Research, London, United Kingdom, 1 , Eden C 3 9 7 Population HealthSciences, Bristol MedicalSchool,University University College London HospitalNHSFoundation Trust, , DixitS 8 3 Division ofDiabetes EndocrinologyandMetabolism, , Rosen S 25-27 June 2018 - Liverpool BT Convention Centre 1 3 , Payne H 10 2 13 Christie HospitalsNHSFoundation Trust, , LaniadoM Imperial College London, London, United Kingdom 4 , Alhasso A 2 Department ofUrology, Freeman Hospital, 4 , van derMeulenJ 1 , KinsellaN 11 BAUS ANNUAL MEETING , Pope A 6 Hampshire HospitalsNHS 5 , Nankivell M 5 The Beatson West ofScotland 2 London SchoolofHygiene & 12 1 , Tyson C , ApDaffyd D 2 , Clarke N 12 The Hillingdon 4 1 University College , Dearnaley D 1 , Goldstein 5 , 1 6 , 71
ePosters: 6 P6-20 1 Thompson J Wilkinson K focused ultrasound asprimarytreatment oflocalized prostate cancer initial diagnosisinmenwhoexperience recurrence following highintensity High rate ofadverse features at salvage radical prostatectomy compared to University College London Hospital,United Kingdom, 1 , BriggsT 1 , SridharA 1 , Nathan S 1,2 , Tan W 2 1 , Sooriakumaran P , Mazzon G 1 , Khetrapal P 25-27 June 2018 - Liverpool BT Convention Centre 2 University College London, United Kingdom 1 , Kelly J 2 , Shaw G 1,2 BAUS ANNUAL MEETING 1 , RajanP 1 , MohammadA 1 ,
72
ePosters: 6 P7-8 P7-7 P7-6 P7-5 P7-4 P7-3 P7-2 P7-1 Chairs: David Thomas &Andrew Moon Tuesday 26June, 1400-1500, Room 12 General Urology 1 ePoster Session 7:
P Zimmermann E 1 Ivaz S 1 1 Georgiades F 1 Yang B 1 Khoo C 1 Stewart H 1 Trail M 1 Morton S Microbiology andVirology, Western General Hospital,Edinburgh, United Kingdom ‘infection’? Results ofaprospective clinicalstudy Is itsafe to carryoutflexible cystoscopy whenurinarydipstick ispositive for scrotal exploration A multicentre prospective study evaluating theoutcomes from emergency testicular torsion Centralisation ofpaediatric services: assessing impactinsuspected strongly withsurgical treatment andoutcome Pelvic fracture urethral injury–thenature ofthecausative injurycorrelates trauma centre The contemporary managementoftraumatic renal injuryat aUKmajor Uromune® inmenwithrecurrent urinary tract infections The first experience intheUnited Kingdomofusingthenovel treatment major urological surgery What isabnormal?theutilityofc-reactive protein asamarker ofsepsispost extensive radiological investigation oftheupperurinarytract A clearhistory oflower urinarytract haematuria doesnotalways require University College London Hospitals,NHSFoundation Trust, London, United Kingdom St Mary’s Hospital,ImperialCollege Healthcare NHSTrust, London, United Kingdom Alexandra Hospital,Redditch, United Kingdom Urology at Royal Berkshire Hospital,Reading, United Kingdom Charing Cross Hospital,London, United Kingdom, East Lancashire HospitalsNHSTrust, Blackburn,United Kingdom Department ofUrology, Western General Hospital,Edinburgh, United Kingdom, Freeman Hospital, Newcastle, United Kingdom 1 1 , BugejaS 1 1 , CullenJM 1 , Foley S , Crawford R 1 , Fitzpatrick J 1 , AbedO 1 , Aldiwani M 1 , Cichosz R 1 1 , Charlesworth P , Frost A 1 , DickL 1 , Wemyss-Holden G 1 , CartwrightR 1 , HaqK 1 , Dragova M 1 , Fulton E 1 , OmarI 1 , Rajjayabun P 1 , Lee T 1 1 2 , Angel-Scott H , RashidT 1 , MacGregor E 1 1 , AndrichD , LukA 1 , Srirangam S 1 2 Imperial College London, United Kingdom 25-27 June 2018 - Liverpool BT Convention Centre 1 1 , MacKenzie K 1 , MundyA 1 1 , Clayton F , Vale J 1 1 , Mayer E 1 1 , O’Hare T 1 , Kalima P BAUS ANNUAL MEETING 1 2 Department ofMedical 1 , Tahira A 2 , Donat R 1 , Harding C 1 , Mariappan 1 73
ePosters: 7 P7-10 P7-9 1 Mosli-lynch C 1 Petrides N Device to remotely monitor catheter output:results ofapilottrial Can avirtualstone clinicimprove patient care at areduced cost? University College London Hospitals,United Kingdom, Kent andCanterbury Hospital,United Kingdom 1 , Kheirandish P 1 , Barton-Grimley D 1 , Papadopoulos G 2 , Vismer M 2 1 , Shrotri N 25-27 June 2018 - Liverpool BT Convention Centre 2 OpSense MedicalDevices, London, United Kingdom 1 , KrishnanR BAUS ANNUAL MEETING 1
74
ePosters: 7 P8-7 P8-6 P8-5 P8-4 P8-3 P8-2 P8-1 Chairs: MarkSpeakman&NickCampain Wednesday 27 June, 1100-1200, Room 4 General Urology 2 ePoster Session 8: Hospital, Cambridge, United Kingdom R 1 Barber N 1 Rintoul-hoad S 1 Blach O 1 Johnstone C 1 Fadel M 1 Johnston M 1 Khan F & Cancer, ImperialCollege London, London, United Kingdom severe LUTS in menwithBPH aquablation vs. TURPwith blindedoutcome assessment for moderate-to- The WATER study clinicalresults –aphaseIIIblinded randomized trialof operation for menof75 years andover Age isbutanumber:greenlight laserprostatectomy isasafe day surgery Prospective review ofthefirst 100cases Day caseTURPinastand-alone unitwithnobeds-isthisfeasible? Prostatic arterial embolisation: outcomes at aUKtertiary referral centre prostatic hyperplasia symptoms andcatheter-dependent urinaryretention inpatients withbenign Prostatic artery embolisation for thetreatment oflower urinarytract results from theUnited Kingdom Rezūm water vapour thermaltherapy for benign prostatic hyperplasia: early single centre patient outcome data for 13250-watt HoLEPsinprostates >75cc from a Can alow power holmiumlaserenucleate large prostates? operative and Frimley Park Hospital,Surrey, United Kingdom, KIng’s College Hospital,London, United Kingdom Worthing Hospital,United Kingdom Aintree University Teaching Hospital,Liverpool, United Kingdom St George’s NHSFoundation Trust, London, United Kingdom Department ofUrology, Basingstoke andNorthHampshire Hospital,United Kingdom, Luton &Dunstable NHSFoundation Trust, United Kingdom, 1 1 , SaleemiA 1 1 , Teixeira H , DasR 1 , Thomas A 1 , GehringT 1 , Kumar P 1 1 , GionaS , Katmawi-Sabbagh S 1 , Barrass B 1 , Peacock J 2 , AhoT 1 1 , Ravi R , Montgomery J 1 , KhanA 3 , WATER study group 1 , Taneja S 1 1 , Lucky M , Woodhams S 1 , Brown C 1 1 1 , Rajkumar G , MohammedA 1 2 , Baird A Princess ofWales Hospital,Brigend,Wales, 1 , Catterwell R 25-27 June 2018 - Liverpool BT Convention Centre 1 1 2 Norwich MedicalSchool,United Kingdom 1 , Emara A 1 , AlamA 1 , MuirG 1 , NedasT BAUS ANNUAL MEETING 1 , Nunney I 1 1 , AhmedH 2 Department ofSurgery 2 3 Addenbrooke’s 2 , Hindley 75
ePosters: 8 P8-11 P8-10 P8-9 P8-8 1 Waters D 1 Mosli-lynch C 1 Popriglia F 1 Connell R risk patients Greenlight XPSLaser photoselective vapourization ofprostate (PVP) inhigh Pilot trialofadevice to remotely monitor andasses voiding treatment device (TIND) implantation for theBPHrelated bladderoutletobstruction 3 years follow upresults ofMediTate® temporary implantablenitinol catheterisation Chronic urinaryretention intheelderly:outcomes for surgery vs longterm Hermitage MedicalClinic,Dublin,Ireland University College London Hospital,United Kingdom, San LuigiHospital,Orbassano -Turin, Italy Royal Hampshire County Hospital,Winchester, United Kingdom 1 , KhalidR 1 , Voss J 1 , Amparore D 1 , Barton-Grimley D 1 , Ramanayake J 1 , Omeire F 1 , Bertolo R 1 , JonesB 2 , Vismer M 1 1 , Checcucci E 1 2 25-27 June 2018 - Liverpool BT Convention Centre 2 OpSense MedicalDevices, London, United Kingdom 1 , FioriC 1 BAUS ANNUAL MEETING
76
ePosters: 8 P9-7 P9-2 P9-1 Chairs: David Nicol &Archie Fernando Wednesday 27 June, 1200-1330, Room 4 Renal Cancer andTestis Cancer ePoster Session 9: P9-5 P9-4 P9-3 P9-6 Kingdom, University Hospital,United Kingdom, practice F 1 Neves J 1 Zang W 1 Ward K 1 Phan Y 1 Mains E Quddus B 1 Johnston T dissection inacentralised singlesurgeon post-chemothe A comparison ofrobotic andopenretroperitoneal lymphnode 1 Hospitals, United Kingdom, cT1a renal cell carcinoma Staging CTchest isnotrequired inthediagnostic evaluation ofpatients with multi-centre study Outcomes oftestes-sparing surgery for thetreatment oftesticular masses: a abnormal testicular ultrasound Benign testicular tumourinnon-palpablescrotal lesionsinpatients with study surveillance: observations from Tayside active surveillance cohort (TASC) Change innephrometry scoring insmallrenal masses (<4cm)onactive following surgical resection recurrence innon-metastatic clearcell renal cell carcinoma (ccRCC) 9p chromosomal deletiononarray-based copy numberanalysis predicts tertiary centre Active surveillance ofsporadic renal masses: experience from asingle Viney R University College London, United Kingdom, Ninewells Hospital,Dundee, United Kingdom Ninewells Hospital,Dundee, United Kingdom Hereford County Hospital,United Kingdom, NHS Lothian University Hospitals,Edinburgh, United Kingdom Addenbrooke’s Hospital,Cambridge, United Kingdom University HospitalsBirminghamNHSFoundation Trust, United Kingdom, 2 , Aitchison M 1,2 1 1 1 , Almekaty K 1,2 1 , Trail M , Loh A , Paterson C 3 University College London HospitalsNHSFoundation Trust, United Kingdom , Parker J 1 , El-Mokadem I 1 , Lee E 2 , Bex A 2,3 1 , PhippsS , Rosli M 1 2 , Coret M , Tanabalan C 2 1 , LangS , Kelly B 2 , Barod R 3 Guy’s andSt Thomas’ NHSFoundation Trust, London, United Kingdom 1 2 , FlemingS 1 , Anankumar A , McNeillA 1 , Adshead J 1 1 , Szewczyk-Bieda M , BhandariC 4 Worcestershire Royal Hospital,United Kingdom 2 2 , Tran M , Walkden M 1 1 , Pratt N , Leung S 2 Royal Shrewsbury Hospital,United Kingdom, 2 Royal Free London NHSFoundation Trust, London, United 1 , BaldwinP 1,2 2,4 2 , Patel K , Lynn N 25-27 June 2018 - Liverpool BT Convention Centre 1 2,3 , NabiG 1 , Laird A , Grant L 1 , NabiG 1 2 , Patel P 1 , Klatte T 1 1 2 , Ramachandran N 1 1 , Garaffa G 1 , RiddickA 2 BAUS ANNUAL MEETING University College London 2 , ShabbirM 1 , Thomas B 3 , Patki P rapy surgical 3 Royal Stoke 3 , MinhasS 1 2 , Mumtaz 2 , 77
ePosters: 9 P9-15 P9-14 P9-13 P9-12 P9-11 P9-10 P9-9 P9-8 Hospitals, Addenbrookes Hospital,United Kingdom, Netherlands, Kingdom, Tran M1 1 1 Warren H 1 Norton S 1 Rintoul-hoad S 1 Segaran S 1 De LuykN 1 Abushamma F 1 Hughes-Hallett A Patki P Kidney Cancer, Royal Free Hospital,London, United Kingdom, oncological outcome &long-term survival tumours invading therightatrium &peri-diaphragmatic inferior vena cava: Simultaneous cardiac andrenal surgery for renal and retroperitoneal laparoscopic nephrectomies withinaregional centre Outcomes inanoctogenarian cohort -aretrospective analysis of15years of volume Optimal surgical treatment ofT1renal tumours correlates withnephrectomy and oncological outcomes Nephron sparingsurgery (NSS) insinglekidneys: perioperative, functional Retroperitoneal robotic partialnephrectomy for T1bandlarger tumours renal tumours:aselection rather thanalearningcurve The continuous evolution ofrobotic assisted partialnephrectomy incomplex neoadjuvant chemotherapy (NAC) from preoperative data? Can we selectpatients withuppertract Urothelial Carcinoma suitablefor approach improved initialperioperative outcomes over aconventional laparoscopic Introduction ofrobot assisted nephro-ureterectomy: The potential for Challacombe B Urology Centre, Guy’s andSt Thomas’ NHSFoundation Trust Hospital,London, United Kingdom Guy’s &St Thomas’ NHSFoundation Trust, London, United Kingdom University HospitalGeelong,Australia UCL DivisionofSurgery andInterventional Science, London, United Kingdom, Frimley Park Hospital,United Kingdom Guy’s AndSt Thomas’ HospitalNHSFoundation Trust, London, United Kingdom North Bristol NHSTrust, United Kingdom Specialist Centre for Kidney Cancer, Royal Free London NHSFoundation Trust, United Kingdom 2 ,2 , MumtazF , AbenK 8 1 Guy’s HospitalandKing’s College London, United Kingdom , MurugappanS 1 , Fernando A 1 1 , Hussain M , Marconi L 4 Netherlands Cancer Institute, Netherlands, 1 , Catto J, Kockelbergh R,JohnsonM,BirtleA,JonesFowler S,Keeley F 1 1 , Fernando A 3 1 , Neves J , Webster G 2 , Barod R 1 1 , BarberN , NamdarianB 1 , Austin C 1 , HongM 1 , Fowler S 1 2 , NairR , Aitchison M 1 , Al-Akraa M 1 1 , Thomas K 1 , GrillsR 1 1 , Challacombe B 5 , Lo W , Sullivan M 2 1 , MumtazF , Bex A 1 1 , RajangamA 1 7 , Chowdhury S 25-27 June 2018 - Liverpool BT Convention Centre Oxford University Hospitals, Churchill Hospital,United 5 7 BAUS, United Kingdom, , Stewart G 2,4 1 3 , O’BrienT Netherlands Comprehensive Cancer Centre, 1 , Tran M 1 , Catterwell R 1 , O’BrienT 6 , Challacombe B 1 , Patki P BAUS ANNUAL MEETING 1 2 Specialist Centre for 6 1 1 Cambridge University , Aitchison M 1 , Fernando A 8 , Mahrous A 1 , Barod R 1 , 2 , 1 78
ePosters: 9 P9-16 Qureshi K 1 Hendry J cytoreductive nephrectomy inmetastatic renal cell carcinoma Investigation oftheIMDCprognostic modelasapredictor ofoutcome from United Kingdom, NHS Lothian University Hospitals,Edinburgh, United Kingdom, 2 2 , BehI , Aboumarzouk O 3 Cork University Hospital,Ireland, 1 , ClementK 2 2 , OadesG , Leung S 1 , McNeillA 2 , Laird A 4 Addenbrooke’s Hospital,Cambridge, United Kingdom 25-27 June 2018 - Liverpool BT Convention Centre 1 1 , O’Connor K 2 Queen ElizabethUniversity Hospital,Glasgow, 3 , RiddickA BAUS ANNUAL MEETING 4 , Stewart G 4 , 79
ePosters: 9 P10-6 P10-5 P10-4 P10-3 P10-2 P10-1 Chairs: ShahzadShah&NeilHarris Wednesday 27 June, 1100-1230, Room 12 Female, Neurological andUrodynamic Urology 2 ePoster Session 10: P10-9 P10-8 P10-7 1 Itam S 1 Seth J 1 Seth J 1 Mosli-lynch C 1 Dooher M 1 Chan K 1 Luton O 1 Kocadag H 1 Barratt R Pakzad M urethral diverticulum excision Lower urinarytract symptoms andurodynamic findingsbefore andafter Outcomes ofbladderneckclosure for intractable stress urinaryincontinence centralised centre: analysis ofsurgical management2016-2018 Management ofurological complications ofmidurethral tapewithina Mid-urethral tapeprocedures; 10-year experience ofinsertionandremoval bladder inanticoagulated patients –isitsafe? Intravesical botulinumtoxin-A injectionfor thetreatment ofoveractive dysfunction infemales: atertiary centre experience OnabotulinumtoxinA injectionto theexternal urethral sphincter for voiding The outcomes of urethrovaginal fistula repair Increasing vaginal repair ofvesicovaginal fistulae doesnotaffect outcome of themost challenginggroup ofdiverticula Circumferential anddorsalurethral diverticula: acontemporary experience University College Hospitalat Westmoreland Street, London, United Kingdom University College London Hospital,United Kingdom, UCLH, London, United Kingdom University College London Hospitals,United Kingdom Western General Hospital,Edinburgh, United Kingdom, Eastbourne District General Hospital,United Kingdom Morriston Hospital,Swansea, United Kingdom University College London Hospital,United Kingdom Whipps Cross Hospital,London, United Kingdom, 1 1 1 , ItamS , Pakzad M , Barratt R 1 , Kadhim H 1 , SmithH 1 1 , Kotes S 1 , SaidanD 1 , Trimboli M 1 , Pakzad M 1 , Pakzad M 1 1 , Pakzad M 1 , HamidR , LindlyA 2 1 , Whitling P , Pakzad M 2 , Guerrero K 1 , SethJ 1 , HamidR 1 , HamidR 1 1 , KneenA , OckrimJ 1 , HamidR 2 , HamidR 1 , RuddI 1 , O’Connor E 2 , Granitsiotis P 1 , OckrimJ 1 , OckrimJ 1 , Younis A 1 1 , Greenwell T 1 , OckrimJ , Moore J 2 , OckrimJ 2 University College London Hospital,United Kingdom 1 , ItamS 25-27 June 2018 - Liverpool BT Convention Centre 1 , Greenwell T 1 2 , Greenwell T University College London Hospital,United Kingdom, 2 1 Queen ElizabethHospital,Glasgow, United Kingdom 1 1 1 , ShahJ 2 1 , Greenwell T 1 , HamidR 1 , Greenwell T 1 1 1 , OckrimJ BAUS ANNUAL MEETING 2 1 1 , Greenwell T 1 , 80
ePosters: 10 P10-15 P10-14 P10-13 P10-12 P10-11 P10-10 1 Mankaryous G 1 Kocadag H 1 Downey A 1 Kocadag H 1 Kocadag H 1 Fernando A Foundation Trust, London, United Kingdom, London, United Kingdom, cystectomy benign aetiologyandsubsequentrequirement for remnant bladder The incidence ofpyocystis following ilealconduit urinarydiversion for derived tissue matrix Strattice™ avalid concern? Is obstruction ofilealconduit after parastomal hernia repair withporcine interstitial cystitis Outcomes ofsurgery for treatment refractory bladderpainsyndrome / formation? Appendix orileum–whichisthebest material for mitrofanoff channel The long-term outcome ofmitrofanoff inadults fibrosis (RPF)managed inaSpecialist RPF Centre ureterolysis inpatients withureteric obstruction from retroperitoneal laparoscopic ureterolysis including acomparative analysis withopen A prospective study ofthesafety andoutcomes ofrobotic-assisted Whipps Cross Hospital,London, United Kingdom, UCLH, London, United Kingdom Royal Hallamshire Hospital,Sheffield,United Kingdom University College Hospitalat Westmoreland Street, London, United Kingdom, University College Hospitalat Westmoreland Street, London, United Kingdom, Guy’s andSt Thomas’ NHSTrust, London, United KingdomWITHDRAWN 1 , OsmanN 1 1 1 O’Connor E O’Connor E , Kotes S 1 , Challacombe B 2 , Barratt R 1 , Greenwell T, Wood D, OckrimJ 1 , Park J 3 Lister Hospital,Stevenage, United Kingdom 1 1 , MaldeS , MalideS 1 , Pakzad M 1 1 , DeLaRosa A , Mangera A 2 2 , RajaL , RajaL 2 , HamidR 3 Lister HospitalStevenage, United Kingdom 1 , Foley C 1 , Foley C 1 , InmanR 2 University College London Hospital,United Kingdom 1 , O’BrienT 25-27 June 2018 - Liverpool BT Convention Centre 2 , OckrimJ 3 3 , Taylor C , Taylor C 1 , Reid S 1 2 , Greenwell T 2 1 , ChappleC 2 , Wood D , Wood D BAUS ANNUAL MEETING 2 2 Guy’s andSt Thomas’ NHS Guy’s andSt Thomas’ Hospital, 1 , OckrimJ 1 , OckrimJ 1 2
1 , Greenwell T 1 , Greenwell T
1 1 81
ePosters: 10 U9 U8 U7 U6 U5 U4 U3 U2 U1 History ofUrology Unmoderated ePosters: 1 Hodgson D 1 Lee X 1 Connor M 1 Mahesan T 1 Brittain J 1 Chithiramohan A 1 Clement K 1 Grice P 1 Humayun-Zakaria N Imperial College Healthcare NHSTrust, London, United Kingdom John Wickham (1929-2017): acelebration Journal ofUrology (BJU) Francis Seymour Kidd(1878 –1934) –urologist andco-founder ofBritish Mastering stones andbones:HenryJacob Bigelow (1818–1890) Henry HughClutton: ofstones andbones Celsus (c. 25BC–c.50AD) When inRome: thereversal ofcircumcision describedby Aulus Cornelius What isGreek andLatin inurology? dissection The pioneers ofevidence-based radical cystectomy withpelviclymphnode urologists Urologists to thedesertrats –serendipitous skillsoftheworld war II Rising to theoccasion: evolution ofthevacuum erection device Queen Alexandra, Portsmouth, United Kingdom University HospitalLeicester NHSTrust, United Kingdom St. George’s University HospitalsNHSFoundation Trust, London, United Kingdom, Frimley Park Hospital,Surrey, United Kingdom Charing Cross Hospital,London, United Kingdom, Queen ElizabethHospitalBirmingham,United Kingdom Queen ElizabethUniversity Hospital,Glasgow, United Kingdom Leicester General Hospital,United Kingdom University HospitalCoventry &Warwickshire, United Kingdom 1 , Grice P 1 , Lee X 1 , Connor M 1 , BrittainJ 1 1 , MansonR , DrummondL 1 , Menzies-Wilson R 1 1 , Goddard J , Goddard J 1 , Subramonian K 1 , Wharton I 2 2 1 , Bhatt J 1 , AliA 1 1 1 1 1 1 1 2 St George’s Hospital,London, United Kingdom 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 2 Charing Cross Hospital, 82
Unmoderated ePosters 1500-1545 ePoster Presentations: 3minutes perePoster 1410-1500 Paper Presentations: 5minutes perpaper Tuesday 26June, 1330-1630 Room 11A BAUS MeetingofCore Trainees inUrology ePoster PCU-2 ePoster PCU-1 Paper 7 Paper 6 Paper 5 Paper 4 Paper 3 Paper 2 Paper 1 Presentation Service Audit andQIP Whipps Cross HospitalBotox loop audit radiating ourpatients? A closed – are we ‘over-scanning’ andover- assessment ofacute ureteric colic Non-contrast CT-KUB inthe week wait referral pathway Improving theprostate cancer 2 Glasgow andClyde Urology Theatre Lists inGreater Avoidable Factors andDelays to procedures patients undergoing urological and qualityofimplementation in training to improve compliance exercise? Usingsimulation-based Will itever bemore thanatickbox The WHOsurgical safety checklist: operatively: closedloopaudit detection ofbacteriuria pre- procedures through improved day cancellations for urological Minimising thenumberofon-the- sensible ordangerous? ultrasound guidedprostate biopsy: Reducing antibioticsfor Trans rectal Audit Improving Patient Safety Surgical Practice’? AThree Cycle Department Comply with‘Good Do Operative Notes intheUrology Thyroid ShieldUsageinUrology assessing A QualityImprovement Project Radiation Safety Compliance: Title 25-27 June 2018 - Liverpool BT Convention Centre Heather Barnett Adnan Ahmad Danielle Whiting Jade Singh Nisha Pindoria Julian Peacock George Hill Ricky Ellis Eleanor Zimmerman Presenter BAUS ANNUAL MEETING 83
BAUS Meeting of Core Trainees ePoster PCU-11 ePoster PCU-10 ePoster PCU-9 ePoster PCU-8 ePoster PCU-7 ePoster PCU-6 ePoster PCU-5 ePoster PCU-4 ePoster PCU-3 effectively andappropriately? stone unit:Are we diagnosing suspected renal colic inaregional Computed Tomography for radiation inRenal Colic Diagnosis An Audit ofUnnecessary Over- right? Staging TURBT: Are we doingit Bladder Tumour in Trans-Urethral Resection of Audit ofDetrusorMuscleSampling Resection ofBladderTumour undergoing Elective Transurethral Group andSave samplesinpatients need, safety andcost ofroutine Improvement Project into the A Complete Loop Quality Introducing APathway. Day CaseOpticalUrethrotomies, ureteroscopy and prophylactic antibioticusein Pre-operative urinescreening pre-operative urinescreening help? Sepsis post ureteroscopy: does Compliance withBAUS Guidance Biopsy DiagnosisinRenal Masses: Hospital intheSouthofEngland Prostate at aDistrict General Transurethral Resection ofthe The introduction ofday case 25-27 June 2018 - Liverpool BT Convention Centre Tony Tien Nick Simson Tara Sibartie Louise English Sidney Parker Rebecca Hilbert Mei-Ling Henry Kathryn Gillams Sam Folkard BAUS ANNUAL MEETING 84
BAUS Meeting of Core Trainees Seoul, South Korea 당신을 서울로 초대합니다 You’re invited to Seoul
Featuring the SIU-ICUD Joint Consultation on Congenital Lifelong Urology 4th SIU Global Nurses’ Educational Symposium
#SIU2U www.siu-urology.org
8049_SIU2018_BAUS_Prog_Ad_v01.indd 1 26/03/2018 9:15 AM Client: SIU 2018 Docket number: 28-8049 File Size: 100 % Description: SEOUL: CONGRESS Trim Size: 210 mm x 197 mm Publication : BAUS program Ad number : 28-8049-P Type Size: N/A PROOF # 1:1 Date: 2018/06 Bleed Size: 3 mm Operator: H Visible Size: N/A 26 MARCH 2018 9:14 Filename : 8049_SIU2018_BAUS_Prog_Ad_v01 Lase Output @ 100%
COLOURS: C M Y K
SAMDESIGN | T +1 514 953-7227 | E [email protected] BAUS Honorary Secretary Elect Asif Muneer Best wishesandseeyou at themeeting. dedicated theirtimeand expertise inarranging thecourses thisyear. I would like to thankallthecourse directors, faculty, andBAUS staff whohave forms whichwillbedistributed to eachcourse participantsinadvance. can beleftviatheBAUS 2018 Conference Appand/or viaonlinefeedback courses, whichisusedto improve theeducational content eachyear. Feedback As always, we are heavily reliant onyour feedback after attending these Improvement projects. year willfocus ondeveloping astandardised system for trainee-led Quality meeting. We are grateful for BJUIfor runninganothercourse, whichthis retained for anotheryear. Allthree courses willrunontheTuesday ofthe Disease continue, andthePractical Andrology for theGeneral Urologist is The popularcourses Paediatric Urology andModernManagementofStone Curriculum whichwillbehelpfulfor Urology Trainees. course content alignswithandmeetsthecriteria describedintheUrology SAC Finally, there isanew course onthebasicsofResearch Methodology-the overview ofallyou needto know to develop a successful career inurology. senior trainees and recently appointed consultants whichisa‘nutsandbolts’ diagnostics. Inaddition,there isaUrology FinishingSchoolcourse aimed at sure willprove popularwithallthosedelegates undertakingprostate cancer New courses include aSkillsCourse onMRIandTarget Biopsy, whichI’m supervision. they tutor to delegate ratio andallow participantsto benefitfrom expert the SkillsCourse. EachCourse hasalimited numberofspaces to ensure that to bookearlyaswe expect courses willprove to bepopular-inparticular each course willruninparallel to themainmeeting.Delegates are encouraged to delegates at allstages oftheir training andcareer. Asinprevious years This year, theteaching programme hasanumberofcourses whichwillappeal deliver highqualityteaching andreceive thebest delegate feedback. and Skillsportfolio hascontinued to bereduced. This willensure that courses As theannualmeetinghasbeenreduced to a3-day meeting,theTeaching combined withTeaching andSkillscourses for allsubspecialties. BAUS 2018 continues to provide anexcellent BAUS ScientificProgramme teaching from theexperts Focussed, innovative andhigh-quality Teaching andSkillsCourses -Introduction 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 86
Teaching and Skills Courses 7 Methodology 6 5 Wednesday 27 June Tuesday 26June projects: 1 Monday 25June No. Teaching andSkillsCourses -at aGlance 4 3 2 Biopsy ofthe Prostate MR-Imaging andTargeted Skills Course: The BasicsofResearch Teaching Course: Urology FinishingSchool Teaching Course: for trainers *£10 A national workshop quality improvement system for trainee-led Developing astandardised BJU International - Sponsored by Teaching Course: Course Title the General Urologist Practical Andrology for Teaching Course: of UrinaryStone Disease The ModernManagement Teaching Course: Paediatric Urology Teaching Course:
SOLD OUT SOLD OUT SOLD OUT SOLD OUT SOLD OUT
Room 11B/C Room 11A Room 12 Room 12 Location Room 12 Room 13 Room 13 1030-1330 30 1030-1330 30 0830-1030 30 1330-1530 Time 1515-1715 30 1330-1530 30 0900-1200 30 25-27 June 2018 - Liverpool BT Convention Centre Spaces No. of
30
BAUS ANNUAL MEETING £30 £30 £30 required deposit refundable FREE Cost £30 £30 £30 Ahmed Professor Hashim Gnanapragasam Mr Vincent Summerton & MrDuncan Mr AsifMuneer Mr JamesGreen Director Course Mr Rowland Rees Mr AsifMuneer& Mr Daron Smith Peter Cuckow Professor 87
Teaching and Skills Courses at a Glance Ms ZarnieKhadjesari,Lecturer inHealthImplementation, KingsCollege, London London Mr NickSevdalis, Professor ofImplementation Science andPatient Safety, KingsCollege, Ms ElenaPallari, PHDresearcher for theEQUIPproject, KingsCollege, London Mr JamesGreen, BMrJamesGreen, BartsHealthNHSTrust, London Faculty establish QIresources that canbeusedby theirdepartmentandintraining. techniques that canbeusedinQualityImprovement Projects andsignpost trainers to In theshorttimeavailable for thecourse thefaculty willdescribebasictools & How to make aQIproject sustainable basedonbest evidence ‘implementation strategies’ canbeappliedto managechange Strategies to implement changeandovercome barriersto implementation Explainwhat & settingupmechanismsto collect data. Review how best to evaluate aQIproject, baselineandpost-intervention data collection Whether aQIproject actuallymakes adifference designing andcompleting projects (withintheirservice, Trust andnationally). Consider how aQIproject getsprioritisedandunderstand thesuccessful drivers for Why QIprojects succeed orfail! perspective: The course willthenexplore thefollowing areas from atrainer’s and department the SAC, BAUS andTUF supportfor QIinitiative inUrology. Describe thenational EQUIPproject (Education inQuality Improvement Program) and central to theday to day runningofamodernUrology Department. Define QI,provide asnapshotofthecurrent evidence baseonQI,andexplain why QIis and trainees to undertake &embedQualityImprovement (QI) into dailypractice. Course Aim:To develop acadre ofexpert trainers that cansupporttheirdepartments Outline Director: MrJamesGreen Cost: FREE-Sponsored by BJUI*£10refundable depositrequired 30 Places Monday 25June2018 A national workshop for trainers trainee-led Qualityimprovement projects: Developing astandardised system for BJU International Sponsored Course – Teaching Course 1 Room 12 1330 –1530 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 88
Teaching Course Outline 1 Mr Navroop Johal,Great OrmondStreet Hospitalfor Children NHSTrust, London Denmark Mr Yazan Rawashdeh, Consultant Paediatric Urologist, AarhusUniversity Hospital, Mr Divyesh Desai,Great OrmondStreet Hospitalfor Children NHSTrust, London Mr Abraham Cherian,Great OrmondStreet Hospitalfor Children NHSTrust, London Professor Peter Cuckow, Great OrmondStreet Hospitalfor Children NHSTrust, London Faculty better equipped–be itfor forthcoming exams ortheirnext paediatric clinic. We dohope, as usual, to provide a3-hourinteractive feast that willleave delegates and illustrated by appropriate clinicalscenarios. There willalsobedidacticminilectures onkey topics, eachledby apaediatric urologist interested trainees to meet. children withintheBAUS meetingandanopportunityfor established Consultants and outside aspecialist unit.We are grateful that we cancontinue to provide afocus on The aimofthiscourse isto reinforce andsupportthepractice ofpaediatric urology Outline andObjectives Director: Professor Peter Cuckow Cost: £30 30 Places Tuesday 26June2018 Paediatric Urology Teaching Course 2 Room 13 0900 -1200 25-27 June 2018 - Liverpool BT Convention Centre Course Outlines BAUS ANNUAL MEETING 89
Teaching Course Outline 2 Mr Oliver Wiseman, Addenbrooke’s Hospital,Cambridge Mr BenTurney, Churchill Hospital,Oxford Mr Jonathan Glass, Guy’s &St Thomas’ Hospital,London Professor BenChew, University ofBritishColumbia, Vancouver, Canada Mr Daron Smith, University College Hospital,London Faculty encouraged to maximisethelearningopportunitiesfor all. and through round-table discussion ofcasescenarios. Audience participation willbe This willbedelivered through interactive casepresentations from eachofthefaculty, to helpavoid complications andto discuss optionsto dealwiththemwhenthey occur. will beonintra-operative andpost-operative andtricks” decision making,including“tips management willbediscussed inbriefdidacticupdates. The mainfocus ofthecourse The current “best practice” technique for ESWL, FURSandPCNLmedical and preventative therapy. urolithiasis, andguidance for post-operative managementincludingmetabolicscreening To provide insightsinto thecurrent “state intra-operative oftheart” treatment of Objectives Director: MrDaron Smith Cost: £30 30 Places Tuesday 26June2018 Modern ManagementofUrinaryStone Disease Teaching Course 3 Room 13 1330 -1530 25-27 June 2018 - Liverpool BT Convention Centre Course Outlines BAUS ANNUAL MEETING 90
Teaching Course Outline 3 Mr IanEardley, University College London Hospital Mr David Ralph, University College London Hospital Mr Rowland Rees, University HospitalSouthampton Mr AsifMuneer, University College London Hospital Faculty • • • • • • • the course participants shouldhave agoodunderstanding of: The course willfocus onthepractical aspectsrelated to eachcondition. At theendof Objectives will alsobecovered withguidance onlearningthesurgical skills. techniques. Microsurgical techniques usedinthemanagementofmalefactor infertility and sexual dysfunction willbecovered together withanoverview ofspecialisedimaging management ofmenwithpenilecurvature, malefactor infertility, erectile dysfunction andrology conditions encountered withinageneral urology practice. Assessment and tips onhow to setupanddeliver anandrology service. Itwillfocus onthecommonest trainee andconsultant urologists withaninterest inandrology. The course includes diagnosing andmanaginggeneral andrology conditions. The course isaimedat both This course aimsto bothteach andupdate cliniciansonthepractical aspectsof Outline Director: MrAsifMuneer&Rowland Rees Cost: £30 30 Places Tuesday 26June2018 Practical Andrology for theGeneral Urologist Teaching Course 4 Treatment optionsinmenwithsexual dysfunction includingejaculatory disorder ultrasonography andseminalvesiculography asdiagnostic techniques Microsurgical andendoscopic techniques for maleinfertility andtheuseof Doppler imagingandpenileMRInon-surgical treatment options Assessment andsurgical managementofpenilecurvature includingtherole of treatment failures withsurgery Investigation andtreatment oferectile dysfunction andmanagingpharmacological Managing ofurethral strictures Avoiding pitfalls withcommon Andrology procedures How to setupand offer anandrology service Room 12 1515 –1715 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 91
Teaching Course Outline 4 Mr JulianShah,University College London Hospital Mr ArieParnham, Christie Hospital,Manchester Professor JamesCatto, University ofSheffield, Editor European Urology Mr Kieran O’Flynn,Salford Royal Foundation Trust, President BAUS Mr DuncanSummerton, University HospitalsofLeicester, Vice-President BAUS Mr AsifMuneer, University College London Hospital,HonSecretary ElectBAUS Faculty • • Looking aheadasanewly appointed consultant • Combining different roles • • Developing asafe practice • • Settling into your consultant post include: overview ofkey areas whichwillmaintainasafe andsuccessful practice. These areas The course willcover arange oftopics whichinorder to provide delegates withan Objectives successful careers witharange ofleadershiproles. rewarding andtrouble free. The faculty includesconsultants withawealth ofexperience, training years anditisimportantto understand theseareas to make life asaconsultant consultant practice. Anumberofthese areas may notspecificallybe covered withinthe Surgeons withanoverview ofthekey areas pertainingto personaldevelopment and This course provides seniortrainees andrecently appointed Consultant Urological Outline Directors: MrAsifMuneer&DuncanSummerton Cost: £30 30 Places Wednesday 27 June Urology FinishingSchool Teaching Course 5 Impact ofspecialist commissioning andworking innetworks Contributing outsidetheclinicalworkload Developing anacademiccareer withyour clinicalcommitments Avoiding medicolegal pitfalls Dealing withcomplaints, inquests andTrusts Job planning,Appraisal andRevalidation From trainee to trainer -your first 2 years asa consultant Room 12 0830 –1030 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 92
Teaching Course Outline 5 Mr IanPearce, Manchester Royal Infirmary Mr Adam Nelson,Academic ClinicalFellow and SpR,East ofEnglandDeanery Mr Richard Skells, ClinicalTrials Co-ordinator, CambridgeCancer Trials Centre Cambridge Ms AnneGeorge, Research Associate, CRUKCambridge Cancer Centre, University of Hygiene andTropical Medicine Professor JanVan DerMuelen,Professor ofClinicalEpidemiology, London Schoolof Aberdeen Professor Graham MacLennan , Centre for Healthcare RandomisedTrials, University of Mr JonAning,Freeman Hospital. Mr JohnMcGrath, Royal Devon &Exeter NHS Trust Mr Vincent JGnanapragasam, University ofCambridge Faculty Curriculum. The course content alignswithandmeetsthecriteria describedintheUrology SAC • • • • • • • At theendofthiscourse participantsshouldhave agoodunderstanding of: Objectives journals.sagepub.com/page/uro/researchtoolkit participants may have. and knowledge from bothacademicandclinicalbackgrounds to answer any questions present andpublishyour work. The faculty willrepresent awiderange ofexpertise will alsobecovered aswilltipsandideasonhow to optimiseyour findings to help you process andalsootherregulatory aspects.Trial methodologyandtheuseofstatistics funding. Topics willalsoincludehow to navigate themodernIRAS, HRAandethics to undertake audit,participate inclinicaltrials,leadresearch andidentifysources of the basiccomponents required. The course willcover research ideasincluding how The course willexplore thedifferent typesof research whichcanbeundertaken, and The course isintended to teach thebasicsofhow to undertake and perform research. Outline encouraged to have doneGCPtraining priorto enrolling onthecourse. trainees ornew consultants withthe basicsofresearch methodology. Participants are start research aspartoftheirtraining ortheirclinicalwork. The course isgeared to equip This course issuitablefor registrars andappointed consultants lookingto develop or Suitability Director: MrVincent JGnanapragasam Cost: £30 30 Places Wednesday 27 June2018 The BasicsofResearch Methodology Teaching Course 6 The current regulatory framework inclinicaltrials How to ensure your results are publishableandimpactful How to getastudy fundedform localto national How to joinorstart aclinicaltrial Common hurdles andbarriersinclinicalresearch How to planandexecute aresearch project The context ofresearch inthemodernNHS Room 11A 1030 –1330 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 93
Teaching Course Outline 6 c) b) a) 2. MRITargeted Prostate Biopsy g) f) e) d) c) b) a) 1. Multi-parametric MRIoftheprostate Outline • • • • • Objectives urologists to practice contouring theprostate andlesiononMRIultrasound images. urologists how to lookthrough anMRIfor artefacts andlesions. MRIworkstations willallow knowledge ofhow to lookthrough MRIandultrasound anatomy oftheprostate andshow Expert faculty willreview evidence inasuccinct manner, provide attendants withaworking urologists whodealwithmenbeingevaluated withintheprostate diagnostic pathway. This course willprovide acomprehensive andexpert review withhandsontraining for Summary Director: Professor HashimAhmed Cost: £30 30 Places Wednesday 27 June2018 MR-Imaging andTargeted Biopsy oftheProstate Skills Course 7 and treatment conduct andoutcomes Define theimpactofimagingontreatment decisions,monitoring ofactive surveillance vs. transperineal; cognitive versus image-fusion;rigidfusionversus elastic fusion) Have adetailedknowledge ofthedifferent approaches to targeted biopsies(transrectal Undertake contouring oftheMRIandlesionsidentified onMRI reports Deliver astructured review ofareported mpMRIfrom aurologist’s perspective Describe therole ofmulti-parametric MRIinthediagnostic pathway for prostate cancer decisions aswell astreatment conduct (active surveillance, radical, focal) Understand theimpactoftargeted biopsiesonrisk stratification andtreatment Appreciate optimaltargeting techniques withrecorded videosoftechniques fusion andelastic fusion. evidence for transperineal andtransrectal, cognitive and image-fusionaswell asrigid Learn aboutthevarious methodsfor targeting alesionincludingreview ofthe (transrectal andtransperineal) Have aworking knowledge ofanatomical landmarks for theprostate usingultrasound Contour theprostate andlesionswhenpresent for thepurposeoftargeted biopsies Identify lesionsandtheirfeatures onthevarious typesofMRIsequence mpMRI prostate reports Understand aradiology report compliant withnational andinternational guidelinesfor contrast timeframe) biopsy inflammation/bleeding) orerrors in conduct (fieldofview, diffusion acquisition, Spot obvious artefacts oftheMRI(metalimplants,airinrectum, movement, prior on MRI Feel comfortable in reviewing normal anatomical landmarksofthepelvisandprostate Know theguidelinesfor conduct andreporting ofmulti-parametric oftheprostate diagnostic pathway Review theevidence for usingmulti-parametric MRIat various pointsintheprostate Room 11B/C 1030 –1330 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 94
Skills Course Outline 7 Dr ShonitPunwani, UCLHNHSFoundation Trust Dr Tristan Barrett, CambridgeUniversity HospitalsNHSFoundation Trust Mr Christof Kastner, CambridgeUniversity HospitalsNHSFoundation Trust Professor HashimAhmed,ImperialCollege London Faculty e) d) c) b) a) List theindications for transperineal prostate biopsy (primarybiopsy, priornegative This partofthecourse willenabletheattendants to, 3. Transperineal Biopsy with figures andvideoclips. Learn from ‘How sectionswithexpert Idoit’ Faculty describingtheirown techniques targeting biopsy anditsusewithcognitive/visual-estimation targeting andimage-fusion Describe themethodusedfor localanaesthetic, office-based transperineal prostate each method and riskstratification ofprostate cancer as well asadvantages anddisadvantages of Describe thedifferent transperineal mappingbiopsy techniques available for diagnosis transrectal biopsy Define theadvantages anddisadvantages oftransperineal biopsy compared to for focal therapy); biopsy, confirmatory following low riskdiagnosisprior to active surveillance, mapping 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 95
Skills Course Outline 7 MY ENERGY. MY FREEDOM. MY TIME FOR LIFE.
Give your metastatic prostate cancer patients more than just time with ZYTIGA® (abiraterone acetate)
Use ZYTIGA® plus low-dose prednisolone first and early when treating mCRPC and high-risk mHSPC to improve your patients’ survival whilst maintaining their quality of life*, potentially allowing them to enjoy more of life’s moments1–6
Prescribing information and references can be found overleaf. ZYTIGA® is indicated with low-dose prednisone or low-dose prednisolone for:7 • the treatment of metastatic castration resistant prostate cancer (mCRPC) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT) in whom chemotherapy is not yet clinically indicated • The treatment of mCRPC in adult men whose disease has progressed on or after docetaxel chemotherapy regimen • The treatment of newly diagnosed high-risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men, in combination with ADT * Compared to placebo plus low-dose prednisolone in mCRPC and placebo alone in mHSPC.2,3 ZYTIGA® 500mg film-coated tablets PRESCRIBING INFORMATION sugar frequently in patients with diabetes. Use with chemotherapy: ACTIVE INGREDIENT(S): Abiraterone acetate Safety and efficacy of concomitant use of Zytiga with cytotoxic Please refer to Summary of Product Characteristics (SmPC) before chemotherapy not established. Intolerance to excipients: Not to be prescribing. INDICATION(S): Taken with prednisone or prednisolone for taken by patients with galactose intolerance, Lapp lactase deficiency or the treatment of adult men with: - newly diagnosed high risk metastatic glucose-galactose malabsorption. Take sodium content into account for hormone sensitive prostate cancer (mHSPC) in combination with androgen those on controlled sodium diet. Potential risks: Anaemia and sexual deprivation therapy - metastatic castration resistant prostate cancer dysfunction may occur in men with metastatic prostate cancer including (mCRPC) who are asymptomatic or mildly symptomatic after failure those taking Zytiga. Skeletal muscle effects: Cases of myopathy reported. of androgen deprivation therapy in whom chemotherapy is not yet Some patients had rhabdomyolysis with renal failure. Caution is clinically indicated - mCRPC whose disease has progressed on or after a recommended in patients concomitantly treated with drugs known to be docetaxel-based chemotherapy regimen. DOSAGE & ADMINISTRATION: associated with myopathy/rhabdomyolysis. SIDE EFFECTS: Very common: Adults: 1000 mg (two 500mg tablets) single daily dose. Not with food as urinary tract infection, hypokalaemia, hypertension, diarrhoea, increased this increases the systemic exposure (take dose at least two hours after alanine aminotransferase, increased aspartate aminotransferase, peripheral eating; no food for at least one hour post-dose). Swallow whole with water. oedema. Common: sepsis, hypertriglyceridaemia, cardiac failure (including Take with prednisone or prednisolone: for mHSPC, 5mg daily; for mCRPC, congestive heart failure, left ventricular dysfunction and decreased ejection 10 mg daily. Medical castration with LHRH analogue should be continued fraction), angina pectoris, atrial fibrillation, tachycardia, dyspepsia, during treatment in patients not surgically castrated. Children: No relevant rash, haematuria, fractures (includes all fractures, with the exception of use. Hypokalaemia: In patients with pre-existing, or who develop pathological fracture). Other side effects: adrenal insufficiency, myocardial hypokalaemia during treatment with Zytiga, consider maintaining infarction, QT prolongation, other arrhythmias, allergic alveolitis, hepatitis potassium level at ≥4.0 mM. Patients who develop Grade ≥ 3 toxicities fulminant, acute hepatic failure, myopathy, rhabdomyolysis. Refer to (hypertension, hypokalaemia, oedema and other non-mineralocorticoid SmPC for other side effects. FERTILITY/PREGNANCY/LACTATION: toxicities) stop treatment and start appropriate medical management. Not for use in women. Not known whether abiraterone or its metabolites Do not restart Zytiga until symptoms of the toxicity have resolved to Grade are present in semen. A condom is required if the patient is engaged in 1 or baseline. Renal impairment: No dose adjustment, however no sexual activity with a pregnant woman. If the patient is engaged in sexual experience in patients with prostate cancer and severe renal impairment; activity with a woman of childbearing potential, a condom is required along caution advised. Hepatotoxicity: If hepatotoxicity develops (ALT or AST > with another effective contraceptive method. Studies have shown that 5x upper limit of normal - ULN), stop treatment immediately until liver abiraterone affected fertility in male and female rats, but these effects function returns to baseline; restart Zytiga at 500 mg (one tablet) once were fully reversible. INTERACTIONS: Caution with drugs activated by or daily and monitor serum transaminases at least every 2 weeks for metabolised by CYP2D6 particularly when there is a narrow therapeutic 3 months and monthly thereafter (see Special warnings & precautions). index e.g. metoprolol, propranolol, desipramine, venlafaxine, haloperidol, If hepatotoxicity recurs on reduced dose, stop treatment. If severe risperidone, propafenone, flecanide, codeine, oxycodone and tramadol, hepatotoxicity develops (ALT or AST 20xULN), discontinue Zytiga and dose reduction should be considered. Avoid strong inducers of CYP3A4 do not restart. Hepatic impairment: Mild (Child-Pugh class A) - no dose (e.g. phenytoin, carbamazepine, rifampicin, rifabutin, rifapentine, adjustment required. Moderate (Child-Pugh class B) - approximately 4x phenobarbital, St John’s wort). Zytiga is a CYP2C8 inhibitor. Monitor for increased systemic exposure after single oral doses of 1,000 mg. Moderate/ signs of toxicity if combined with drugs with a narrow therapeutic index Severe (Child-Pugh class B or C) – no clinical data for multiple doses. eliminated predominately by CYP2C8. May increase concentrations of Use with caution in moderate impairment, benefit should clearly outweigh drugs eliminated by OATP1B1. Food (see Dosage & Administration). risk. CONTRAINDICATIONS: Pregnancy or potential to be pregnant. Caution with medicines known to prolong QT interval or induce Torsade Hypersensitivity to active substance or any excipients. Severe hepatic de pointes e.g. quinidine, disopyramide, amiodarone, sotalol, dofetilide, impairment (Child-Pugh Class C). SPECIAL WARNINGS & PRECAUTIONS: ibutilide, antiarrhythmic medicinal products, methadone, moxifloxacin and Zytiga may cause hypertension, hypokalaemia and fluid retention due to antipsychotics. Use of Zytiga with spironolactone is not recommended. increased mineralocorticoid levels. Cardiovascular: Caution in patients Refer to SmPC for full details of interactions. LEGAL CATEGORY: POM with history of cardiovascular disease. In patients with a significant risk for congestive heart failure (history of cardiac failure, uncontrolled MARKETING BASIC PRESENTATIONS PACK SIZES AUTHORISATION NHS hypertension, ischaemic heart disease) consider an assessment of cardiac NUMBER(S) COSTS function before treating (echocardiogram). Safety not established in patients with left ventricular ejection fraction < 50% or NYHA Class II to IV Blister pack 56 tablets EU/1/11/714/002 £2735 (pre-chemotherapy) and III or IV (post-chemotherapy) heart failure. Before treatment cardiac failure should be treated and cardiac function MARKETING AUTHORISATION HOLDER: JANSSEN-CILAG optimised. Correct and control hypertension, hypokalaemia and fluid INTERNATIONAL NV, Turnhoutseweg 30, B-2340 Beerse, Belgium. retention pre-treatment. Caution in patients whose medical conditions FURTHER INFORMATION IS AVAILABLE FROM: Janssen-Cilag Limited, might be compromised by hypertension, hypokalaemia or fluid retention 50-100 Holmers Farm Way, High Wycombe, Buckinghamshire, HP12 4EG, UK. e.g. heart failure, severe or unstable angina pectoris, recent myocardial Prescribing information last revised: November 2017 infarction or ventricular arrhythmia, severe renal impairment. Monitor blood pressure, serum potassium and fluid retention and other signs and Adverse events should be reported. Reporting forms and symptoms of congestive heart failure before treatment, then every two information can be found at www.mhra.gov.uk/yellowcard weeks for 3 months, and monthly thereafter. QT prolongation observed in or search for MHRA Yellow Card in the Google Play or patients experiencing hypokalaemia with Zytiga treatment. Consider Apple App Store. Adverse events should also be reported to discontinuation if there is a clinically significant decrease in cardiac Janssen-Cilag Limited on 01494 567447 or at [email protected]. function. Hepatotoxicity & hepatic impairment: Measure serum transaminases pre-treatment and every two weeks for first three months, © Janssen-Cilag Limited 2017 then monthly. If symptoms/signs suggest hepatotoxicity, immediately measure serum transaminases. If ALT or AST > 5x ULN, stop treatment and 1. Fizazi K et al. Lancet Oncol 2012; 13(10): 983–992. monitor liver function. Restart treatment after liver function returns to 2. Fizazi K et al. N Engl J Med 2017; 377(4): 352–360. baseline; use reduced dose (see dosage and administration). No clinical 3. Ryan C et al. Lancet Oncol 2015; 16: 152–160. data in patients with active or symptomatic viral hepatitis. Rare reports of 4. Sternberg C et al. Annals Oncol 2013; 24: 1017–1025. acute liver failure and hepatitis fulminant, some fatal. Corticosteroid 5. Naim AB et al. Presented at the American Society of Clinical Oncology withdrawal: Monitor for adrenocortical insufficiency if prednisone or (ASCO) Annual Meeting 2014, May 30–June 3, Chicago, IL, USA. prednisolone is withdrawn. Monitor for mineralocorticoid excess if Abstract e16102. Zytiga continued after corticosteroids withdrawn. Bone density: 6. Chi KY et al. Presented at European Society for Medical Oncology Decreased bone density may be accentuated by Zytiga plus glucocorticoid. (ESMO) Annual Congress 2017, 8 –12 September, Madrid, Spain. Prior use of ketoconazole: Lower response rates may occur in patients 7. ZYTIGA® Summary of Product Characteristics. November 2017. previously treated with ketoconazole for prostate cancer. Hyperglycaemia: Job number: PHGB/ZYT/1117/0023a Use of glucocorticoids could increase hyperglycaemia, measure blood Date of preparation: January 2018 made by ACC Liverpool. No oneisto return to thebuildinguntilofficialannouncements have been by avenue steward, where they willreceive furtherassistance. Delegates withaccess requirements willbeguidedto the nearest refuge point building whentheemergency isover. This isnecessary sothat we canreadily contact everyone to return to their restaurant nearJury’s Inn(pleaseseeplanbelow). the event organiser’s staff are requested to muster onthepiazzaoutside In theevent ofanevacuation ofACC Liverpool, alldelegates, exhibitors and building. Pleaseleave by thenearest available exit! Donotusethelifts!” “Attention please–Attention please!We have anemergency withinthe In theevent ofanemergency thefollowing announcement willbemade: Emergency Procedures 25-27 June 2018 - Liverpool BT Convention Centre BAUS ANNUAL MEETING 98
Emergency Procedures 70 YEARS OF THE
The British Association of Urological Surgeons 35/43 Lincoln’s Inn Fields, London WC2A 3PE, UK Tel: +44 (0) 20 7869 6950 Fax: +44 (0) 20 7404 5048 Email: [email protected] www.baus.org.uk
Registered Charity No: 1127044 Registered Company No: 06054614 VAT Registration No: 380 5441 59
The British Association of Urological Surgeons www.baus.org.uk